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ABSTRACT 
Introduction 
Chronic, low-grade inflammation is a hallmark of insulin resistance (IR) and underlies 
pancreatic β-cell failure and the development of type 2 diabetes (T2D), a disease 
characterized by a reduction in β-cell functional mass.  However, therapeutics that directly 
protect β-cells from stressors, such as inflammation and oxidative stress, are limited.  Amylin, 
a neuro-hormone, is co-secreted with insulin, therefore hyperinsulinemia often coincides with 
hyper secretion of amylin.  Increased secretion of amylin is associated amyloid deposition 
which have detrimental effects on β-cell function.  In pancreatic islets, β-secretase (BACE) 
modulates the deposition of cytotoxic islet amyloid, an initiator of intra-islet inflammation and 
oxidative stress, making BACE inhibition a therapeutic target.  Insights into mechanisms 
involved in islet inflammation and the associated effect(s) of BACE, may reveal an opportunity 
to develop novel therapeutics to protect and preserve β-cells in T2D.  In addition to their 
antidiabetic properties, aspalathin (Asp), Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic 
acid (PPAG), and an unfermented Rooibos extract (GRT) may have anti-inflammatory effects 
in β-cells and may additionally modulate BACE activity.  
Aim 
To determine if GRT or two of its most bioactive polyphenols have BACE inhibition activity and 
can reduce pro-inflammatory effects in rat insulinoma (INS1) pancreatic β-cells. 
Methods 
A model of moderate inflammation was established in INS1 cells using a cytokine cocktail, 
containing tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interferon-γ (IFN-γ).  Rat 
insulinoma cell viability, function, and oxidative stress was measured in response to the 
cytokine cocktail and exposure to Asp, PPAG, and GRT by quantifying cellular adenosine 
triphosphate (ATP) production, cell death via apoptosis and necrosis, proliferation rate, 
insulin/amylin secretion and content, reactive oxygen species (ROS) production and nitrate 
(NO2-) generation.  Beta secretase inhibition profiling of GRT, Asp, and PPAG was assessed 
using fluorescence resonance energy transfer (FRET) in a purified enzyme assay, followed 
by kinetically assessing BACE activity in vitro.   
Results 
The cytokine cocktail induced a state of moderate inflammation after 24 hours, mainly through 
IL-1β.  High concentrations of Asp (1000 µM) and moreso, GRT (1 mg/ml), showed a trend 
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towards BACE inhibition compared to controls (56.20% ± 2.05, p<0.0001 and 39.80% ± 0.55, 
p<0.0001), but reduced mitochondrial dehydrogenase activity in inflamed INS1 cells (19.02% 
± 2.98, p<0.0001; 36.88% ± 1.53, p<0.0001), while PPAG showed no measurable effect.  
Lower concentrations of Asp (0.1–10 μM), PPAG (0.1–10 μM), and GRT (0.0001-0.01 mg/ml) 
may have a protective effect on inflamed pancreatic β-cells as an increase, albeit not 
significant, in overall cell viability and function was observed, with a concomitant decrease in 
oxidative stress after 24 hours (97.66% ± 3.5, p<0.66; 95.54% ± 5.61, p<0.52; 96.80% ± 3.67, 
p<0.55).   
Conclusion 
Aspalathin and morseo, GRT, may potentially ameliorate inflammation-induced β-cell stress 
at low concentrations, while higher concentrations have some regulation of BACE activity in a 
dose dependent manner.   
Key words: amylin, inflammation, BACE2, type 2 diabetes, Rooibos, polyphenols. 
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OPSOMMING 
Inleiding 
Kroniese, lae graad ontsteking is ‘n kenmerk van insulienweerstandigheid (IR) en is 
onderliggend aan pankreatiese beta-sel wanfunksie en die ontwikkeling van tipe 2 diabetes 
(T2D), 'n siekte wat gekenmerk word deur 'n vermindering in β-sel funksionele massa. 
Terapeutiese middels, wat β-selle direk teen stressors soos inflammasie en oksidatiewe stres 
beskerm, is egter beperk.  Amilien, ‘n neuro-hormoon, en insulien word gesamentlik deur β-
selle afgeskei; daarom word hipersekresie van insulien geassosieer met verhoogde sekresie 
van amilien.  Die toename in amilien sekresie word geassosieer met die ophoping van 
amiloïed, wat ‘n nadelige effek op β -sel funksie het.  In die pankreaseilande moduleer beta-
sekretase (BACE) die sitotoksiese ophoping van amiloïed, wat ontsteking en oksidatiewe stres 
aanstig; en maak dus BACE-inhibisie 'n terapeutiese teiken.  Insig oor die onderliggende 
meganismes betrokke by pankreaseiland-inflammasie asook die geassosieerde effekte van 
BACE, kan moontlik 'n geleentheid onthul vir die ontwikkeling van nuwe terapieë om β-selle 
te beskerm en te bewaar tydens T2D.  Benewens hul antidiabetiese eienskappe kan 
aspalatien (Asp), Z-2-(β-D-glukopiranoksieloksie)-3-fenielpropeniensuur (PPAG) en 'n 
ongefermenteerde Rooibosekstrak (GRT), anti-inflammatoriese effekte in β-selle hê, en 
moontlik β-selle beskerm deur BACE-aktiwiteit te moduleer.   
Doelstelling 
Om te bepaal of GRT, en twee van sy bioaktiewe polifenole, ontsteking in pankreatiese β-selle 
(INS1) kan verminder en ook BACE inhibisie eienskappe besit. 
Metodes 
'n Model van matige ontsteking is in INS1-selle gevestig met behulp van 'n sitokien-mengsel 
van tumornekrosefaktor-α (TNF-α), interleukien-1β (IL-1β) en interferon-γ (IFN-γ).  Sel-
lewensvatbaarheid, funksie, en oksidatiewe stres was bepaal in reaksie tot die sitokien 
mengsel na Asp, PPAG, en GRT behandeling, deur intrasellulêre adenosietrifosfaat (ATP), 
sel-dood via apoptose en nekrose, selproliferasie tempo, insulien/amiliensekresie en -inhoud, 
reaktiewe suurstofspesies (ROS) produksie en nitraat (NO2-) generasie, te meet.  Beta 
sekretase inhibisie deur GRT, Asp, en PPAG was bepaal met behulp van fluoressensie 
resonansie energie-oordrag (FRET) in 'n gesuiwerde ensiem-toets, gevolg deur kinetiese 
assessering van BACE aktiviteite in vitro. 
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Resultate 
Die sitokien-mengsel het na 24 uur 'n toestand van matige ontsteking veroorsaak, hoofsaaklik 
deur IL-1β.  'n Neiging tot BACE inhibisie, vergeleke met die kontrole (56.20% ± 2.05, 
p<0.0001 en 39,80% ± 0.55, p<0.0001), is teen die hoër konsentrasies van Asp en GRT 
gesien.  Hoë konsentrasies Asp (1000 μM) en tot 'n groter mate, GRT (1 mg/ml) het 
lewensvatbaarheid van ontsteekte INS1 selle verminder (19.02% ± 2.98, p<0,0001; 36,88% ± 
1,53, p<0,0001), terwyl PPAG geen meetbare effek getoon het nie.  Laer konsentrasies van 
Asp (0.1–10 μM), PPAG (0.1–10 μM), en GRT (0.0001-0.01 mg/ml) het sel-lewensvatbaarheid 
en funksie verbeter met gepaardgaande verlaging in oksidatiewe stress na 24 uur (97.66% ± 
3.5, p<0.66; 95.54% ± 5.61, p<0.52; 96.80% ± 3.67, p<0.55).   
Gevolgtrekking 
Aspalathin, en veral GRT, het teen laer konsentrasies die β-sel in ‘n mate teen sitokien-
geïnduseerde ontsteking beskerm, terwyl hoër konsentrasies, op 'n dosis-afhanklike manier, 
BACE-aktiwiteit matig moduleer. 
Sleutelwoorde: amilien, ontsteking, BACE2, tipe 2 diabetes, Rooibos, polifenole. 
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CHAPTER 1 
Introduction 
Type 2 diabetes is a disease characterised by IR of insulin responsive tissues such as muscle, 
liver, and adipose tissues which contributes to β-cell dysfunction and failure, ultimately 
resulting in reduced β-cell functional mass (Figure 1.1) (Abedini and Schmidt, 2013; Altirriba 
et al., 2010; Esterházy et al., 2011; Jeong and An, 2015; Sandovici et al., 2016).  Underlying 
to the development of T2D are inflammatory as well as metabolic aberrations, that include 
chronic, low-grade inflammation, increased body mass, particularly white adipose tissue 
(WAT), and dysregulated glucose metabolism (Duncan et al., 2003; Saltiel, 2000).   
Initially, in the pre-diabetic and early phases T2D,  β-cells maintain euglycemia by increasing 
insulin secretion through compensatory hyperplasia/hypertrophy  of the β-cell mass (Altirriba 
et al., 2010; Bourlier et al., 2008; Dludla et al., 2014; Donath, 2014; Esterházy et al., 2011; 
Henegar et al., 2008).  In T2D, β-cell dysfunction leads to β-cell failure which is associated 
with: increased endoplasmic reticulum (ER) stress; mitochondrial dysfunction; and of 
particular interest to this study, inflammation and oxidative stress (Abedini and Schmidt, 2013; 
Harding and Ron, 2002; Hull et al., 2004; Prentki and Nolan, 2006; Robertson et al., 2004; 
Weir and Bonner-Weir, 2004).  Immune cell infiltration, elevated pro-inflammatory cytokine 
levels, and activation of nuclear factor kappa-B (NF-ᴋB); all associated with inflammation in 
the pancreatic islets, are pathological key features of T2D (Donath et al., 2008, 2005).  
Continuous exposure of β-cells to inflammation and hyperglycemia, leads to the production of 
reactive species, including ROS and reactive nitrogen species (RNS), which result in the 
oxidative damage of cellular machinery causing a loss in cell structure and function (Bansal 
and Bilaspuri, 2011; Pham-Huy et al., 2008).   
Pancreatic β-cell failure leads to reduced β-cell functional mass due to an imbalance between 
β-cell growth (proliferation and/or neogenesis) and death (apoptosis and/or necrosis) (Akpinar 
et al., 2005).  This imbalance as a result of increased cell death is due to the stimulation of 
several mechanisms; all associated with β-cell failure, and is enhanced by glucotoxicity and 
lipotoxicity (Figure 1.1) (Jeong and An, 2015; Sandovici et al., 2016). 
Since amylin, a neuro-hormone, is co-secreted with insulin, hyperinsulinemia coincides with 
hyper secretion of amylin (Cooper et al., 1987; Westermark et al., 1986).  Abnormalities in 
amylin folding, secretion, and function exacerbates β-cell dysfunction (Clark et al., 1996a, 
1996b; Kahn et al., 1999a).  The increased amylin secretion results in associated aggregation 
of amyloid deposits which can physically disrupt islet structure and induce inflammation, 
Stellenbosch University  https://scholar.sun.ac.za
  2 | P a g e  
 
perpetuating dysfunction.  However, in the progression of T2D, amyloid predominantly exerts 
its toxic effect by activating multiple overlapping mechanisms and downstream signalling 
pathways (Abedini and Schmidt, 2013; Jeong and An, 2015).  Amyloid induced toxicity is 
associated with increased oxidative stress responses as well as low density lipoprotein (LDL) 
uptake, suggesting that the underlying mechanisms of amylin toxicity involves changes in 
pathways associated with oxidative stress as well as lipid homeostasis (Janciauskiene and 
Ahrén, 2000).  Amylin is also seen to interact with immune cells that activate inflammasomes, 
triggering signalling cascades that produce pro-inflammatory cytokines, such as IL-1β, by 
activating the NF-κB pathway, the inflammation master switch (Abedini and Schmidt, 2013; 
Masters et al., 2010; Tak and Firestein, 2001; Westwell-Roper et al., 2014). 
A positive correlation is seen between amylin and BACE2 (Alcarraz-Vizán et al., 2017, 2015).  
Beta secretase 1 is a protease expressed in the brain where it contributes to the development 
of Alzheimer’s disease (AD) (Southan and Hancock, 2013; Vassar, 2014; Venugopal et al., 
2008).  Beta secretase 2 is mainly expressed in the pancreas and although its function is not 
fully elucidated, it has several physiological functions (Vassar, 2014).  Overexpression of 
amylin has been shown to block autophagy in β-cells, interfering with the degradation of 
BACE2 thus resulting in increased cleavage of transmembrane protein 27 (TMEM27) 
(Alcarraz-Vizán et al., 2017, 2015).  Although TMEM27 plays a beneficial role in β-cell 
proliferation and insulin signalling, BACE2 cleavage of TMEM27 increases the deposition of 
amyloid and subsequent induction of inflammation and oxidative stress and thus presents as 
a therapeutic target (Esterházy et al., 2011; Southan and Hancock, 2013).   
It is vital to elucidate the underlying mechanisms of β-cell dysfunction and failure to prevent or 
delay the onset and progression of T2D.  Theoretically, β-cell protection can be accomplished 
through mechanisms preventing β-cell dysfunction induced by stressors such as oxidative 
stress and inflammation.  Rooibos (Aspalathus linearis) is known as a rich source of 
polyphenols with antioxidant and anti-inflammatory properties (Beltrán-Debón et al., 2011; 
Joubert et al., 2008; Joubert and de Beer, 2011).  Aspalathin and PPAG, both phenolic 
components of Rooibos, have been shown to directly stimulate insulin secretion from β-cells 
(Bramati et al., 2002; Kawano et al., 2009; Ku et al., 2015; McKay and Blumberg, 2007).  
Rooibos reduces oxidative stress through direct scavenging of free radicals and interfering 
with inducible nitric oxide synthase (iNOS), through interaction with several enzyme systems 
(Ayeleso et al., 2014; Kawano et al., 2009; Nijveldt et al., 2001).  Furthermore, Asp may exert 
its effect via an insulin/insulin-like signalling pathway (Chen et al., 2013; Kawano et al., 2009).  
In addition to antioxidant properties, polyphenols, including flavonols and flavones, have a 
protective effect against Aβ formation and aggregation, by inhibiting BACE activity (Shimmyo 
et al., 2008).   
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It can be proposed that chronic, low-grade inflammation perpetuates the deleterious 
effects of amyloid and that BACE regulation might be a key therapeutic target through the 
modulation of amyloid deposition.  We hypothesized that Rooibos may have anti-inflammatory 
effects in β-cells and may additionally modulate BACE activity, enhancing the anti-diabetic 
effect.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1:  Diagrammatic presentation of mechanisms involved in type 2 diabetes.  
Type 2 diabetes is a disease characterised by IR in muscle, liver, and adipose tissues which 
leads to β-cell dysfunction and failure, ultimately resulting in reduced β-cell functional mass 
as a result of increased inflammation and oxidative stress.  Several mechanisms are activated 
to compensate for cell dysfunction including increased insulin secretion; which then results in 
increased amylin secretion as it co-secreted with insulin.  Beta secretase 2 correlates with 
amylin levels and is involved in TMEM27 cleavage, which influences β-cell proliferation and 
insulin signalling; making BACE inhibition a therapeutic target. 
Stellenbosch University  https://scholar.sun.ac.za
  4 | P a g e  
 
Literature Review 
1.1. Progression of Type 2 Diabetes: Potential Role of Amyloid 
1.1.1. Type 2 Diabetes  
Type 2 diabetes is a complex disease associated with IR and subsequent hyperglycemia, 
which increases β-cell dysfunction leading to β-cell failure and ultimately results in reduced β-
cell functional mass (Altirriba et al., 2010; Esterházy et al., 2011; Jeong and An, 2015).  Insulin 
resistance can be defined as the inability of exogenous or endogenous insulin to increase 
glucose uptake and utilization; while in a physiologically normal subject insulin exerts this 
effect (Lebovitz, 2001).  At the initial stage of T2D, the pancreatic β-cells adapt to IR by 
increasing its functional mass as well as insulin secretion to meet the elevated metabolic 
demands.  However, the continuous state of hyperglycemia eventually exerts an adverse 
effect on the functionality of β-cells, resulting in impaired insulin secretion and a reduction in 
insulin gene expression, ultimately resulting in β-cell death (Altirriba et al., 2010; Dludla et al., 
2014; Donath, 2014).  Pancreatic β-cell mass is regulated by a balance of β-cell growth 
(replication) and by β-cell death (apoptosis/necrosis) (Akpinar et al., 2005).  Apoptosis is a 
genetically programmed cell death, characterised by cell shrinkage, membrane blebbing, 
chromatin condensation, and deoxyribonucleic acid (DNA) fragmentation, followed by 
engulfment of the impaired cell by neighbouring cells (Kerr et al., 1972; Renehan et al., 2001).  
Necrosis on the other hand is an uncontrolled cell death that lacks the characteristics of 
apoptosis and occurs as a result of severe disease or injury (Golstein and Kroemer, 2007).  
Mechanisms leading to a decline in β-cell mass and function include: glucotoxicity, lipotoxicity, 
and the formation of amyloid deposits (section 1.1.2; subsection 1.1.2.3), which increase 
inflammation (section 1.2), oxidative stress (section 1.1.3), and ER stress as presented in 
Figure 1.2 (Abedini and Schmidt, 2013; Harding and Ron, 2002; Hull et al., 2004; Prentki and 
Nolan, 2006; Robertson et al., 2004; Weir and Bonner-Weir, 2004).  Glucotoxicity occurs when 
cells are chronically exposed to excessive glucose levels that cause irreversible β-cell damage 
(Robertson et al., 2003).  Lipotoxicity occurs when there is an over-accumulation of un-
oxidized long-chain fatty acids (FA), which saturate the storage capacity of adipose tissue, 
resulting in the accumulation of lipids or intermediate lipid metabolites in non-adipose tissues 
such as the muscle, heart, liver, and pancreatic-islets (ectopic fat).  Ectopic lipid deposition 
can have deleterious effects as these lipids are driven into alternative non-oxidative pathways, 
which lead to the formation of lipid moieties that promote cellular dysfunction (Kusminski et 
al., 2009).  
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Islet pathology in T2D is associated with elevated pro-inflammatory cytokine levels, and the 
activation of NF-ᴋB (Donath et al., 2008, 2005).  It is important to note, all the above mentioned 
mechanisms are linked with inflammatory responses (section 1.2) (Donath et al., 2003; Ehses 
et al., 2009; Hotamisligil and Erbay, 2008; Jourdan et al., 2013; Lerner et al., 2012; Masters 
et al., 2010; Oslowski et al., 2012; Pickup, 2004; Westwell-Roper et al., 2014).  Therefore, it 
has been proposed that T2D is an inflammatory as well as a metabolic disease (Duncan et 
al., 2003). 
Chronic, low-grade inflammation, a hallmark of several metabolic diseases, negatively 
influences the function of heart, liver, and pancreatic tissues (Abedini and Schmidt, 2013; 
Sandovici et al., 2016).  The decline in pancreatic β-cell function with age, in the setting of IR, 
is a key factor in the progression of T2D (Sandovici et al., 2016) and is characterized by a 
Figure 1.2:  Factors involved in amyloid depositions and subsequently in the 
progression of type 2 diabetes.  Schematic presentation of factors involved in IR and 
pancreatic β-cell dysfunction including hyperglycemia and hyperlipidemia, which result in 
glucotoxicity and lipotoxicity; with both leading to amyloid deposition and the progression of 
T2D by means of chronic low-grade inflammation (Adapted from Bonora, 2008). 
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reduction in β-cell functional mass.  This reduction in β-cell functional mass results in 
hyperglycemia due to insufficient insulin secretion relative to cellular metabolic demands, 
which is initially compensated for by hypersecretion of insulin (Altirriba et al., 2010; Esterházy 
et al., 2011).  It is proposed that processes such as inflammation, increased oxidative stress, 
impaired β-cell proliferation, and increased apoptosis result in loss of pancreatic cell functional 
mass (Jeong and An, 2015; Sandovici et al., 2016).  The above mentioned processes are also 
associated with increased formation and deposition of toxic islet amyloid polypeptide (IAPP) 
(Jeong and An, 2015), as described in section 1.1.2.  
 Insulin Signalling, Insulin Resistance, and Beta-cell Failure 
The pancreas comprises of an exocrine and endocrine part, with the latter containing the islets 
of Langerhans crucial for glucose homeostasis.  The main types of islet endocrine cells are: 
β-cells secreting insulin; α-cells secreting glucagon; and δ-cells responsible for somatostatin 
secretion (Elayat et al., 1995).  Elevated blood glucose levels stimulate insulin production and 
secretion.  Insulin’s precursor protein carries a signal peptide which directs the peptide chain 
to the interior of the ER where pro-insulin is produced by the cleavage of the signal peptide 
and the formation of disulphide bonds, where after it passes through the Golgi apparatus to 
get packed into vesicles (Skelin et al., 2010).  
Dean and Mathews (1970) described pancreatic β-cell electrical activity by showing that a 
glucose concentration higher than 7 mM results in depolarisation of the β-cell membrane.  The 
depolarised cell membrane leads to the closing of the ATP sensitive K+ channels which results 
in the excitation of a rhythmic electrical impulse.  This impulse activates the voltage dependent 
Ca2+ channels and the subsequent hyperpolarised phase.  The higher the glucose 
concentration the longer the duration of the active phase.  At low levels of glucose, the ATP 
levels are too low to keep the ATP-sensitive K+-channels closed.  However, when the 
extracellular glucose concentration is elevated, glucose enters the cells through glucose 
transporter 2 (GLUT2).  Glucose is then metabolically degraded and leads to increased ATP 
levels that are responsible for closing the K+-channels in the plasma membrane.  The closed 
K+-channels cause depolarisation of the plasma membrane which results in the opening of the 
voltage gated Ca2+ channels and the subsequent influx of extracellular Ca2+ (Dean and 
Matthews, 1970; Guo et al., 2014).  Electrical activity together with Ca2+ influx results in insulin 
release (Ashcroft and Rorsman, 1989). 
After insulin release, insulin signalling is initiated when insulin binds with its specific receptor 
found mainly in muscle and fat tissues, inducing intracellular cascades.  The insulin signalling 
pathway includes at least four distinct insulin receptor substrates (IRSs) which are key 
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regulatory proteins, with IRS-1 and IRS-2 considered the most relevant as they are linked to 
the actions of insulin as well as β-cell function (Greenberg and McDaniel, 2002; Kulkarni et 
al., 1999).  Insulin receptor substrate-2 knockout mice are seen to result in IR and β-cell 
dysfunction with a 50% reduction in β-cell mass.  However, IRS-1 knockout mice are seen to 
impede somatic growth while enhancing β-cell mass as these mice are 50% smaller in size 
compared to controls, while their β-cell mass is increased by two-fold.  Insulin receptor 
substrate-1 knockout mice display mild IR and are hyperinsulinemic while IRS-2 knockout 
mice develop severe diabetes after 10 weeks.  It can be postulated that a signalling balance 
between IRS-1 and IRS-2 may be required for normal β-cell function (Burks and White, 2001; 
Kahn, 1998a). 
Insulin receptor-mediated tyrosine phosphorylation of IRS activates two major pathways; the 
phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) as well as the mitogen-activated 
protein kinase (MAPK) pathways, both regulated by negative feedback (Figure 1.3).  The 
PI3K/AKT pathway gets activated downstream of the insulin receptor and is involved in insulin 
action on glucose uptake and gluconeogenesis suppression.  The MAPK pathway is 
associated with gene expression and additionally cell growth regulation and differentiation by 
interacting with the PI3K/AKT pathway (Figure 1.3).  The PI3K pathway catalyses the addition 
of a phosphate molecule to carbon-3 of the inositol ring of phosphoinositide, converting 
membrane phosphatidylinositol into phosphatidylinositol-3-phosphate (PIP), and generates 
phosphatidylinositol-3,4,5-triphosphate (PIP3) from phosphatidylinositol-4,5-bisphosphate 
(PIP2).  Protein kinase B binds to PIP3 inducing AKT activation through the activation of 
kinases upstream.  Protein kinase B is then released to translocate to the cytoplasm, nucleus, 
and even mitochondria to phosphorylate various substrates associated with gluconeogenesis, 
synthesis of glycogen, as well as glucose uptake (Schultze et al., 2012).  Protein 3-
phosphoinositide-dependent protein kinase-1 (PDK1), an AKT activating kinase, is seen to 
activate isoforms of protein kinase C (PKC), essential for GLUT-4 dependent regulation of 
glucose uptake (Figure 1.3). 
Mitogen-activated protein kinases consist of subfamilies of serine/threonine kinases, including 
extracellular signal-regulated kinases (ERK1/2), p38, and c-Jun terminal kinases (JNK).  The 
JNK and p38 kinases are activated by cellular stressors such as free fatty acids (FFA), 
interleukin-6 (IL-6), IL-1β, and TNF-α, and are therefore collectively known as stress-activated 
MAPKs.  Cellular events in the cytoplasm are regulated by activated MAPKs, by 
phosphorylation of threonine and tyrosine.  Activated MAPKs translocate to the nucleus where 
it plays a vital function in phosphorylation of transcription factors (TF) such as activator protein 
1 (AP-1), controlling the expression of various pro-inflammatory genes downstream (Huang et 
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al., 2009).  Insulin signalling can be blocked by serine phosphorylation of IRS-1, which 
inactivates tyrosine phosphorylation of IRS.   
Importantly, the NF-ᴋB pathway is activated by AKT and MAPK, amplifying pro-inflammatory 
cytokine production, which contributes to IR and thus T2D.  Insulin also activates other IRS 
serine kinases, which play a vital role in mediating inflammatory signalling pathways, 
suggesting a possible link between insulin signalling and inflammatory responses (Qatanani 
and Lazar, 2007).  Increased PI3K levels are seen to stimulate the MAPK pathway through 
activation of SOS, Ras, C-Raf, GRB-10, and MEK, exacerbating the transcription of growth 
factors (GF) by ERK (Figure 1.3).  Nitric oxide (NO), an endogenous signalling molecule, 
produced by iNOS, is able to degrade IRS.  The activity of iNOS therefore leads to a decline 
in the activities of PI3K/AKT, consequently resulting in the reduction of insulin signalling and 
insulin activity (Zeyda and Stulnig, 2009).  
Figure 1.3: Downstream pathways stimulated by insulin secretion.  Binding of insulin to 
its receptor leads to the activation of several downstream signalling pathways, including the 
PI3K/AKT (black arrows), MAPK (grey arrows), and NF-κB (red arrows) pathways; playing a 
vital role in glucose uptake as well as the transcription and expression of several pro-
inflammatory cytokines and GFs (Adapted from Cruz et al. 2012). 
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As mentioned previously, T2D involves IR in mainly muscle, liver, and fat tissues, which is 
initially compensated for by increased insulin secretion.  When insulin production becomes 
impaired (β-cell exhaustion), glucose intolerance or overt diabetes develop (Kahn et al., 1998; 
Larsson and Ahrén, 1996).  Subjects with T2D present with increased insulin levels (Yalow 
and Berson, 1960) as well as high glucose levels during the fasting state, suggesting the 
presence of IR or decreased insulin sensitivity (Shen et al., 1970).  Although insulin secretion 
in response to oral glucose in T2D individuals is increased, the first phase of insulin secretion 
is blunted (Ward et al., 1984), and the peak plasma insulin is delayed (Bonora et al., 1983).  
However, elevated levels of circulating insulin, in addition to normal glucose levels, results in 
impaired β-cell function (Perley and Kipnis, 1967; Polonsky et al., 1988).  Decreased β-cell 
functional mass is seen as a triggering event in the progression of T2D (Weyer et al., 1999).  
Studies have shown that the volume of β-cells reduces by 40-60% in T2D individuals and an 
abnormality in the volume is already observed in individuals with increased fasting glucose 
levels (Butler et al., 2003).  Studies also showed that the rate of β-cell replication is not 
impaired in T2D individuals, but rather an increased rate of apoptosis (Butler et al., 2003).  
Approximately 1% of β-cells enter the mitotic phases gap 1 (G1), synthesis (S), G2 and mitosis 
(M) from the resting (G0) phase, confirming a low turnover rate of β-cells.  Various GFs such 
as: epidermal growth factor (EGF), transforming growth factor α (TGF-α), growth hormone 
(GH), and insulin growth factor-1 (IGF-1), are all vital in β-cell renewal and growth.  Glucose 
also plays a role in maintaining an adequate amount of β-cells by stimulating proliferation at 
non-toxic concentrations, important for overall regulation of metabolism (Skelin et al., 2010). 
1.1.2. Amylin and Amyloid Deposition  
A risk factor for the development of metabolic diseases, including T2D, is ageing; especially 
in individuals with genetic and epigenetic predispositions.  Ageing leads to chronic, low-grade 
inflammation, which deleteriously influences the function of various tissues, including 
pancreatic islets (Abedini and Schmidt, 2013; Donath, 2014; Sandovici et al., 2016).  Genes 
upregulated with age are significantly enriched for processes associated with immune and 
inflammatory responses as well as extracellular matrix organization (Sandovici et al., 2016).  
Prolonged exposure of human islets to high concentrations of glucose results in increased 
synthesis of IAPP, and therefore implies that prolonged hyperinsulinemia is associated with 
increased secretion of amylin (Gasa et al., 2001; Hou et al., 1999).  As mentioned previously, 
the neuro-hormone amylin is co-secreted with insulin from pancreatic β-cells (Cooper et al., 
1987; Westermark et al., 1986), and abnormalities in its folding, secretion, and function have 
detrimental effects on islet function and glucose regulation, leading to islet amyloidosis and β-
cell dysfunction, and consequently T2D (Clark et al., 1996a, 1996b; Kahn et al., 1999). 
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 Amylin Formation, Secretion, and Function 
The precursor peptide of islet amyloid is amylin, a product of the pancreatic islet cells (Johnson 
et al., 1988; Westermark et al., 1987).  The amylin gene, located on chromosome 12, leads to 
the formation of amylin peptides which fold to form α-helix monomers, oligomers, and cross 
β-sheet amyloid fibrils (Abedini and Schmidt, 2013; Cohen and Calkins, 1959).  Protofibrils 
can be formed either by parallel stacking of molecules with parallel and antiparallel β-strands 
or antiparallel with parallel interaction between molecules as indicated by Figure 1.4 (Jaikaran 
and Clark, 2001).  Initially, similar to insulin, amylin is synthesised as an 89-residue pre-
prohormone (Sanke et al., 1988), followed by the removal of a 22-residue signal peptide, 
leading to the 67-residue pre-IAPP, then enzymatically cleaved by pro-protein convertase-1/3 
(PC1/3) and PC2 in the Golgi apparatus forming a 37-residue mature hormone (Badman et 
al., 1996; Higham et al., 2000; Marzban et al., 2005); PIC1/3 and PIC2 also play a role in the 
conversion of pro-insulin to insulin (Bailyes et al., 1992).  Additional post-translational 
alterations include the formation of a disulphide bridge between the 2nd and 7th residue, as well 
as amidation of the C-terminus tyrosine (Roberts et al., 1989).  Mature amylin, together with 
insulin, is stored in the insulin secretory granule at a ratio of 1:50 to 1:100, and co-secreted in 
response to β-cell stimulation by glucose (Alcarraz-Vizán et al., 2015; Hanabusa et al., 1992; 
Jeong and An, 2015; Kahn et al., 1991, 1990; Thomaseth et al., 1996).  Amylin levels are 
approximately 10-15% of insulin levels, during the fasting state (Hanabusa et al., 1992; 
Kautzky-Willer et al., 1994; Thomaseth et al., 1996); this may be due to the variation in 
clearance rates of amylin and insulin, as amylin clearance is slower than insulin (Leckström et 
al., 1997; Zhang et al., 2016). 
The function of amylin is not fully elucidated; however, studies have demonstrated that amylin 
is involved in several physiological processes.  Under normal physiological conditions, 
increased levels of blood glucose result in the release of amylin and insulin (Mulder et al., 
1996).  Insulin increases glucose uptake from the circulation into fat and muscle cells, while 
insulin and amylin inhibit glucose release from the liver.  The latter is done by reducing 
glucagon secretion and thus decreasing postprandial glucose (Gedulin et al., 1997).  However, 
amylin is seen to inhibit insulin-stimulated glycogen synthesis which may lead to IR (Leighton 
and Cooper, 1988; Sowa et al., 1990).  Amylin and insulin also suppress postprandial 
secretion of glucagon from islet α-cells to regulate postprandial glycaemia (Akesson et al., 
2003; Gedulin et al., 1997).  However, in T2D individuals, plasma amylin and insulin decrease, 
implying that postprandial insulin: glucagon regulation is compromised and glucose levels are 
increased (Kahn et al., 1998).  
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Amylin also regulates carbohydrate storage to transfer triglycerides into muscle glycogen, 
(James et al., 1999) and satiety, by acting as a neurohormone and reducing food intake via 
receptors situated in the brainstem.  High plasma levels of amylin, delay gastric emptying and 
subsequently improve postprandial glucose (Kong et al., 1997; Paulsson et al., 2014; 
Thompson et al., 1997; Woerle et al., 2008), while amylin deficiency do not delay gastric 
emptying in response to hyperglycemia (Woerle et al., 2008).  Amylin also regulates blood 
pressure by vasodilation through the renin–angiotensin system (RAS) (Brain et al., 1990; Chin 
et al., 1994; Zhao et al., 2003), as well as renal filtration by regulating K+ and Na2+ excretion 
(Harris et al., 1997; Wookey et al., 1998, 1996).  Angiotensin-converting enzyme (ACE) 
inhibition is associated with a reduction of amylin binding in the renal cortex (Wookey et al., 
1998).  Reduced glomerular filtration correlates with the accumulation of amylin in circulation 
and is excreted in urine.  Therefore, individuals with renal failure may have increased 
concentrations of circulating amylin (Ludvik et al., 1994).  Amylin is also associated with Ca2+ 
homeostasis in bones (Alam et al., 1993; Gilbey et al., 1991).  Taken together, it can be said 
that amylin is curtailed in several physiological processes and that any defect in amylin 
secretion or function might have detrimental consequences.   
 
 
Figure 1.4: Amyloid formation in pancreatic islets.  Diagrammatic presentation of amyloid 
formation from cytotoxic amylin aggregates to the deposition of amyloid.  *Possible 
conformation of stacked hIAPP molecules within a protofilament: 1) antiparallel stacking of 
peptide molecules with parallel interaction between molecules; or 2) parallel stacking of 
molecules with parallel and antiparallel β-strands (Adapted from: Hull et al., 2004 and Jaikaran 
and Clark, 2001). 
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 Factors Causing Amylin Aggregation 
Amylin is subjected to post-translational alterations that affect its function as well as its 
tendency to aggregate.  Non-enzymatic alterations such as the deamination of the asparagine 
(Asn) residue in amylin results in a lowered net charge of amylin at a physiological potential 
of hydrogen (pH), suggesting decreased solubility and accelerated formation of amyloid 
(Abedini and Schmidt, 2013; Alcarraz-Vizán et al., 2015; Chargé et al., 1995; Jeong and An, 
2015).  Proteins folding to a compact tertiary structure, in their unaggregated state, lead to the 
formation of amyloid.  Amyloid can also form when polypeptides are not ordered and fail to 
adopt a compact tertiary structure in their natural soluble state (Abedini and Schmidt, 2013).   
Some amyloidogenic precursor proteins form small cytotoxic aggregates that adopt a mutual 
structure regardless of their amino acid (aa) sequence, and have characteristics associated 
with metabolic diseases (Kayed et al., 2003; Yao et al., 2013).  These cytotoxic aggregates 
are soluble and appear to represent an early intermediate in the amyloid fibril formation 
pathway (Figure 1.4) (Porat et al., 2003; Shirahama and Cohen, 1967).  Thus amyloid 
represents a continuous sequence of toxicity from early cytotoxic aggregates to mature 
amyloid fibrils, with the early small aggregates expressing the cytotoxicity associated with 
amyloid and the conventional amyloid deposits indicating the end stage of the process, being 
less cytotoxic (Hardy and Selkoe, 2002; Janson et al., 1999; Kayed et al., 2003; Li et al., 2011; 
Ludvik et al., 1994; Porat et al., 2003; Zhao et al., 2009).  
Cellular environmental salt concentrations, chemical modifications, isomerization, natural 
ligands, deamination, oxidation, and glycation affect amylin stability.  The amylin sequence 
can be altered genetically, where mutations have been seen to be associated with diabetes 
(Clark and Nilsson, 2004).  A mutation in the S20G gene is indicated as an important amylin 
gene mutation, where a glycine for serine substitution occurs in mature amylin; resulting in 
increased hydrophobicity and amyloidogenic characteristics of IAPP, which may increase its 
fibrillogenic potential (Sakagashira et al., 2000).  Other factors contributing to amylin 
aggregation include the prevention of the disulphide bond formation, deamination, and the 
absence of PC2 during amylin processing.  Ions, such as Ca2+ and Zn2+, have been shown to 
play a role in maintaining the structure of amylin by inhibiting aggregation of amyloid while 
Cu2+ ions are thought to play a role in the pathological mechanisms of amyloidosis in diabetes.  
Copper-promoted ROS production and the mitochondrial disruption affect the degeneration of 
pancreatic islets, which leads to the production of caspase-3 and poly (ADP-ribose) 
polymerase (PARP), which in turn promote apoptosis (Jeong and An, 2015; Taylor et al., 
2008). 
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 Proposed Mechanisms of Amylin Toxicity 
Amyloid deposits may physically disrupt tissue structure, resulting in organ dysfunction.  
However, under most circumstances activation of multiple overlapping mechanisms and 
downstream signalling pathways are proposed to lead to the pathogenesis of T2D (Abedini 
and Schmidt, 2013; Jeong and An, 2015).  Non-receptor based mechanisms include the 
disruption and permeabilization of cell membranes by amyloid fibrils and soluble oligomers, 
leading to increased intracellular Ca2+ which activates several pathogenic pathways, including 
ROS production, altered signalling pathways, mitochondrial dysfunction, cytochrome C 
release, and apoptosis (Abedini and Schmidt, 2013; Wang and Youle, 2009).  Receptor 
mediated amyloid toxicity include FAS, p75NRT, and the receptor for advanced glycation end-
products (RAGEs).  Originally, RAGE was investigated for its ability to bind advanced glycation 
end-products (AGEs) but is now recognised as a multi-ligand pattern receptor with various 
classes of ligands including amyloid forming polypeptides.  The receptor for advanced 
glycation end-products not only elicits signalling pathways leading to inflammatory responses 
and apoptosis, but it also plays a role in the internalization of bound amyloidogenic ligands 
(Abedini and Schmidt, 2013; Vlassara, 1997).  In order to compensate for the increased amylin 
levels, autophagy is upregulated as a protective response to toxic aggregate accumulation in 
disease state (Abedini and Schmidt, 2013).  Investigation of the exact mechanism of amyloid 
formation and its subsequent toxicity is highly relevant for the development of therapeutic 
agents for the treatment of T2D. 
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Figure 1.5: Pancreatic islet amyloid deposition.  Diagrammatic presentation of the intracellular mechanisms of pancreatic islet amyloid deposition.    
Inflammation and oxidative stress play a profound role in β-cell pathophysiology, with amyloid deposition being a key contributor to the pro-inflammatory 
pathway via macrophage recruitment and the secretion of pro-inflammatory cytokines.  Amyloid deposits are formed as a result of the polymerisation of 
amylin, a polypeptide co-secreted with insulin.  Beta secretase enzymatic action is crucial in the cleavage of amylin and amyloid formation. 
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1.1.3. Oxidative Stress 
Cells are continuously exposed to different types of stressors, such as inflammation and/or 
aging, that lead to the over production of reactive species called free radicals, including ROS 
and RNS, which by the transfer of their free unpaired electron result in the oxidation of cellular 
machinery causing healthy cells to lose their function and structure (Bansal and Bilaspuri, 
2011; Pham-Huy et al., 2008).  Free radicals play a role in the activation of different signalling 
pathways such as MAPK and ERK (section 1.1.1.1), pathways involved in gene expression 
(Cho and Wolkenhauer, 2003).  Toxicity associated with amylin in pancreatic β-cells correlates 
with increased oxidative stress responses, as well as LDL uptake.  This suggests that the 
underlying mechanisms of amylin toxicity involves changes in pathways associated with 
oxidative stress as well as lipid homeostasis (Janciauskiene and Ahrén, 2000).  Oxidative 
stress plays a significant role in the development of several pathological diseases including 
T2D (Pham-Huy et al., 2008).  The apo-lipoprotein component of LDL forms insoluble 
aggregates through oxidation, due to hydroxyl radical-induced cross-linkage between the apo-
B monomers that are responsible for oxidative damage in diabetic complications (Pham-Huy 
et al., 2008).  Free radical formation in T2D by non-enzymatic glycation of proteins, glucose 
oxidation, and increased lipid peroxidation damages enzymes, cellular machinery, and also 
leads to IR (Maritim et al., 2003).  Insulin signalling is modulated by reactive species in two 
ways; firstly, in response to insulin secretion, the reactive species are produced to exert its full 
physiological function, while in contrast, excess levels of reactive species have a negative 
regulation on insulin signalling, leading to the development of IR, glucotoxicity, β-cell 
dysfunction and ultimately β-cell death (Evans et al., 2003).  Inflammatory responses are 
associated with ROS production via several pathways.  Evidence has shown that 
hyperglycemia triggers the excessive production of free radicals and causes oxidative stress.  
Excessive ROS are seen to damage the tertiary structure of antioxidant enzymes (Ku et al., 
2015; März et al., 1996) and are considered to be mediators of various biological responses, 
such as cell proliferation and extracellular matrix deposition if not in excess (Ku et al., 2015).  
Reactive oxygen species also promote the activation of the nucleotide-binding oligomerization 
domain (NBD), leucine-rich repeat-containing receptors (LRR), and pyrin domain (PYD)- 
protein 3 inflammasome (NLRP3) and caspase 1, leading to the generation of mature IL-1β 
(Maedler et al., 2002; Zhou et al., 2010).  Inflammasomes are also activated by elevated 
insulin demand and ER stress (Oslowski et al., 2012).  Therefore, it can be suggested that 
oxidative stress leads to increased inflammation and vice versa. 
In order to counteract the deleterious effects of these free radical species, the body has an 
endogenous antioxidant system and can also obtain exogenous antioxidants through diet.  
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These antioxidants neutralize the reactive species in order to maintain homeostasis to protect 
the cell from free radical-induced toxicity (Pham-Huy et al., 2008).  However, an imbalance 
between the reactive species and the intrinsic antioxidant defence system leads to the 
phenomenon known as oxidative stress (Sies, 1997).  When antioxidant levels are limited free 
radical-induced damage can become debilitating and cumulative.  The elevation in the levels 
of ROS seen in T2D may be due to the decrease in destruction or increase in the production 
by catalase (CAT), superoxide dismutase (SOD), and glutathione peroxide (GSH-Px) 
antioxidants (Lipinski, 2001).  The mitochondrion is a major source of oxidative stress, as 
remaining oxygen molecules are transformed to oxygen free radicals during oxidative 
metabolism (Mousa, 2008). 
1.2. Inflammation in Type 2 Diabetes 
Protective mechanisms induced by inflammation are vital for the health of an organism and 
dysregulation of the inflammatory responses can damage tissue, which leads to the onset of 
chronic diseases such as T2D.  Initially, inflammation promotes β-cell proliferation and insulin 
production in order to compensate for IR, thus exerting a beneficial role (Maedler et al., 2002).  
However, chronic inflammation is detrimental to pancreatic β-cell function.  As indicated 
earlier, inflammation in pancreatic β-cells arises because of several mechanisms, including 
over stimulation of pro-inflammatory pathways; of particular interest to this study is the 
association with ageing and amyloid deposition (Figure 1.5).  Inflammatory markers such as 
TNF-α, C-reactive protein (CRP), IL-1β, and IL-6, positively correlate with characteristics of IR 
and the development of T2D (Ford, 2003; Pradhan et al., 2001; Vozarova et al., 2002; Yudkin 
et al., 1999).  These markers and the main contributors to inflammation in T2D will be 
discussed in this section. 
1.2.1. Adipose-derived Inflammation   
Type 2 diabetes is associated with an increase in body mass, particularly WAT, and is 
important in lipid and glucose metabolism (Saltiel, 2000).  White adipose tissue secretes 
factors with paracrine, endocrine, as well as autocrine effects.  Moreover, WAT stores 
triacylglycerol (TAG), to regulate energy levels, protects other organs from ectopic fat and 
thus, from lipotoxicity (Torres-Leal et al., 2012).  In addition to adipocytes, WAT comprises of 
pre-adipocytes, fibroblasts, connective tissue matrix, stromovascular cells, nerve fibers, lymph 
nodes, and immune cells (e.g., macrophages) which secrete bio-active substrates (Fain et al., 
2004; Kershaw and Flier, 2004).  Proteins known as adipokines are also produced by 
adipocytes which allow interaction between adipocytes and other tissues (section 1.2.1.4) and 
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affect physiological processes (Torres-Leal et al., 2012).  In addition to adipokines, pro- and 
anti-inflammatory factors, such as chemokines, cytokines and acute-phase proteins are 
secreted (section 1.2.1.3).  Pro- (e.g. TNF-α, IL-6, and monocyte chemoattractant protein-
1(MCP-1)) and anti-inflammatory (e.g. IL-10) proteins secreted by adipocytes are proposed to 
promote T2D progression by chronic, low-grade systemic inflammation, leading to IR in obese 
subjects (Kang et al., 2016; Weisberg et al., 2003; Xu et al., 2004).  
 Proposed Mechanisms of Adipose-derived Inflammation 
Hyperplasia, increasing the number of cells, and/or hypertrophy, increasing the size of 
adipocytes are features associated with obesity and are associated with the production of 
increased extracellular matrix, increased angiogenesis, endothelial cell activation, 
macrophage infiltration, and secretion of inflammatory cytokines (Bourlier et al., 2008; 
Henegar et al., 2008).  Hypertrophic adipocytes cause an imbalance between increased tissue 
mass and blood flow, causing hypoxia, macrophage infiltration, and inflammation (Goossens, 
2008).  Hypertrophic adipocytes are also seen to increase the expression and release of pro-
inflammatory adipokines in humans (Skurk et al., 2007).  Very large adipocytes can become 
lipolytic, resulting in elevated levels of FFA in plasma leading to lipotoxicity through impairment 
of non-adipose organs function (DeFronzo, 2004).  It has been observed that TNF-α and IL-6 
have stimulatory effects on lipolysis (Petersen et al., 2005; Trujillo et al., 2004; van Hall et al., 
2003).  The former increases the levels of cyclic adenosine monophosphate (cAMP) and 
increases the function of lipase, along with downregulation of perilipin by activating MAPK 
(Souza et al., 2003).  In the liver, TNF-α downregulates expression of genes involved in FA 
oxidation as well as glucose uptake and metabolism (Guilherme et al., 2008).  Therefore, TNF-
α impairs lipid metabolism, resulting in excess FFA in plasma that promote the development 
of IR.  It is also seen that increased levels of IL-6 promotes FFA elevation in circulation and 
increases oxidation of body fat in humans (Lyngsø et al., 2002; van Hall et al., 2003).  Apart 
from ATP synthesis, the mitochondria remove circulating FFA via β-oxidation.  The latter 
occurs in tissues where glucose homeostasis is relevant, such as the liver, muscle and 
adipose tissue (Maassen et al., 2007).  Impaired mitochondrial β-oxidation of FA, in addition 
to increased glucose uptake, results in the accumulation of TAG, (Vankoningsloo et al., 2005), 
lipotoxicity in β-cells (Maassen et al., 2007), and hepatic IR (Zhang et al., 2007).  Free fatty 
acids available are associated with lipotoxicity that leads to β-cell death.  Prolonged exposure 
of β-cells to FFAs has cytostatic and pro-apoptotic effects.  The cytostatic action is likely as a 
result of the FFA-induced reduction of intra islet glucose metabolism, while the pro-apoptotic 
effects are mostly caspase mediated, partially dependent on the ceramide pathway, and is 
possibly B-cell lymphoma 2 (Bcl-2) regulated (Briaud et al., 2001; Lupi et al., 2002).  Interaction 
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between lipotoxicity and glucotoxicity is seen to be deleterious on β-cell function as it alters 
glucose homeostasis (Poitout and Robertson, 2002). 
 Macrophage Infiltration and Inflammation 
It can be said that obesity co-exists with inflammation in adipocytes.  Some pro-inflammatory 
cytokines are secreted by adipocytes, while the majority are primarily generated from infiltrated 
macrophages in the adipocytes (Maury et al., 2009).  The imbalance between anti-
inflammatory and pro-inflammatory cytokines leads to chronic, low-grade inflammation 
promoting metabolic diseases linked to obesity (Dandona et al., 2004; Ghanim et al., 2004; 
Johnson et al., 2012; Lumeng and Saltiel, 2011; Roche, 2004).  Pro-inflammatory cytokines 
produced in adipose tissue, as a result of macrophage infiltration, cause IR in tissues and 
impair multiple tissue functions (Weisberg et al., 2006).  It is been seen that both diet-induced 
obese mice as well as genetically modified obese mice have a significant increase in infiltrated 
macrophages (Davis et al., 2008; Lumeng et al., 2008; Murano et al., 2008).  
Increased expression of macrophage-specific inflammatory-genes in the WAT of obese mice, 
such as macrophage inflammatory protein-1α (MIP-1α) and MCP-1 correlate positively with 
the production of insulin (Xu et al., 2003).  Although, several obesity models have shown that 
adipocytes and macrophages localized in adipose tissue produce pro-inflammatory mediators, 
mechanisms on adipocyte hypertrophy, inflammation, and macrophage recruitment and 
activation are not fully elucidated.  Direct regulation of toll-like-receptor (Tlr)-4 by certain 
saturated fatty acids (SFAs) is proposed to play a role in the process, because palmitate and 
other SFAs directly stimulate pro-inflammatory cytokine expression and NF-κB activation in 
adipocytes and macrophages (Song et al., 2006; Suganami et al., 2007).  Suganami et al. 
indicated that FFA released from hypertrophic adipocytes signal macrophages through Tlr-4 
and stimulate release of TNF-α.  It is also seen that C3H / HeJ mice, which are Tlr-4 deficient 
mice, are less susceptible to fat-induced inflammation and IR, and are protected against 
hyperglycemia and inflammation in adipose tissue (Poggi et al., 2007; Suganami et al., 2007).  
Proteins associated with macrophages positively correlate with increased body mass.  
Furthermore, immunohistochemical analysis revealed that adipocytes expressing F4/80 
(F4/80+), a macrophage marker, positively correlates with increased adipocyte size and body 
mass.  Human adipose tissue stained for cluster of differentiation 68 (CD68), a macrophage 
antigen, showed similar correlations (Weisberg et al., 2003).  
The link between obesity, impaired insulin activity, and inflammation involving pro-
inflammatory cytokines was first demonstrated by Hotamisligil and co-workers (1993), with 
increased expression of TNF-α messenger ribonucleic acid (mRNA) in adipose tissue of obese 
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mice (fa/fa rat and ob/ob mouse).  The study also indicated improved insulin action on glucose 
uptake when TNF-α was neutralized in these obese fa/fa mice (Hotamisligil et al., 1993).   
 Cytokines, Chemokines, and Acute-phase Proteins Associated with Adipose-
derived Inflammation 
Interleukin-6 can be categorized as both anti- and pro-inflammatory; acting as a defence 
mechanism in an early state of inflammation, while during chronic inflammation is damaging 
(Kamimura et al., 2003).  Interleukin-6 decreases inflammatory responses by stimulating the 
synthesis of anti-inflammatory cytokines (Starkie et al., 2003; Steensberg et al., 2003; Z Xing 
et al., 1998).  Visceral adipocytes, contribute to approximately 10-35% of IL-6 in circulation at 
basal levels (Mohamed-Ali et al., 1997).  Furthermore, the expression of IL-6 mRNA is 
elevated in adipose tissue and hypertrophy of adipocytes increases the secretion of IL-6 
(Bastard et al., 2000; Fried et al., 1998; Kern et al., 2001; Sopasakis et al., 2004).  It has been 
demonstrated that IL-6 mRNA increases in IR obese individuals (Bastard et al., 2000; Fried et 
al., 1998; Kern et al., 2001; Rotter et al., 2003), correlating with decreased rates of glucose 
stimulated insulin secretion (GSIS) (Bastard et al., 2002).  Hepatic insulin dependent glycogen 
synthesis (Klover et al., 2003; Senn et al., 2002) and glucose uptake are also downregulated 
by IL-6 in adipocytes (Rotter et al., 2003), mediated by increased expression of suppressor of 
cytokine signalling (SOCS)-3. The latter inhibits the insulin receptor and targets IRS for 
proteosomal degradation and downregulate transcription of IRS-1 (Rotter et al., 2003; Sabio 
et al., 2008).  
Monocyte chemoattractant protein-1 is also secreted by adipocytes (Christiansen et al., 2005; 
Skurk et al., 2007), and correlates positively with adipocyte size (Skurk et al., 2007).  Animal 
models of obesity (Sartipy and Loskutoff, 2003; Takahashi et al., 2012) as well as obese 
individuals (Bruun et al., 2005; Christiansen et al., 2005; Kim et al., 2006) show increased 
levels of circulating MCP-1.  Furthermore, it has been observed that MCP-1 levels are elevated 
in T2D individuals compared to non-diabetic individuals (Ezenwaka et al., 2009; Herder et al., 
2006; Nomura et al., 2000).  Expression of MCP-1 mRNA increases in adipocytes 
(Christiansen et al., 2005; Dahlman et al., 2005).  Studies have shown the IR-inducing effects 
of MCP-1 and attempted to elucidate the underlying mechanisms by which MCP-1 impairs 
insulin action.  Adipocytes treated with exogenous MCP-1 showed a decrease in insulin-
stimulated glucose uptake as well as decreased expression of genes such as PPAR-γ, GLUT-
4, and lipoprotein lipase (Sartipy and Loskutoff, 2003).  In cultured skeletal muscle cells from 
humans, increased MCP-1 levels reduced insulin-stimulated phosphorylation of AKT, 
glycogen synthase kinase-3α (GSK3α) and GSK3β proteins.  Altered GSK3 leads to impaired 
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insulin signalling and reduced glucose uptake (Sell et al., 2006).  Mice overexpressing MCP-
1 have normal adiposity, impaired insulin sensitivity and increased adipose macrophage 
infiltration (Kamei et al., 2006).  Furthermore, it is seen that MCP-1 overexpression 
downregulates insulin-stimulated tyrosine phosphorylation of the insulin receptors and IRS 
proteins, and decreases AKT phosphorylation leading to IR in the liver and muscle of mice 
(Kamei et al., 2006).  The above-mentioned studies suggest MCP-1 as an inflammatory link 
between IR and obesity.  
Cytokines released from adipocytes (Wieser et al., 2013) also alter the pituitary-adrenal axis 
(Jones and Kennedy, 1993) accelerating pancreatic β-cell impairment (Oh et al., 2011).  
Cytokines have the ability affect the secretion of hormones from the anterior pituitary by acting 
on the hypothalamus, the pituitary gland or both.  Cytokines involved include TNF-α, IL-1, IL-
2, IL-6, and interferon-tau (IFN-τ).  Cytokines stimulate the hypothalamic-pituitary-adrenal 
(HPA) axis, suppressing the hypothalamic-pituitary-thyroid and gonadal (HPG) axis, as well 
as GH secretion (Jones and Kennedy, 1993).  Cytokines stimulate the HPA axis to secrete 
glucocorticoids and catecholamines.  Catecholamines in turn increase IL-6 production 
(Papanicolaou et al., 1998).  Interleukin-6 stimulates β-cell death, via signal transducers and 
activators of transcription-3-mediated production of NO (Oh et al., 2011).  Glucocorticoids 
result in hepatic Zn2+ accumulation, gluconeogenesis, inhibit insulin secretion and decrease 5' 
AMP-activated protein kinase (AMPK) activity (Delaunay et al., 1997; Tsigos et al., 1997). 
 Adipokines 
Adipokines secreted by adipocytes include the following; (1) adiponectin, an adipocyte-
secretory protein, which is decreased in obese and diabetic states, negatively correlated with 
IR, and have a beneficial effect on postprandial glucose and lipid metabolism, increasing 
insulin sensitivity (Arita et al., 1999; Berg and Scherer, 2005; Weyer et al., 2001).  Adiponectin 
exerts its protective effect via the AMPK pathway, against glucose metabolism impairment, 
reducing the risk for T2D (Hug et al., 2004).  (2) Resistin, an inflammatory bio-marker and 
potential mediator of metabolic diseases associated with obesity, competes with 
lipopolysaccharides for Tlr-4 binding and leads to altered signalling mechanisms, including 
NF-κB and MAPK signalling pathways (Bokarewa et al., 2005; Tarkowski et al., 2010).  The 
NF-κB pathway may be activated upon activation of the Akt/PI3K pathway via resistin binding 
to Tlr-4 (Sánchez-Solana et al., 2012).  Resistin increases the secretion of pro-inflammatory 
cytokines via MAPK and increases ROS, thereby inhibiting endothelial nitric oxide synthase 
(eNOS) (Nagaev et al., 2006; Sánchez-Solana et al., 2012).  Resistin downregulates various 
steps involved in insulin signalling in adipocytes and stimulate the expression of SOCS-3 
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(Steppan et al., 2005).  Downstream, resistin inhibits the AMPK pathway and hepatic 
gluconeogenesis, and stimulates skeletal muscle uptake of glucose (Barnes and Miner, 2009).  
(3) Leptin, an appetite-supressing hormone, has systemic metabolic actions, indicating energy 
reserves to the central nervous system (CNS) (Bates and Myers, 2003).  Leptin also reduces 
triglyceride accumulation in liver and skeletal muscle through the direct activation of AMPK 
and indirect actions mediated through the CNS, thereby improving insulin sensitivity 
(Minokoshi et al., 2002).  Furthermore, leptin regulates pancreatic β-cell function through direct 
actions such as; leptin resistance in pancreatic β-cells which is one factor that contributes to 
the hyperinsulinemia, β-cell failure, and consequent glucose intolerance in the obese state 
(Morioka et al., 2007), and indirectly through the CNS as sustained hypothalamic leptin 
signalling in the hypothalamus restrain pancreatic insulin release and IR (Boghossian et al., 
2006).  (4) Adipocytes produce angiotensinogen, renin, ACE, and cathepsin D & G (non-
RAAS) (Cassis, 2000).  Angiotensin is involved in the regulation of blood pressure 
(Bestermann et al., 2005).  Locally angiotensin plays a role in growth and development by 
stimulating prostacyclin (conversion of pre-adipocytes to adipocytes) and increasing the 
synthesis and storage of lipids in adipocytes (Ailhaud et al., 2000).  (5) Plasminogen activator 
inhibitor-1 (PAI-1) promotes a pro-thrombotic state.  Activation of coagulation induces PAI-1 
expression by adipocytes and indirectly increases macrophage infiltration, IL-6, and TNF-α 
secretion with FFA and triglycerides exacerbate the process (Berg and Scherer, 2005). 
1.2.2. Amyloid-derived Inflammation  
The deposition of amyloid fibrils in tissue is known as amyloidosis.  Systemic amyloidosis 
occurs when a circulating amyloidogenic precursor protein deposits in various organs.  
Primary systemic amyloidosis occurs when there is deposition of a monoclonal 
immunoglobulin (Ig) light chain and may take place in almost all disorders of B lymphocyte 
lineage, while secondary amyloidosis is associated with chronic low grade inflammation which 
occurs by the accumulation of a N-terminal fragment of acute phase protein serum amyloid A 
(Benditt et al., 1971; Hull et al., 2004).  Localized amyloidosis includes diseases characterized 
by the deposition of amyloid in one specific target organ (Hull et al., 2004).  Senile amyloidosis, 
familial, and transthyretin-associated amyloidosis (ATTR), arise from deposition, in the target 
tissue (e.g. nerve or pancreatic tissue), of wild-type or one or more than 50 mutated forms of 
transthyretin, the most common being the point mutation Val30Met (Saraiva et al., 1984; P 
Westermark et al., 1990).   
Islet inflammation, induced by amyloid toxicity as previously described (section 1.1.2.3), is 
involved in pancreatic β-cell dysfunction and apoptosis by activating pro-inflammatory 
responses (Figure 1.5).  Evidence has shown that amylin interacts with immune cells, resulting 
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in the activation of inflammasomes, which trigger signalling cascades, producing pro-
inflammatory cytokines, such as IL-1β, and by activating the NF-κB pathway as seen in Figure 
1.6 (Abedini and Schmidt, 2013; Masters et al., 2010; Tak and Firestein, 2001; Westwell-
Roper et al., 2014).  At cellular and molecular levels, NF-ᴋB is the inflammation master switch 
that regulates protein synthesis, which is vital for the activation and maintenance of 
inflammation.  At tissue level, cellular stresses can modulate phosphorylation as well as 
transcriptional events by activating JNK and NF-ᴋB, respectively, to control enzymatic 
functions and concentrations of receptors, chemokines, and cytokines (Figure 1.6) (Shoelson 
et al., 2006).  Pro-inflammatory cytokines, IL-1β and IFN-γ, promote iNOS expression, thus 
increasing the production of NO locally (Arnush et al., 1998; Corbett et al., 1993, 1992; Russell 
et al., 2013).  Evidence has indicated that pro-inflammatory cytokines can promote β-cell 
apoptosis, providing one mechanism of β-cell death (Eizirik and Mandrup-Poulsen, 2001; 
Marselli et al., 2001).   
Aging of islet cells is associated with inflammation, with macrophage infiltration seen in old 
islet cells as seen in Figure 1.6 (Sandovici et al., 2016).  It has also been shown that pancreatic 
islet macrophage infiltration increased in patients with T2D (Ehses et al., 2007).  However, it 
is possible that early macrophage infiltration may be beneficial to islet functionality as well as 
its plasticity through cellular fusion (Ehses et al., 2007; Hess et al., 2003), while during disease 
progression, activated macrophages accelerate the dysfunction and death of pancreatic islet 
cells.  Death occurs either through apoptosis or necrosis, as a result of increased levels of IL-
1β and IFN-γ (Figure 1.6) (Collier et al., 2006; Grunnet et al., 2009; Gurzov et al., 2010; Steer 
et al., 2005; Weksler-Zangen et al., 2008).  
As indicated in Figure 1.6, metabolic stressors, such as hyperglycemia, induces production of 
IL-1β by pancreatic β-cells.  Interleukin-1β then perpetuates its own production and induces 
the production of several inflammatory factors, including TNF-α, IL-6, IL-8, and MCP-1, which 
attract macrophages as well as other immune cells; this is dependent on the levels of stress 
and the duration of IL-1β exposure (Butcher et al., 2014; Ehses et al., 2007; Richardson et al., 
2009).  Interleukin-8 attracts macrophages which in turn, exacerbates production of IL-1β 
(Ehses et al., 2008).  Interleukin-1β activates the interleukin receptor type I, inducing 
recruitment of receptor adaptor proteins and signalling by several kinases, such as IkB kinases 
(IKKs).  The IKKs phosphorylate IkB proteins promoting their degradation and stimulate NF-
ᴋB proteins, which translocate to the nucleus from the cytoplasm.  Once in the nucleus, the 
different NF-ᴋB subunits transactivate various genes (eg. iNOS) involved in inflammation 
(Baldwin, 1996; Corbett et al., 1992).  Research proposes that the IKK/NF-ᴋB axis serves as 
the link between inflammation and IR (de Luca and Olefsky, 2008; Shoelson et al., 2006).  
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Tumour necrosis factor-α is seen to influence glucose metabolism, inhibit insulin action and 
blunt pancreatic β-cell function via inflammatory processes (Pickup, 2004).  As mentioned in 
adipose inflammation earlier (section 1.2.1), it can be suggested that TNF-α has an important 
function in the insulin signalling pathway by inhibiting tyrosine kinase activity of the insulin 
receptor, thus reducing the phosphorylation and activation of IRS-1, which in turn reduces the 
cells response to insulin (Figure 1.6).  Reduction of gene expression, which encodes for 
proteins that form the insulin receptor substrates, has also been attributed to TNF-α (Stephens 
and Pekala, 1991).  Tumour necrosis factor-α stimulates the transcription of the IL-6 gene 
(Vanden Berghe et al., 2000; Z Xing et al., 1998) and induces the generation of its receptor 
(März et al., 1996). 
Pro-inflammatory cytokines have been linked with β-cell dysfunction and might lead to 
increased sensitivity to β-cell toxicity, through increased production of the free radical NO, 
which down-regulates cellular metabolism by mitochondrial function inhibition (Figure 1.6) 
(Greenberg and McDaniel, 2002).  Maedler et al. (2002) proposed that that intra-islet 
expression of pro-inflammatory cytokines, particularly IL-1β, contributes to β-cell glucotoxicity 
in the pathogenesis of T2D (Maedler et al., 2002).  Thus, it appears that IL-1β might be a 
master regulator of inflammation in the pancreatic islets in T2D.  Although it has been shown 
that IL-1β can inhibit GSIS in β-cells, the impact of anti-inflammatory cytokines on β-cell 
function is not fully understood (Russell and Morgan, 2014).  A few studies have indicated that 
anti-inflammatory cytokines reverse the inhibitory effects of pro-inflammatory cytokines on 
insulin secretion from β-cells (Marselli et al., 2001).  It can be argued that anti-inflammatory 
cytokines are likely to inhibit IL-1β induced NO production in β-cells; by modulating NF-kB 
activation (Russell and Morgan, 2014).   
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1.3. Beta Secretase Regulation on Beta-cell Inflammation 
The role of BACE in disease progression is controversial and has led to many conjectures of 
whether BACE has a beneficial or detrimental effect in the development of T2D.  Two 
analogues exist, namely BACE1 and BACE2, and while both are type I aspartyl 
transmembrane proteins and 50-68% similar in homology, these proteases target different 
protein substrates (Alcarraz-Vizán et al., 2015; Mirsafian et al., 2014; Southan and Hancock, 
2013; Vassar, 2014; Venugopal et al., 2008).  The latter can be attributed to the fact that 
BACE1 and BACE2 share no similarity in their promotor regions, suggesting that these 
proteases are distinct in their regulation of gene transcription and thus function (Alcarraz-Vizán 
et al., 2015; Casas et al., 2010).  The overall structure of BACEs follow the general structure 
of the aspartyl protease family; comprising a C-terminal domain, a N-terminal domain, and a 
connecting inter-domain (Mirsafian et al., 2014).  The polypeptide, BACE1, consists of 501 aa 
(Lajtha et al., 2008), while BACE2 consists of 518 aa (Bennett et al., 2000).  Polygenetic 
Figure 1.6: Pancreatic beta-cell inflammation.  Diagrammatic presentation of the underlying 
mechanisms involved in pancreatic β-cell inflammation involved in β-cell dysfunction, IR, and 
subsequently T2D (Adapted from Donath et. al. 2014). 
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analysis has shown that BACE1 and BACE2 are similar to cathepsins and pepsins, both these 
proteases are involved in protein cleavage (Southan and Hancock, 2013; Turk et al., 2012), 
suggesting a role for BACE in protein cleavage.  Beta secretase proteases are synthesised in 
the ER as pro-BACE proteins, followed by maturation in the Golgi apparatus.  Beta secretase 
proteins were previously described to cycle between different compartments of the secretory 
pathway in varying proportions in the trans-Golgi, plasma membrane, and endosomes.  Beta 
secretase 1 is mostly found in the secretory pathway of the Golgi apparatus, while BACE2 is 
found in the endocytic pathway, supporting the hypothesis that these proteases differ in 
function (Casas et al., 2010).  Proteins on the cell surface play a role in cell-to-cell 
communication and many of these plasma membrane proteins are involved in insulin secretion 
and pancreatic β-cell mass expansion (Casas et al., 2010; Stützer et al., 2013).  These plasma 
membrane proteins are controlled through cleavage by proteases, including BACE (Stützer et 
al., 2013).  Proteases control the amount, localization, and activities of its substrate targets; 
and are therefore important in mechanisms involved in pancreatic β-cells, to maintain 
homeostasis.  Interfering with the levels of these proteases will not only alter the abundance 
of its substrate proteins but may alter the expression and activities of various other 
downstream proteins indirectly.  
Beta secretase 1 is mostly expressed in the brain and, to a lesser extent, in the pancreas and 
is involved in the cleavage of the amyloid precursor protein (APP), forming amyloid-beta (Aβ), 
a hallmark of AD (Southan and Hancock, 2013; Vassar, 2014; Venugopal et al., 2008).  Beta 
secretase 1 knock-out mice fail to produce Aβ (Southan and Hancock, 2013a; Venugopal et 
al., 2008), whereas overexpression of BACE1 led to elevated levels of Aβ formation (Vassar, 
2014).  Although it is known that BACE1 in the brain plays a significant role in the pathogenesis 
of AD, the role of BACE1 in pancreatic islet cells remains unclear despite its high abundance 
(Stützer et al., 2013).  The high levels of BACE1 expressed in healthy pancreatic islets, 
therefore it can be suggested that BACE1 might be involved in the progression of T2D if 
homeostasis is altered.  Similarly, high levels of BACE2 are expressed in the pancreas, more 
specifically pancreatic β-cells, suggesting that BACE2 might also be involved in the 
progression of T2D (Vassar, 2014).  This suggestion is supported by data that has shown that 
BACE2 is one of only a few proteases reported to play a role in the regulation of pancreatic β-
cell mass and function (Esterházy et al., 2011).   
Aggregation of IAPP directly contributes to β-cell dysfunction, therefore exacerbating 
deleterious effect of T2D (Abedini and Schmidt, 2013; Alcarraz-Vizán et al., 2015a; Jeong and 
An, 2015).  Overexpression of IAPP has been shown to block autophagy in β-cells, interfering 
with the degradation of BACE2 and resulting in increased cleavage of TMEM27.  A positive 
correlation is seen between BACE2 and IAPP.  The latter can be explained by the strong 
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correlation seen between the process of amyloidogenesis and the loss of pancreatic β-cell 
mass and insulin secretion deficiency.  It can further be explained by BACE2 inhibition 
counteracting hIAPP-induced insulin secretory defects by increasing insulin secretion 
(Alcarraz-Vizán et al., 2017, 2015).  Understanding how β-cells respond to amyloidosis is thus 
essential for novel therapeutic approaches. 
Transmembrane protein 27 is expressed in pancreatic β-cells where it plays a functional role 
in β-cell proliferation, β-cell mass, as well as GSIS (Esterházy et al., 2011; Southan and 
Hancock, 2013).  Transmembrane protein 27 is regulated by ectodomain shedding, resulting 
in a N-terminal fragment released into the extracellular space and a C-terminal fragment which 
remains in the membrane and is further processed through regulated intermembrane 
proteolysis (RIP).  The shedding process is known to inactivate TMEM27 (Esterházy et al., 
2011; Stützer et al., 2013).  Transmembrane protein 27 levels are reduced in diabetic animals, 
with associated decreased islet mass, whereas increased expression of TMEM27 increases 
islet mass as well as cellular insulin content (Akpinar et al., 2005; Altirriba et al., 2010).  
Reduced levels of TMEM27 correlate negatively with BACE2 expression (Alcarraz-Vizán et 
al., 2015).  The expression of TMEM27 and its role in β-cell mass, as well as insulin-stimulatory 
activity led to the hypothesis that β-cell growth and function can be improved by targeting the 
proteases involved in TMEM27 cleavage, in particular BACE2 (Esterházy et al., 2011; Stützer 
et al., 2013).  Beta secretase 2 knockout in mice resulted in higher β-cell mass, proliferation, 
and glucose homeostasis supporting the above mentioned hypothesis (Alcarraz-Vizán et al., 
2015; Vassar, 2014).  The provided evidence thus suggests contradicting roles of BACE2 in 
the progression T2D, suggesting BACE2 may have both beneficial and detrimental effects on 
pancreatic β-cells.  Inhibition of the enzymatic activity of proteases of pancreatic β-cells affects 
intracellular trafficking of the insulin receptor, the expression of the insulin gene, and insulin 
content proposing that BACE is involved in maintaining β-cell function.  Moreover, BACE2 
inhibition has shown to reduce toxic amyloid depositions in pancreatic islets (Alcarraz-Vizán 
et al., 2015; Casas et al., 2010), therefore BACE2 can be suggested as a therapeutic target.  
It has been proposed that BACE2 operates exclusively at intracellular sites, therefore its 
expression could be readily restricted to the site of administration (Abdul-Hay et al., 2012).  
The double drug target status of BACE’s, with the incomplete functional picture of both BACE1 
and BACE2, thus needs further investigation into the effect of its inhibition (Southan and 
Hancock, 2013).  
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1.4. Current Anti-diabetic Therapies: Implications for Beta-cells 
It is important to elucidate the underlying mechanisms of β-cell dysfunction to prevent or delay 
the onset and progression of T2D in individuals at risk.  To date, treatments attempting to 
protect β-cells focus mainly on pathogenic targets of T2D, such as IR and β-cell dysfunction.  
Theoretically, β-cell protection can be accomplished through mechanisms preventing β-cell 
dysfunction induced by stressors such as glucotoxicity, lipotoxicity, IR, oxidative stress, and 
inflammation.  
Lifestyle changes, such as regular exercise and a healthy diet, are shown to improve insulin 
sensitivity and reduce β-cell insulin demand, as well as improve the immediate environment 
of islets through improved blood flow and a reduction in stressors.  Lifestyle changes also 
decrease FFA and thus lipotoxicity (Eriksson and Lindgärde, 1991; Laaksonen et al., 2005; 
Pan et al., 1997; Tuomilehto et al., 2001).  
1.4.1. Pharmaceutical Therapies 
 Glucotoxicity 
Conventional T2D drugs including biguanides (i.e.Metformin), sulphonylureas (i.e. Glyburide, 
Glipizide, and Glimepiride), alpha-glucosidase inhibitors (i.e. Acarbose and Miglitol), and 
thiazolidinediones, PPAR-γ agonists (i.e. Rosiglitazone and Pioglitazone) are seen to protect 
β-cells by decreasing glucose levels and consequently glucotoxicity (Figure 1.7), as seen in 
clinical trials attempting to prevent or delay the onset of T2D.  It seems that thiazolidinediones 
are more effective due to its agonists’ antioxidant, anti-inflammatory, and anti-apoptotic 
properties (Parulkar et al., 2001).  Rossetti and co-workers showed that stabilization of glucose 
levels with phlorizin, a glycosuric agent, restores insulin secretion, and subsequently reduces 
the risk of glucotoxicity (Rossetti et al., 1990).   
 Insulin Resistance 
Impaired insulin secretion can also be targeted via mechanisms involved in IR.  Islets that 
have the IRS-1 polymorphism show a reduction in mature insulin granules and impaired 
glucose responses (Marchetti et al., 2002).  It’s seen that thiazolidinediones stimulate insulin 
signalling pathways (Marchetti et al., 2002).  It can be postulated that amendment of insulin 
sensitivity of islets should lead to (1) improved insulin secretion, as an elevation in insulin 
response to oral glucose tolerance test (OGTT) is seen by using PPAR-γ agonists, and (2) 
improved survival of β-cells as using Rosiglitazone (a thiazolidinedione part of PPAR-γ 
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agonists) is seen to maintain islets in a better condition than treatment with Metformin (a 
biguanide) or Glibenclamide (a sulphonylurea) (Miyazaki et al., 2002).  The deficiency of 
protection by Metformin is surprising as it has both anti-apoptotic (Marchetti et al., 2004) and 
anti-inflammatory (Hattori et al., 2006) properties; whereas the deficiency of protection by 
Glibenclamide is coherent with the finding that Glibenclamide has a pro-apoptotic effect on β-
cells (Maedler et al., 2005).  These findings indicate that IR plays a crucial role in β-cell 
impairment and that insulin sensitizing agents may improve insulin secretion by reducing 
hyperglycemia and consequently β-cell stress.   
 Lipotoxicity 
Beneficial effects of decreased body mass on β-cells can be improved further by anti-obesity 
drugs such as lipase inhibitors (i.e. Orlistat) (Torgerson et al., 2004) which reduce the 
accumulation of excessive adipose.  The deleterious effects of FFA are seen to be prevented 
by pre-incubation with Rosiglitazone (Lupi et al., 2004), acting via its anti-inflammatory 
properties, as elevated FFA levels is seen to stimulate the NF-κB pathway.  Thus, β-cell 
protection against lipotoxicity may be utilised through this mechanism.  It has been observed 
that thiazolidinediones are able to decrease circulating FFA (Balfour and Plosker, 1999).  As 
mentioned before (section 1.2.1.3; 1.2.1.4), adipose tissue secretes damaging molecules 
(Unger and Zhou, 2001), and therefore damaging effects may not only be as a result of FFA 
but also cytokines.  Furthermore, statins (i.e. Pravastatin), are seen to reduce lipotoxicity, 
especially a reduction in triglycerides (Freeman et al., 2001), mediated by its antioxidant and 
anti-inflammatory properties (Liao and Laufs, 2005), reducing oxidative stress and 
inflammation.  However, statins are also implicated in perpetuating T2D by perpetuating IR as 
reviewed by (Cybulska and Kłosiewicz-Latoszek, 2018). 
 Oxidative Stress and Inflammation 
Treatment with antioxidant agents, such as aminoguanidine and N-acetylcysteine, decreases 
abnormalities in insulin gene expression and the deficit of transcription factors (e.g. PDX-1) 
due to hyperglycemia (Tanaka et al., 1999).  Protection of β-cells from oxidation might be due 
to Gliclazide, a sulphonylurea which has the ability to scavenge free radicals (Kimoto et al., 
2003).  Protection of β-cells might also be accomplished by RAS inhibitors and statins, both 
seen to have pleiotropic effects, decreasing endothelial dysfunction, oxidative stress, and 
inflammation.  Proposed mechanisms of RAS inhibitors on β-cell function include increased 
levels of K+, improved insulin secretion, increased blood flow and β-cell perfusion (Carlsson 
et al., 1998) as well as anti-apoptotic properties (Tikellis et al., 2004).  Additionally, RAS 
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inhibitors prevent glucotoxicity in β-cells (Lupi et al., 2006), by decreasing oxidative stress 
(Nakayama et al., 2005).  Angiotensin II impairs insulin signalling pathways, while RAS 
inhibitors are seen to improve these pathways (Andreozzi et al., 2004; Shiuchi et al., 2004).  
Protection by RAS inhibitors, seen with improved glucose metabolism can be explained by the 
additional use of ACE inhibitors, which increase bradykinin, exerting its function on signalling 
and glucose transport (Henriksen et al., 1999).  Moreover, a reduction in angiotensin II 
promotes proliferation of pre-adipocytes into mature adipocytes (Sharma et al., 2002), 
reducing FFA and increasing adiponectin, consequently improving glucose consumption in 
skeletal muscles, glucose production in the liver and β-cell insulin secretion.  Furthermore, 
some angiotensin II receptor blockers (ARBs), such as Telmisartan, bind to PPAR-γ amplifying 
its effect on glucose metabolism (Benson et al., 2004). 
Taken together, protection of pancreatic β-cells by an insulin sensitizing effect, in addition to 
reduced glucotoxicity, lipotoxicity, oxidant stress, and inflammation by thiazolidinediones may 
be used to explain glucose responses exerted by monotherapy with, for example, 
Rosiglitazone when compared to monotherapy with Glibenclamide (sulphonylurea) or 
Metformin (biguanide), as seen in the ADOPT Study (Kahn et al., 2006). 
It is important to note that these drugs do not just exert its protective effect on one of the 
stressors directly but might indirectly have an effect on another stressor(s), exerting its 
functions through several shared mechanisms. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Current anti-diabetic therapies.  Schematic presentation of therapies used to 
target pathophysiological factors such as; glucotoxicity, IR, lipotoxicty, chronic low-grade 
inflammation, and oxidative stress to prevent, delay, or treat T2D (Bonora, 2008). 
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1.4.2. Potential Role of Rooibos in Beta-cell Inflammation 
Therapeutics available for treatment of T2D are limited in their ability to treat the disease state 
due to issues with patient compliance, a lack of systemic efficacy, and adverse side effects 
(Ku et al., 2015).  As a result of the latter, traditional medicine, such as plant-derived products, 
are studied for the beneficial properties they possess (Waisundara and Hoon, 2015).  Plant 
polyphenols have long been of interest due to their strong antioxidant properties and ability to 
ameliorate diabetic complications (Chen et al., 2013; Kawano et al., 2009; Kumarappan and 
Mandal, 2008; Zang et al., 2006).  Rooibos (Aspalathus linearis), an indigenous South-African 
plant, is well known as a rich source of polyphenols with antioxidant and anti-inflammatory 
properties (Beltrán-Debón et al., 2011; Joubert et al., 2008; Joubert and de Beer, 2011).  It 
has been shown that plasma antioxidant status improves as a result of polyphenol exposure, 
also decreasing oxidative stress (Dludla et al., 2014; Villaño et al., 2010).  Aspalathin, unique 
to Rooibos, and PPAG, both phenolic components of Rooibos, have been shown to increase 
glucose uptake in muscle cells and insulin secretion from β-cells (Bramati et al., 2002; Kawano 
et al., 2009; Ku et al., 2015; McKay and Blumberg, 2007).  Additionally, the improved uptake 
of glucose as a result of PPAG can be attributed to PPAG’s improved FA oxidation in IR rats 
(Muller et al., 2013).  It has been seen that Rooibos exerts hypolipidemic activity in 
hyperlipidemic mice but the effect was strictly diet dependent (Beltrán-Debón et al., 2011).  
Cardiomyocytes that were pre-treated with fermented Rooibos extract showed reduced ROS 
formation as well as apoptosis (Dludla et al., 2014).  Possible mechanisms by which Rooibos 
flavonoids reduce oxidative stress are through direct or indirect scavenging of free radicals, 
interfering with inducible iNOS, inhibition of xanthine oxidase, immobilization as well as 
adhesion of leukocytes to the endothelial wall through interaction with several enzyme 
systems (Ayeleso et al., 2014; Kawano et al., 2009; Nijveldt et al., 2001).  The previously 
reported anti-inflammatory effects of Rooibos might be as a result of a decline in macrophage 
recruitment observed in studies (Beltrán-Debón et al., 2011).  Also, it has been proposed that 
Asp might exert its effect via an insulin/insulin-like signalling pathway (Chen et al., 2013; 
Kawano et al., 2009).  
1.4.3. Potential Role of Rooibos on Amyloid Formation  
In addition to antioxidant properties, several studies have indicated that polyphenols, including 
flavonols and flavones, have a protective effect against Aβ formation and aggregation 
(Shimmyo et al., 2008).  Secondary metabolites of plants have a relatively low molecular 
weight and lipophilicity and are thus good candidates as BACE1 inhibitors (Jeon et al., 2003).  
A study performed by Jeon et al. (2003) showed that the methanolic extract of commercial 
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green tea has high inhibitory activity of BACE1.  Catechin, a type of polyphenol commonly 
found in green tea, has also been seen to inhibit BACE1 in a dose dependent and non-
competitive manner.  Similarly, a study performed by Shimmyo et al. (2008) showed that four 
flavonols; quercetin, kaempherol, myricetin, and morin, and one flavone, apigenin, directly 
inhibited BACE1 activity in both a cell-free system and neuronal cells (Shimmyo et al., 2008).  
However, therapeutic BACE1 inhibition to block Aβ production and associated toxicity needs 
to be balanced as negative effects might arise from diminishing other physiologic functions of 
BACE1, in particular processing of substrates involved in neuronal function of the brain and 
periphery (Koelsch, 2017). 
Luteolin and its two derivatives, orientin and isoorientin have been reported to have antioxidant 
(Ko et al., 1998), anti-inflammatory, and anti-diabetic effects (Alonso-Castro et al., 2012; Fu 
et al., 2010; López-Lázaro, 2009).  In addition, Choi et al. (2014) showed inhibition of 
acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and BACE1 by luteolin, orientin, 
and isoorientin, found at 0.007 g, 0.263 g, and 0.450 g per 100 g soluble solids (SS), 
respectively (Joubert and de Beer, 2011).  In the same study by Choi et al (2014), apigenin, 
and its derivatives vitexin and isovitexin also showed inhibitory activity against AChE and 
BChE, while only vitexin showed inhibitory activity against BACE1 (Choi et al., 2014).  It is 
proposed that the BACE1 promoter contains NF-κB binding elements (Bourne et al., 2007) 
and therefore elevated BACE1 expression elevates Aβ levels via NF-κB-dependent pathways 
(Buggia-Prevot et al., 2008).  Moreover, research has suggested that luteolin suppresses 
signal transducer and activator of transcription-1 (STAT-1), interferon regulatory factor-1 (IRF-
1), and NF-κB signalling pathways, thus attenuating inflammatory response of microglial cells 
(Kao et al., 2011).  Chronic treatment with luteolin is seen to inhibit BACE1 activity and reduce 
Aβ levels in the brain (Zheng et al., 2015).  The underlying protective mechanism of luteolin 
might thus be mediated by the inhibition of NF-κB (Fu et al., 2014).   
Quercetin and rutin, both flavonoids found respectively at 0.001 g and 0.245 g per 100 g SS 
in unfermented Rooibos (Domitrović et al., 2012; Joubert and de Beer, 2011; Kang et al., 2013; 
Pan et al., 2014; Shi et al., 2013), enhanced the transcription of nuclear factor-like 2 (Nrf2), 
which upregulates the expression of the proteasome catalytic subunits.  It is seen that both 
quercetin and rutin reduce the activation of caspase-3 in APP695-transfected SH-SY5Y bone 
marrow derived cells, where the reduction correlates with the reduction of proteasome activity 
(Martín-Aragón et al., 2016).  Interestingly, degradation of BACE proteins is regulated by the 
ubiquitin-proteasome pathway (UPP) (Qing et al., 2004) as a lowering of BACE and an 
enhancement of its processing is seen in APP695-transfected SH-SY5Y bone marrow derived 
cells treated with rutin (Martín-Aragón et al., 2016).  In the case of BACE inhibition studies for 
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flavonoid derivatives, many controversial results have been reported and might be as a result 
of the difference in concentrations used.   
Diabetes is a chronic, systemic, and slow progressing disease.  Insights into the mechanisms 
involved in inflammation, including that of BACE, and resultant dysfunction of pancreatic β-
cells in the pathogenesis of T2D, may reveal an opportunity for the development of novel 
therapeutics that directly protect and preserve β-cells.  The protective role of antioxidants, 
such as plant polyphenols, against inflammation is increasingly under investigation.  Taking 
into consideration all of these aforementioned anti-diabetic properties of Rooibos, as well as 
the possible BACE inhibitory properties of specific phenolic compounds, we postulate that 
Rooibos may have acute anti-inflammatory effects in pancreatic β-cells and additionally may 
have the ability to modulate BACE, thus further enhancing the anti-diabetic effect.  
Thus, the question that arises is whether chronic, low-grade inflammation perpetuates 
the deleterious effects of amyloid and what the implications for BACE regulation are? 
1.5. Models to Study Beta-cell Inflammation 
1.5.1. Cellular Mechanistic Studies 
Living organisms are not the sum of their components, but rather the interaction between 
cellular components and their environment that determines functionality.  Failure of these 
interactions to maintain homeostasis leads to pathophysiology and thus progression of 
complex and often chronic diseases.  Despite the indication of numerous physiological 
processes such as insulin secretion, inflammation, and amyloid formation, some of the exact 
molecular mechanisms underpinning T2D still need to be elucidated.  Therefore, it is vital to 
perform research on these exact mechanisms, integrate the mechanisms by which they are 
beneficial or deleterious on tissues and organ systems, and find ways to identify signals 
mediating the processes.  Understanding the link between these pathological mechanisms 
and the consequent health outcomes may lead to potentially novel molecular and cellular 
therapeutic targets for disease prevention or delay.  However, challenges such as knowing 
exactly what to measure, when to take a measurement, and linking specific measurements to 
a disease/health outcome remain.  Identification of proteins involved in physiological 
processes of interest and quantifying their content as well as function are pre-requisites to 
overcome these challenges.  The lack of appropriate animal models needs to be considered, 
since animal models used don’t always reveal the full effect of a protein or substance.  Animal 
models could be used to test novel molecules previously identified in cell culture studies, 
bearing in mind that interspecies translation needs to be negotiated.  
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1.5.2. Pancreatic Beta-cell Lines vs. Rodent Models  
 Pancreatic Beta-cell Lines 
Research using β-cells is limited by the availability of pancreatic tissue and cellular and 
hormonal heterogeneity amongst donors.  The isolation, purification of β-cells and the 
maintenance of their in situ properties remain challenging.  In vitro cell culture studies provide 
an opportunity to assess physiological and pathophysiological processes before translating 
the findings to animal models.  Additionally, cell lines allow researchers to determine the 
effects of treatments, under different conditions, subsequently leading to the potential 
development of therapeutics (MacDonald, 1990; Skelin et al., 2010).  Cell structure, behaviour, 
and functional preservation is vital in ensuring that responses observed represent responses 
in the human body.  Furthermore, it is important that there is consistency amongst 
experiments, and that the experiments are reproducible.  Immortal cell lines are populations 
of cells that continuously undergo division and are not limited by the “Hayflick” limit proposed 
by Leonard Hayflick, who discovered that cultured human cells have limited capacity to divide, 
after which the cells become senescent.  Therefore, these cells can be grown for continuous 
periods in vitro and are used to determine protein functions and to assess effects of exogenous 
protein expression on signalling of transcriptional processes (Shay and Wright, 2000).  Since 
the majority of cells used have a tumourogenic origin, allowing continuous growth, they may 
have genetic mutations, altered chromosomal content and protein expressions, and thus 
modified metabolism profiles (MacDonald, 1990).  These changes over a period of continuous 
growth indicate that cell lines also have disadvantages; however, with these shortcomings 
taken into consideration, invaluable information is gathered without the use of sentient 
animals.  Furthermore, by using a single cell line heterogenous cell to cell interaction is absent, 
which influences other cellular mechanisms and cell functions.  The latter may explain why 
some pancreatic β-cell lines present with impaired secretory properties and are unable to 
respond to glucose under normal physiological conditions (Skelin et al., 2010).  To date, no β-
cell line mimics human β-cell physiology entirely, but they are important in investigating 
molecular mechanisms underlying β-cell function as well as dysfunction (Skelin et al., 2010).  
Insulin-secreting cell lines that are widely used include rat insulinoma cells (RIN), hamster 
pancreatic beta cells (HIT), transgenic C57BL/6 mouse insulinoma cells (MIN), insulinoma 
cells (INS1) and beta-tumour cells (βTC).  However, RIN cells have abnormal properties of 
glucose transport and/or phosphorylation and exhibit abnormal glucose sensitivity which fail 
to stimulate insulin release (Halban et al., 1983).  Hamster pancreatic beta cells have low 
insulin content, about 2.5 - 20 times lower than in normal hamster islets, which contain about 
56 μg of insulin per mg protein (Santerre et al., 1981).  Transgenic C57BL/6 mouse insulinoma 
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cells sometimes show a sudden loss of glucose-induced insulin secretion as the passage 
number increases, possibly due to an  outgrowth of cells with a poor response to glucose or a 
reduced gene expression responsible for glucose-induced insulin secretion (Miyazaki et al., 
1990).  Beta-tumour cells are seen to have increased hexokinase activity after several 
passages and thus influencing glucose sensitivity (Efrat, 2004; Efrat et al., 1988).  The INS1 
insulinoma cell line is derived from rat insulinomas, induced by X-ray irradiation, and 
possesses important properties of β-cells, such as good responses to glucose and moderate 
levels of insulin content (Asfari et al., 1992).  Thus, although, β-cell lines are associated with 
some limitations, they provide valuable information about physiological and pathophysiological 
processes.   
 Rodent Models 
The alternative to cell lines is the use of animal models, in the case of amyloid studies, 
transgenic animal models such as rodents do not develop islet amyloid deposits, even though 
the IAPP sequence are present; making it difficult to study the effect of amyloid deposits in the 
progression of T2D (Gilead and Gazit, 2008).  The IAPP sequence of rats (rIAPP) differ from 
human IAPP (hIAPP) in 6 of the 37 aa as indicated in Figure 1.8, and contains 3 proline 
residues in this region known to not favour β-sheet structures.  Non-transgenic rodent models 
used to study T2D thus limit the investigation of amyloid and its effect on the associated 
physiological processes (P. Westermark et al., 1990).  These models are seen to result in 
maintained elevated levels of plasma insulin in addition to increased levels of glucose, 
indicating that IR rather than insulin insufficiency is a factor in diabetic models.  Therefore, 
mimicking islet amyloid-related impairment of β-cells, as observed during development of T2D, 
incorporation of hIAPP into rodent models may be used to investigate the disease state 
(Höppener et al., 1999).  It is seen that transgenic mice overexpressing hIAPP are not effective 
in inducing islet amyloid formation and deposition (Höppener et al., 1993).  In overcoming this 
limitation Hoppener et al (1999) crossed hIAPP transgenic mice with ‘ob’ mice.  The 
homozygous mice (ob/ob) developed IR and subsequently diabetes as a result of a mutation 
in the leptin gene (Zhang et al., 1994).   
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Taking all the above-mentioned advantages and disadvantages of pancreatic β-cell lines and 
transgenic rodent models into consideration, using the INS1 cell line for the purpose of this 
specific study seems suitable.   
1.6. Summary 
In T2D pancreatic β-cells are subject to damage as a consequence of inflammation and the 
formation of amyloid.  With the incidence of T2D increasing globally therapeutic protection of 
β-cells remains a health care priority.  In order to complete the picture of T2D progression, 
mechanisms involved in inflammation and subsequent amyloid depositions and vice versa, 
needs further investigation.  Investigating these mechanisms may provide insights into the role 
of inflammation and BACE regulation in pancreatic β-cell impairment and may thus reveal an 
opportunity for the development of novel therapeutics to protect and preserve pancreatic β-
cells, in this case by targeting the activities of BACE.  The protective effect of antioxidants, 
from plant polyphenols, against inflammation is increasingly under investigation.  Rooibos 
extract, rich in Asp and PPAG, may provide novel therapeutics by directly targeting BACE to 
regulate this enzyme’s activities, consequently decreasing inflammation and the progression 
of T2D.  Thus far, neither the BACE inhibitory effect, nor the anti-inflammatory effect of 
Rooibos in β-cells has been reported on. 
 
Figure 1.8: Human amylin vs. rat amylin.  Primary sequence of human and rat IAPP.  Amino 
acid residues in pink indicate the six differences between human and rat IAPP (Lopes et al, 
2007).  The IAPP sequence of rats differ from hIAPP in 6 of the 37 aa, 5 of the aa are found 
between the 20th and 29th residue, hIAPP (20-29) is SNNFGAILSS and rIAPP (20-29) is 
SNNLGPVLPP (Betsholtz et al., 1989; Glenner et al., 1988; P. Westermark et al., 1990).   
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Study Aim and Objectives 
Aim 
To determine if GRT or two of its most bioactive polyphenols have BACE2 inhibition activity 
and can reduce pro-inflammatory effects in INS1 pancreatic β-cells. 
Objectives 
1. To test drug targets in pancreatic beta-cells with induced inflammation.  
Establish a model of inflammation in INS1 cells by the preliminary screening of individual 
cytokines as well as a cytokine cocktail to induce moderate inflammation, representative of 
the disease state; T2D.  Assess the effect(s) on β-cell function (i.e. GSIS, proliferation rate, 
and amylin secretion), viability (i.e. cellular ATP production and cell death), and oxidative 
stress (ROS and NO production). 
2. To screen GRT extract, as well as two of its most bioactive polyphenols, Asp and 
PPAG, for beta secretase inhibition activity.  
In achieving this objective, a purified enzyme assay will be used to screen potential drug 
targets (derived from and including Rooibos) for BACE2 inhibition activity.  Following these 
concentration response studies, the effective concentration(s) of the potential targets will be 
used to screen in vitro, using pancreatic β-cells with experimentally induced inflammation. 
3. Determine the association between beta secretase 2 regulation and beta-cell 
inflammation. 
Changes in BACE enzyme activity will be measured in the INS1 cells with induced 
inflammation (objective 2).  Possible correlations between BACE2 activity and inflammation 
will be investigated. 
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CHAPTER 2 
Materials and Methods 
A complete list indicating the suppliers and catalogue numbers of consumeables, assays, and 
equipment are found in Addendum F. 
The protective effect of Asp, PPAG, and Afriplex GRT extract on pancreatic β-cells with 
experimentally induced inflammation, was assessed.  Rat insulinoma cells were used to 
assess cell viability, function, and oxidative stress, all measured in several experimental 
techniques to verify findings.  Furthermore, BACE inhibition activity of Asp, PPAG, and GRT 
was assessed in a purified BACE enzyme assay as well as kinetically in vitro (Figure 2.2).  
The GRT extract (Afriplex (Pty) Ltd., Paarl, South Africa) contains 12.78% of Asp (Figure 2.1 
A) and 0.42% of PPAG (Figure 2.1 B) (Patel et al., 2016).  Aspalathin (batch: SZ1-356-54) 
has a purity of ± 99% and was produced synthetically based on a method described by Han 
et al. (2014).  Synthetic PPAG has a purity of ˃99% (high-performance liquid chromatography 
(HPLC)) and was produced based on a method described by Marais et al. (1996).  Both Asp 
and PPAG were produced by High Force Research Ltd. (Durham, England). 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Figure 2.1: Chemical structure of Asp and PPAG.  Chemical structure of Asp (A) and PPAG 
(B) (From: Muller et al. 2012;2013). 
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Figure 2.2: Experimental design.  The protective effect of Asp, PPAG, and Afriplex GRT extract on INS1 pancreatic β-cells with induced 
inflammation was assessed.  Cytokine cocktail A contains: 1.1 ng/ml of TNF-α, 1.0 ng/ml of IFN-γ, and 0.1 ng/ml of IL-1β.  The dosages of Asp 
and PPAG were: 0.1, 1, 10, 100, and 1000 μM, while GRT dosages were: 0.0001, 0.001, 0.01, 0.1, and 1.0 mg/ml.  Cell viability, function, 
oxidative stress, and protein expression was assessed.  Beta secretase inhibition activity of Asp, PPAG, and GRT was also assessed in a purified 
BACE enzyme assay and kinetically, compared to a known BACE inhibitor (LY2886721). 
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2.1. Purified Beta Secretase Enzyme Assay 
Beta secretase inhibition was assessed using a BACE activity detection kit.  The assay is 
based on the FRET method.  This assay is useful as it measures the fraction, or efficiency, of 
transferred energy from a donor (fluorophore) to an acceptor (chromophore) (Jares-Erijman 
and Jovin, 2003).  Initially, the donor absorbs the energy due to the excitation of incident light 
and transfers this energy to a nearby acceptor.  The emitted light is at wavelengths centred 
near the emission maximum of the acceptor.  Energy transfer manifests itself by decreasing 
or quenching of the fluorescence signal of the donor accompanied by an increase in acceptor 
fluorescence intensity (Masters, 2014).  Thus, by attaching fluorophores, referred to as probes, 
to known sites within molecules (i.e. BACE), the efficiency of energy transfer can be 
measured.  In this assay the fluorescence signal is enhanced when BACE cleaves the 
substrate.  The BACE inhibition activity of various concentrations of Asp, PPAG, and GRT was 
measured after 2 hours incubation at room temperature.  Thereafter, the fluorescence signal 
was measured at Ex320 nm / Em405 nm, by using a SpectraMax i3 multimode plate reader.  
Beta secretase inhibition by Asp, PPAG, and GRT was compared to a known BACE inhibitor, 
N - (3 - ((4aS, 7aS) – 2 – amino - 4a, 5, 7, 7a – tetrahydro - 4H – furo [3, 4-d] [1, 3] thiazine - 
7a - yl) – 4 - fluorophenyl) – 5 - fluoropicolinamide (LY2886721).  This inhibitor is a potent and 
selective BACE inhibitor with an IC50 of 20 nM for recombinant hBACE.  The inhibitor does not 
inhibit other aspartyl proteases such as cathepsin D, pepsin, and renin (End et al., 2001; Lubet 
et al., 2006).  Fluorescence values used were extrapolated from the standard curve generated.  
Values used for the standard curve were: 100, 200, 300, and 500 pmol.  Concentrations of 
Asp, PPAG, and GRT were as follows:     
 
Table 2.1: Concentrations of Asp, PPAG, and GRT.  Concentrations of Asp, PPAG, and 
GRT used for experiments. 
 
Treatment Concentrations 
LY2886721 (µM) 0.0039 0.039 0.39 3.9 39 
GRT (mg/ml) 0.0001 0.001 0.01 0.1 1.0 
PPAG (µM) 0.1 1.0 10 100 1000 
Asp (µM) 0.1 1.0 10 100 1000 
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2.2. Cell Maintenance 
All cell culture procedures were performed by applying aseptic techniques (Addendum A). 
2.2.1. Thawing of Rat Insulinoma Cells 
A cryogenic vial containing 1.9 x106 INS1 cells (passage number 22; which was the same 
passage number consistently used for this study), stored in liquid nitrogen, was thawed in a 
pre-warmed water bath at 37°C.  Thereafter, the cell suspension was transferred into a 15 ml 
falcon tube containing 10 ml pre-warmed complete growth medium (RPMI 1640 supplemented 
with 200 mM L-glutamine, 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) and 10% fetal bovine serum (FBS).  The 15 ml falcon tube was centrifuged at 800 x 
g for 5 minutes.  The complete growth medium was aspirated, and the pellet resuspended into 
10 ml of pre-warmed complete growth medium.  The 10 ml of cell suspension was then divided 
into two 75 cm2 cell culture flasks with the addition of 10 ml pre-warmed complete growth 
medium (total volume of 15 ml).  Following one day of incubation under standard cell culture 
conditions (37°C in humidified air containing 5% CO2) the complete growth medium was 
refreshed.  The cells were then incubated under standard cell culture conditions for another 
three days, before sub-culturing (section 2.2.2).  
2.2.2. Sub-culture  
Sub-cultures of INS1 cells were created by scraping the adhered cells in the 75 cm2 cell culture 
flasks when a confluency of 80-90% was reached after 4 days.  Thereafter, the cells in the 
growth medium were mixed and a small volume (± 500 μl) of the cell suspension was collected 
for cell counting and viability assessment.  A volume of 10 μl, containing both cell suspension 
and trypan blue in a 1:1 ratio, was added to one of the haemocytometer chambers.  
Subsequently, the viability of the cells was determined by counting the viable (unstained) and 
non-viable (blue stained) cells (Figure 2.3 A).  Cells were counted in four of the nine 1.0 x 1.0 
mm blocks (Figure 2.3 B).  If the % cell viability was below 90% the cells were discarded.  The 
viable cells, (Figure 2.3 A and C), were then seeded at 8x105 cells per 75 cm2 culture flasks 
and at 7.9 x105 cells per 25cm2 culture flasks, in a total volume of 15 ml and 3 ml of pre-
warmed complete growth medium, respectively.  For the experiments, cells were seeded at 
1x104 cells per well into a 96-well plate and at 3x105 cell per well into a 6-well plate, in a total 
volume of 200 μl per well and 3 ml complete growth medium, respectively, and plates were 
then incubated under standard cell culture conditions (Figure 2.3 C).  After three days of 
incubation the 96-well plates were used for assays. 
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2.3. Treatment  
Although the study aimed to mimic a T2D scenario in INS1 cells, co-exposure to high glucose 
levels, in addition to inducing an inflammatory state, was excluded for the preliminary 
screening of GRT, Asp, and PPAG.  Glucotoxicity induce inflammation and therefore 
inflammation was directly induced with cytokines. 
2.3.1. Inflammation Model – Rat Insulinoma Cells 
In order to assess the putative protective effect of Asp, PPAG, and GRT against the damaging 
effects of T2D on pancreatic β-cells, a model of moderate inflammation was developed.  The 
model was developed by exposing INS1 cells to inflammatory stressors such as; TNF-α, IFN-
γ, IL-1β, as well as two cytokine cocktails containing different concentrations of all three 
cytokines for periods of 3, 6, and 24 hours.  The concentrations of TNF-α assessed were 100; 
25; 10; and 1.1 ng/ml.  The concentrations of IFN-γ assessed included 100; 50; 10; and 1 
ng/ml and for IL-1β 10; 1; 0.1; and 0.01 ng/ml.  Cytokine cocktail A contained: 1.1 ng/ml of 
TNF-α, 1 ng/ml of IFN-γ, and 0.1 ng/ml of IL-1β (Chellan, 2014).  The second cytokine cocktail, 
B, contained: 25 ng/ml of TNF-α, 10 ng/ml of IFN-γ, and 10 ng/ml of IL-1β (Yang et al., 2015).  
After each time point, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
Figure 2.3: Cell viability.  Equation for cell viability (A); blocks (1.0 x 1.0 mm) counted on 
haemocytometer to calculate the cell number and relative viability (B); equation for calculating 
the volume of cell suspension (ml) needed for seeding (C). 
A B 
C 
Stellenbosch University  https://scholar.sun.ac.za
  42 | P a g e  
 
tetrazolium (MTT) assay (section 2.4.1) was performed to assess cell viability, measured by 
mitochondrial dehydrogenase tetrazolium activity.  The efficacy of Asp, PPAG, and GRT at 
various dosages against moderate inflammation induced in pancreatic β-cells by these 
cytokines was the assessed.  The stressors were made up in complete growth medium; the 
latter on its own without cytokines served as negative control or vehicle control.  Cytokine 
cocktail A was most effective in inducing a moderate state of inflammation in β-cells and was 
thus used for co-treatment in the experiments. 
2.3.2. Exposure to Asp, PPAG, and GRT  
The protective effect of Asp, PPAG, and GRT on moderate inflammation in INS1 pancreatic 
β-cells was assessed by exposing the INS1 cells to various dosages of Asp, PPAG, and GRT 
for 24 hours.  Concentrations of Asp, PPAG, and GRT were the same concentrations as 
indicated in Table 2.1.  A MTT assay was used to assess cell viability at all concentrations.  
For the co-treatment with cytokine cocktail A, and either Asp, PPAG, or GRT, a MTT assay 
was performed after 24 hours to assess cell viability.  All the treatments were made up in 
complete growth medium, the latter served as negative control, while cytokine cocktail A 
served as positive control. 
2.4. Cell Viability  
2.4.1. MTT Assay  
The MTT assay is a quantitative colorimetric assay that measures cell survival and 
proliferation by detecting mitochondrial dehydrogenase activity in living cells, as the 
tetrazolium ring is only cleaved in active mitochondria.  The signal generated is dependent on 
the degree of mitochondrial dehydrogenase activity in the cells (Mosmann, 1983).  Tetrazolium 
salt is used in this colorimetric assay as it measures the activity of various dehydrogenase 
enzymes (Slater et al., 1963).  The conversion of the yellow tetrazolium solution to purple 
formazan crystals indicates the rate of mitochondrial dehydrogenase activity (Riss et al., 
2004).  After exposing the INS1 cells to stressors (cytokines) and/or either Asp, PPAG, or 
GRT, the growth medium was aspirated, and the cells washed with pre-warmed Dulbecco’s 
phosphate buffered saline with Ca2+ and Mg2+ (DPBS).  Afterwards, 50 μl of pre-warmed MTT 
solution (2 mg MTT / ml DPBS) was added into each well followed by incubation under 
standard cell culture conditions for 30 minutes.  After incubation 200 μl dimethyl sulfoxide 
(DMSO) and 25 μl Sorensen’s glycine buffer (pH 10.5) were added to each well to dissolve 
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the purple formazan crystals produced in the cells and the absorbance was then measured 
on a plate reader at 570 nm (Riss et al., 2004). 
2.4.2. The ATP Assay  
The ability of cells to synthesize ATP and maintain intracellular ATP levels is essential for cell 
survival.  In dead cells synthesis of ATP ceases and endogenous ATPases rapidly deplete the 
remaining ATP from the cytoplasm (Riss et al., 2004).  Cellular ATP levels were measured 
using the CellTiter-Glo® Luminescent Cell Viability Assay.  The ATP assay was performed to 
verify the MTT results as it is known that plant polyphenols can interact with MTTs.  
Luminescence relies on luciferase which generates the signal, where mono-oxygenation of 
luciferin is catalysed by luciferase in the presence of Mg2+, ATP, and molecular oxygen.  
Luminescent signals are proportional to the amount of ATP (Crouch et al., 1993; Riss et al., 
2004).  The INS1 cells were exposed to the co-treatment of cytokine cocktail A with the 
different dosages of either Asp, PPAG, or GRT as indicated in Table 2.1.  After 24 hours, 25 
μl of the media was transferred to a clean 96-well plate and frozen (-20˚C) for later assessment 
of oxidative stress (section 2.6.3).  Thereafter, 75 μl of the CellTitter-Glo® reagent was added 
to each well of the white walled 96-well plate and incubated under standard cell culture 
conditions for 30 minutes, shaken attentively every 10 minutes to lyse the cells.  Following 
incubation, a 5 μl sample of the lysate was transferred to a clean 96-well plate to measure the 
protein concentrations, using the Bradford protein assay according to the manufacturer’s 
instructions.  Luminescence of the cellular ATP in the remaining lysates was measured using 
the SpectraMax i3 multimode plate reader.  Cellular ATP was normalised to the protein content 
of each well determined by the Bradford protein quantification assay (section 2.5.4). 
2.4.3. Apoptosis/Necrosis 
 Kinetic Assay 
2.4.3.1.1. Annexin-V and Propidium Iodide  
To assess whether Asp, PPAG, or GRT have a toxic effect on INS1 cells with induced 
moderate inflammation, annexin-V (AV) and propidium iodide (PI) fluorescence was measured 
kinetically.  Annexins are ubiquitous homologous proteins which bind phospholipids in the 
presence of Ca2+.  The apoptotic process includes loss of phospholipid asymmetry during early 
stages, resulting in translocation of phosphatidylserine from the inside of the lipid bilayer to 
the external surface of the cell membrane by the Mg2+/ATP dependent enzyme, 
aminophospholipid translocase (Binder et al., 2000; Hoekstra et al., 1993).  Allowing the 
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fluorescein isothiocyanate (FITC) conjugated anti-AV antibody to bind with 
phosphatidylserine, indicating early apoptosis.  Propidium iodide intercalates with DNA in 
dead cells, where broken membranes have permitted entry of PI; indicative of late apoptosis 
and necrosis (Nicoletti et al., 1991; Suzuki et al., 1997; Vermes et al., 1995).  Following the 
co-treatment of cytokine cocktail A with the different dosages of either Asp, PPAG, or GRT 
(Table 2.1), anti-AV (1.5 μl / 100 μl) and PI (1 mg/ml) was added to each well of a black wall 
96-well plate.  The plate was placed into the SpectraMax i3 multimode plate reader to measure 
the fluorescence every hour for 24 hours. Temperature was maintained at 37°C with 5% CO2.  
The fluorescence signal of AV was read at Ex485 nm/Em535 nm; while PI was read at Ex535 
nm/Em617 nm.  Fluorescent readings were normalised by a MTT assay to ensure that the 
fluorescence signals obtained are representative of and correlated with the number of live 
cells. 
2.4.3.1.2. Caspase-3/7 Activation 
To assess the effect of Asp, PPAG, and GRT on the induction of apoptosis in cytokine-
exposed INS1 cells caspase-3/7 fluorescence was measured.  Activation of caspase-3 and -
7 are known to play a role in the execution-phase of the apoptosis pathways (both intrinsic 
(mitochondrial) and extrinsic (receptor mediated)) (Salvesen, 2002).  Caspase-3/7 Green 
Detection Reagent was used as a fluorogenic substrate for activated caspases-3/7.  Activation 
of caspase-3/7 in apoptotic cells, results in a DEVD (Asp-Glu-Val-Asp) peptide that is cleaved 
enabling the fluorescent dye to bind to DNA resulting in fluorescence (Chang and Yang, 2000).  
The assay is indicative of caspase-3/7 activation and the associated cellular plasma 
membrane permeabilization, and thus cell death.  Cells were co-treated with cytokine cocktail 
A and the different dosages of either Asp, PPAG, or GRT (Table 2.1), as well as caspase-3/7 
(10 μM/well) in a black wall 96-well plate.  Fluorescence was measured every hour for 24 
hours at Ex485 nm / Em535 nm using the SpectraMax i3 multimode plate reader.  
Temperature was maintained at 37°C with 5% CO2.  Fluorescent readings were normalised 
by performing a MTT assay. 
 Flow Cytometry 
To obtain samples to perform the flow cytometry assays described below, INS1 cells were 
cultured in clear 6-well cell culture plates.  Cells were seeded at a cell density of 3x105 
cells/well followed by 4 days of incubation under standard cell culture conditions.  Three 6-
well plates were seeded on the same day to serve as replicates.  Cells were then co-treated 
and incubated for a period of 24 hours.  Concentrations used for flow cytometry samples were 
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chosen based on results seen in previous experiments.  The cytokine cocktail was the same, 
while only one concentration (100 μM Asp, 100 μM PPAG, 0.1 mg/ml GRT, as well as 39 μM 
of the LY2886721 BACE inhibitor, A) per treatment was chosen due to results observed in 
section 3.4.2.  The BACE inhibitor was used to see if it influences cell viability on its own.  After 
24 hours of exposure to co-treatment, the cells were scraped into 2 ml Eppendorf tubes.  
Thereafter, the samples were centrifuged at 600 x g for 5 minutes, followed by aspirating the 
supernatant.  The pellet of INS1 cells was resuspended to 1 x 106/ml and stained with an anti-
AV antibody (1.5 μl /100 μl) and PI (1 mg/ml) at 37˚C for 30 minutes.  Samples were then 
centrifuged at 600 x g for 5 minutes, the stain aspirated, and the cells washed with DPBS.  
Thereafter, fresh DPBS (100 μl) was added, the cells resuspended and put on ice.  Flow 
cytometry was performed on the samples using a BD Accuri ™ C6.  The start-up of the flow 
cytometer was done according to the start-up procedures of the flow cytometer, this included 
running of the 6 and 8 bead standards to ensure that the flow cytometer is performing 
optimally.  A threshold was set for samples using unstained and individually stained (one 
fluorescent probe only) of untreated cells using the pre-set AV/PI template.  The untreated cell 
population was located in the lower left quadrant on the FL-1 vs FL-4 plot.  Increased FL-1 
fluorescence (FITC) intensity (green) indicates a shift to early apoptosis measured by the FITC 
conjugated anti-AV antibody, while a shift in the FL-4 fluorescence colour (red) indicates late 
apoptosis or necrosis measured by PI.  The samples were run on a medium flow rate, with a 
collection limit based on the gated population of interest. 
 Fluorescent Imaging – Caspase-3/7 Activation 
To verify INS1 cell viability results seen in the kinetic measuring of caspase-3/7 activation, 
fluorescent images were taken of the 96-well plates after the 24 hours of readings (section 
2.4.3.1.2) using the Nikon inverted microscope.  Images were taken using the 20X objective, 
resulting in a 200X magnification.  Dimethyl sulfoxide (0.1%) was used as a control of cell 
death.  Fluorescent images were taken as well as phase microscopy images. 
2.5. Cell Function 
2.5.1. Sample Collection 
Cell function of INS1 cells was assessed by their insulin response to glucose stimulation.  
Following 24 hour of exposure to cytokine cocktail A and the different concentrations of either 
Asp, PPAG, or GRT (Table 2.1), the treatments were aspirated from the 96-well plate.  
Thereafter, 100 μl of Krebs-Ringer bicarbonate-HEPES buffer (KRBH) containing 2.8 mM of 
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glucose was added to each well and the plate incubated under standard cell culture conditions 
for 30 minutes.  This served as a washing step.  To assess basal insulin secretion of the INS1 
cells, the KRBH was aspirated and 100 μl of KRBH containing 2.8 mM of glucose was added 
to each well, followed by 90 minutes of incubation under standard cell culture conditions.  To 
determine GSIS, 100 μl of KRBH containing 16.7 mM of glucose was added to each well, 
followed by 90 minutes of incubation under standard cell culture conditions.  After incubation, 
taking care not to disturb the cells, the KRBH from the basal insulin secretion and the GSIS 
plates were transferred to clean 96-well plates and frozen at -20°C (Llanos et al., 2015; 
Malmgren et al., 2009; Pereverzev et al., 2002).  
To assess the insulin content of the cells, 100 μl of EtOH-HCl (≥99.8% EtOH; 37% HCl) was 
added to each well to lyse the remaining INS1 cells.  The 96-well plate containing the cells 
and EtOH-HCl solution was frozen at -20˚C. 
Above mentioned cell culture plates were stored at -20˚C and used for later enzyme-linked 
immunosorbent assay (ELISA) analysis. 
2.5.2. Insulin ELISA 
 Insulin Secretion 
Insulin secreted into the KRBH media by INS1 cells, at both basal and stimulated glucose 
levels, was measured by using a rat/mouse insulin ELISA kit.  Previously stored samples (at -
20˚C) were brought to room temperature.  Basal samples were diluted 16x, while the glucose 
stimulated samples were diluted 32x.  The diluted samples were added to the pre-coated 
ELISA kit as described by the kit protocol.  The absorbence of the bound substrates was read 
at Ex450 nm / Em570 & 630 nm using the SpectraMax i3 multimode plate reader.  
Concentrations of insulin secreted were extrapolated from the standard curve provided with 
the ELISA kit, using the following insulin concentrations: 0.2, 0.5, 1.0, 2.0, 5.0, and 10 ng/ml.  
In order to ensure the ELISA was successful a positive and negative quality control was used 
in addition to the standards listed above. 
 Insulin Content 
Insulin content in INS1 cells was measured using the same rat/mouse insulin ELISA kit used 
to assess insulin secretion.  Previously stored samples (at -20˚C) were brought to room 
temperature.  The plate containing the cells with the EtOH-HCl was sonicated followed by 
centrifuging the plate for 5 minutes at 5000 x g.  The supernatant containing insulin was 
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transferred to a clean 96-well plate and the insulin content measured by an ELISA.  To 
normalise for cell numbers, the lysed cells left in the plate were used for protein determination 
by the Bradford method (section 2.5.4).  The KRBH samples were subsequently added to the 
pre-coated ELISA kit as described by the kit protocol.  The absorbence of the bound substrates 
was read at Ex450 nm / Em570 & 630 nm using the SpectraMax i3 multimode plate reader.  
Concentrations of insulin secreted were extrapolated from the standard curve provided with 
the ELISA kit.  The insulin concentrations used for the standard curve were 0.2, 0.5, 1.0, 2.0, 
5.0, and 10 ng/ml.  In order to ensure the ELISA was successful quality controls were used.  
Subsequently, the respective protein concentrations were used to normalise the insulin 
secretion and cellular content as determined by the ELISA kit. 
2.5.3. Amylin ELISA 
 Amylin Content 
The concentrations of cellular amylin content were determined, using the same stored 
samples (-20˚C) used to assess insulin content described earlier.  Samples were brought to 
room temperature, where after a competitive ELISA assay was performed, where the IAPP in 
the samples competes with a set amount of IAPP bound to the plate for sites of the biotinylated 
detection antibody.  Thereafter, advidin conjugated to horseradish peroxidase (HRP) was 
added to each well, followed by 30 minutes of incubation.  After incubation, a 3,3',5,5'-
tetramethylbenzidine (TMB) substrate was added and stopped after 15 minutes by the addition 
of sulphuric acid solution.  The IAPP was then measured spectrophotometrically at 450 nm 
using the SpectraMax i3 multimode plate reader.  Values used were extrapolated from the 
standard curve generated.  Standard curve values were: 62.5, 125, 250, 500, 1000, 2000, and 
4000 pg/ml. 
 Amylin Secretion 
The concentrations of IAPP secreted were determined, by using the same stored samples (-
20˚C), used to assess the GSIS described earlier (section 2.5.2.1).  Samples were brought to 
room temperature, where after an ELISA, described in section 2.5.3.1, was done.  The IAPP 
was then measured spectrophotometrically at 450 nm using the SpectraMax i3 multimode 
plate reader.  Values used were extrapolated from the standard curve generated.  
Subsequently, the respective protein concentrations were used to normalise the amylin 
secretion and cellular content as determined by the ELISA kit. 
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2.5.4. Bradford Protein Quantification Assay  
The Bradford assay was used in order to determine protein content (Bradford, 1976).  As 
mentioned in the respective subsections (section 2.4.2, 2.5.2, and 2.5.3), this was done to 
compensate for relative cell numbers of the insulin and amylin assays.  Briefly, a 5 μl sample 
of cell lysate from each well was transferred to a 96-well assay plate.  Thereafter, 200 μl of 
the Bradford reagent was added to each well followed by 10 minutes of incubation at room 
temperature.  After incubation, the absorbance was measured at 570 nm on a plate reader.  
Protein content values used were extrapolated from the standard curve generated.  Protein 
values used for the standard curve were: 0.125, 0.25, 0.5, 0.75, 1, 1.5, and 2 mg. 
2.5.5. Proliferation Rate of Rat Insulinoma Cells 
The rate of β-cell proliferation was assessed by measuring 5-bromo-2'-deoxyuridine (BrdU) 
incorporation into cellular DNA.  The pyrimidine analogue gets incorporated into newly 
synthesised DNA instead of thymidine of proliferating cells and the extent of incorporation is 
quantifiable using an anti-BrdU antibody (Gratzner, 1982; Gratzner et al., 1975; Köhler and 
Milstein, 1975).  Incubated with media containing BrdU, cells were co-treated for 24 hours with 
cytokine cocktail A and the different dosages of either Asp, PPAG, or GRT (Table 2.1).  
Thereafter, the media were removed, the cells fixed, and the DNA denatured in order to 
improve the accessibility of the incorporated BrdU to the detection antibody (mouse anti-BrdU 
body).  The cells were incubated for 60 minutes with the primary antibody.  Thereafter, binding 
of the primary antibody to the incorporated BrdU was detected with an anti-mouse IgG, HRP-
linked antibody, after 30 minutes incubation at room temperature.  To enhance the signal, a 
chemiluminescent reagent was added and the relative light units (RLU) measured using the 
SpectraMax i3 multimode plate reader.  The RLU intensity in proportion to the amount of BrdU 
incorporated, is a direct indication of cell proliferation. 
2.6. Oxidative Stress  
2.6.1. Reactive Oxygen Species – End-point Assay 
Reactive oxygen species production in INS1 cells, as a measure of endogenous oxidative 
stress, was assessed by measuring dichlorofluorescein (DCF) fluorescence produced from 
the oxidised non-fluorescent fluorescein derivative (2’7’-dichlorofluorescein, DCFH).  The 
fluorescence emitted by the conversion of DCFH to DCF by the free radicals is relative to the 
amount of ROS (Keston and Brandt, 1965; LeBel et al., 1992; Wang and Joseph, 1999).   
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To assess ROS production, INS1 cells were co-treated with the cytokine cocktail A and the 
different dosages of either Asp, PPAG, or GRT for 24 hours (Table 2.1).  After 24 hours, the 
media were aspirated, and the cells washed with pre-warmed DPBS.  Thereafter, 50 μl of 
DCFH (10 μM) was added to each well followed by 45 minutes of incubation under standard 
cell culture conditions.  The DCFH was then aspirated and 50 μl of DPBS was added to each 
well.  The DCF fluorescence signal was measured by using the SpectraMax i3 multimode 
plate reader at Ex485 nm / Em535 nm. 
2.6.2. Reactive Oxygen Species – Kinetic Assay 
To assess oxidative stress, ROS production was measured kinetically over 24 hours.  The 
INS1 cells were co-treated with cytokine cocktail A and the different dosages of either Asp, 
PPAG, or GRT (Table 2.1) with the addition of DCFH (10 μM) to each well of a black wall 96-
well plate.  The plate was placed into the SpectraMax i3 multimode plate reader to measure 
the fluorescence every hour for 24 hours.  Temperature was maintained at 37°C with 5% CO2.  
The fluorescence signal was measured at Ex/Em 485/535 nm.  Fluorescent readings were 
normalised by a MTT assay. 
2.6.3. Nitric Oxide – End-point Assay 
To further assess the effect of Asp, PPAG, and GRT, at different dosages (Table 2.1), on 
oxidative stress in INS1 pancreatic β-cells exposed to cytokine cocktail A, a colorimetric assay 
was done in order to measure the levels of NO2- in an aqueous solution.  Nitric oxide formation 
can be indirectly measured by assessing the number of NO2- present.  Nitrates are stable and 
non-volatile breakdown products of NO.  The Griess assay uses sulfanilamide and N-1-
napthylethylenediamine dihydrochloride (NED) under acidic (phosphoric acid) conditions to 
detect NO2- levels (Green et al., 1982; Griess, 1879).   
In order to perform the Griess assay the stored samples (section 2.4.2) were bought to room 
temperature.  Thereafter 25 μl of the samples was transferred to a clean 96-well plate, and 25 
μl of the Griess reagent added to each sample.  Samples were incubated in the dark at room 
temperature for 15 minutes, and the absorbance was read at 520 nm, as well as 540 nm using 
the SpectraMax i3 multimode plate reader.  The Griess reagent was made up according to the 
protocol of the manufacturer.  Values used were extrapolated from the standard curve 
generated.  Nitrite values used for the standard curve were: 1.56, 3.13, 6.25, 12.5, 25, 50, and 
100 μM.  
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2.7. Beta Secreatse Inhibition in Rat Insulinoma Cells 
In order to validate the effect seen in the purified BACE inhibition assay (section 2.1), BACE 
inhibition activity of GRT, PPAG, and Asp was assessed in the INS1 cells, using the same 
BACE activity detection kit described in section 2.1.  The cells were exposed to the different 
dosages of either Asp, PPAG, or GRT and cytokine cocktail A in a black 96-well plate.  The 
same BACE inhibitor, LY2886721 (section 2.1), was used at two different concentrations (A: 
39 μM, and B: 3.9 μM) to serve as positive control as it is cell-permeable.  Concentrations of 
Asp, PPAG, and GRT were the same concentrations indicated in Table 2.1.  Thereafter, 24-
hour kinetic readings were obtained at every 1 hour.  The fluorescence signal was measure 
at 320 nm and 405 nm using the SpectraMax i3 multimode plate reader.  Temperature was 
maintained at 37°C with 5% CO2 for the duration of this assay. 
2.8. Western Blots 
2.8.1. Sample Collection 
For western blot analysis, INS1 cells were cultured in 25 cm2 flasks.  Cells were seeded at a 
cell density of 7.9x105 cells/well followed by 4 days of incubation under standard cell culture 
conditions.  Three 25 cm2 flasks per treatment group were seeded on the same day to serve 
as technical replicates, this process was then performed again on two different days to serve 
as three biological repeats.  Cells were co-treated and incubated for a period of 24 hours.  The 
concentration of the cytokines in the cytokine cocktail was the same, while only one treatment 
concentration (100 μM Asp, 100 μM PPAG, 0.1 mg/ml GRT, as well as 39 μM of the 
LY2886721 BACE inhibitor) was selected.  After 24 hours co-treatment, cells were lysed by 
adding 300 μl/flask of lysis buffer containing 10 μl/ml phenylmethylsulfonyl fluoride (PMSF).  
Thereafter the cells were scraped and mixed with the other two repeats and transferred into a 
2 ml Eppendorf tube and frozen at -20˚C for western blot analysis. 
2.8.2. BCA Protein Determination 
Stored samples (section 2.8.1) were thawed on ice.  Thereafter the samples were 
homogenised at 25 Hertz (Hz) for 60 seconds, followed by 60 seconds on ice, repeated 5 
times, using a tissue lyser.  Samples were then centrifuged at 15 000 x g at 4˚C for 15 minutes, 
where after the supernatant was transferred to a clean 2 ml Eppendorf tube for future analysis.  
Protein concentrations were determined using the bicinchoninic acid assay (BCA) assay 
(Smith et al., 1985).  To determine the protein concentration, 5 μl of sample as well as 
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standards were added to a clean 96-well plate, followed by 25 μl of reagent A’ (20 µl of reagent 
S to each 1 ml of reagent A), and the addition of 200 μl of reagent B to each well.  The plate 
was then incubated for 15 minutes and the absorbance read at 630 nm and 750 nm using the 
SpectraMax i3 multimode plate reader.  Values used were extrapolated from the standard 
curve generated. 
2.8.3. Running of SDS-PAGE Gels 
After protein determination (section 2.8.2), loading volumes of samples were calculated to 
load 30 μg of protein per well.  Previously stored samples were thawed on ice; where after 25 
μl of each sample was mixed with 75 μl of 4X sample buffer (SB).  The samples were then 
heated on a heating block at 95˚C for 15 minutes to denature the proteins.  Samples and 
markers of protein mass (precision plus protein™, WesternC™ and PageRuler™ Prestained 
Protein Ladder), used to help identify proteins of interest following chemiluminescent detection 
were loaded onto a 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) precast gel.  
The gels were run at 150 V in a tetra cell tank filled with running buffer till the protein reached 
the bottom of the gel as indicated in Figure 2.4. 
 
Figure 2.4: Western blot; loading of SDS-PAGE gels.  Loading of markers and samples on 
a precast SDS-PAGE gel. 
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2.8.4. Transfer of Proteins to PVDF Membrane 
The SDS-PAGE gels were transferred to an activated polyvinylidene difluoride (PVDF) 
membrane.  Activation of the PVDF membrane is done by shaking the membrane in 100% 
methanol for 2 minutes.  Thereafter, the PVDF membrane and stacks, provided with the 
transfer kit, were shaken in transfer buffer for 3 minutes.  The stacks, membrane, and gel were 
then assembled in the cassette according to the protocol provided by the kit (Figure 2.5) and 
allowed 10 minutes of transfer.  In order to ensure that the protein transferred from the gel 
onto the membrane, a Ponceau S stain was done on the PVDF membrane for 10 minutes on 
a shaker. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.8.5. Primary and Secondary Antibodies 
The PVDF membrane was blocked in tris-buffered saline with tween 20 (TBST) containing 5% 
non-fat milk to minimise non-specific binding for 2 hours on the shaker, followed by 2 quick 
washes with TBST.  Thereafter, primary antibodies diluted in TBST with 5% bovine serum 
albumin (BSA) according to product specifications (Table 2.2), were added to the membranes 
Figure 2.5: Western blot; PVDF membrane transfer.  The transfer of the proteins from the 
SDS-PAGE gel to the PVDF membrane was assembled as follows: in order from the anode 
(+) to the cathode (-); filter paper; PVDF membrane; SDS-PAGE gel; and then filter paper.  
Transfer occurs from the cathode (-) to the anode (+), as indicated with the arrow direction. 
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and incubated at 4˚C on a shaker overnight.  The following morning the membranes were 
washed in TBST for 10 minutes on the shaker, repeated 3 times.  To detect antibody binding 
to the protein, the PVDF membrane was incubated with the corresponding secondary antibody 
(Table 2.2) at a 1:4000 dilution, with 2 μl of strepavidin in TBST containing 2.5% non-fat milk 
for 90 minutes on a shaker.  Thereafter the membrane was washed with TBST for 10 minutes, 
three times.  The housekeeping protein used was β-tubulin.   
 
Table 2.2: Antibodies: western blots.  Primary and secondary antibodies used for western 
blots. 
 
2.8.6. Chemiluminescent Detection 
Labelled proteins were visualised using a chemiluminescent kit.  The membrane was 
incubated for 5 minutes with enhanced chemiluminescent substrate (ECL), followed by 
imaging of the membrane on the Chemi Doc MP (BioRad).  Image Lab Software was used to 
analyse images.  For this study, all proteins were normalised to the housekeeping protein, β-
tubulin in order to determine the relative expression of the specific protein.   
2.9. Statistical Analysis 
Statistical analyses were performed using the GraphPad Prism 5.0 Software.  Blot analysis 
were done using the ImageLab software.  All experiments were performed with three technical 
repeats of three independent experiments.  The trapezoidal method (Figure 2.6) was used to 
calculate the area under the curve (AUC) of the kinetic assay results.  One-way Analysis of 
Primary 
Antibody 
Monoclonal / 
Polyclonal 
Molecular 
Weight (kDA) 
Primary Antibody 
Dilution 
Secondary 
Antibody (1:4000) 
Anti-Amylin Monoclonal ± 10 1:500 Anti-Mouse 
Anti-TMEM27 Monoclonal ± 38 1:1000 Anti-Rabbit 
Anti-BACE2 Polyclonal ± 45 1:500 Anti-Rabbit 
Anti-pNF-κB Monoclonal ± 65 1:1000 Anti-Rabbit 
Anti-NF-κB Monoclonal ± 65 1:1000 Anti-Rabbit 
Anti-β-Tubulin Polyclonal ± 55 1:1000 Anti-Rabbit 
Anti-COX2 Polyclonal ± 74 1:1000 Anti-Rabbit 
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Variance (ANOVA) with the Tukey post hoc test for correction was conducted if p<0.05.  A 
Man-Whitney test was also conducted where appropriate and as indicated.  p-Values less than 
0.05 were considered statistically significant.  Data was expressed as mean ± standard error 
of the mean (SEM). 
p-Values less than 0.1 were considered as a trend.  As suggested in a review by Figueiredo 
Filho et al. (2013); although these trends are not statistically significant it may be of biological 
significance to note and will need to be further interogatted.  A small effect seen may be 
exacerbated in a physiological system during a disease state, as factors such as stressors 
may exert synergestic effects on each other.   The small sample size and associated SEM 
may potentially affect the statistical outcome of the data (Figueiredo Filho et al., 2013).   
 
 
 
Figure 2.6: Trapezoidal method; area under the curve.  Diagrammatic presentation of 
graphs generated from kinetic experiments, using the trapezoidal method to analyse data. 
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CHAPTER 3 
Results 
The effect(s) of GRT and two of its major bioactive polyphenols (Asp and PPAG), on BACE 
activity and pro-inflammatory effects in INS1 pancreatic β-cells was assessed.  Cell viability 
was assessed by using MTT and ATP assays, together with an AV/PI as well as a caspase-
3/7 activation assay.  Cell function was assessed by measuring intracellular insulin and amylin 
content and secretion following glucose stimulation, as well as the rate of pancreatic β-cell 
proliferation.  Oxidative stress was assessed by measuring ROS production and generation 
of nitrites from NO by using DCF and Griess assays, respectively.  Beta secretase inhibition 
was assessed using a purified enzyme assay followed by a cell-based assay measuring BACE 
activity.  Overall no change in mitochondrial dehydrogenase activity was observed, except at 
the highest concentrations of Asp (1000 µM) and GRT (1 mg/ml) where a decrease in activity 
was observed.  A reduction in cellular ATP production was seen at 1000 µM of Asp and 1 
mg/ml of GRT, while an increase in apoptosis/necrosis was seen at these concentrations of 
Asp and GRT.  Insulin secretion increased after glucose stimulation, while no major effect was 
seen in insulin or amylin content.  The proliferation rate of inflamed INS1 cells decreased at 
the highest concentrations of Asp (1000 µM), PPAG (1000 µM), and GRT (1 mg/ml).  The end-
point DCF assays showed a reduction in ROS production in the cells exposed to Asp, PPAG, 
or GRT relative to the pro-inflammatory cytokine cocktail A; except at the highest 
concentrations of Asp (1000 µM) and GRT (1 mg/ml) where an increase in ROS production 
was seen relative to the negative control.  However, the kinetic DCF assays showed that Asp, 
PPAG, and GRT at high concentrations decreased ROS production.  High concentrations of 
Asp (1000 µM) and GRT (1 mg/ml) seem to have BACE inhibitory activity as reduced BACE 
activity was observed. 
Data presented is the mean (± SEM) of three independent biological repeats (n=3); with three 
technical repeats, relative to the negative control.  The mean was calculated by averaging the 
9 replicate values.  The negative control refers to INS1 cells not exposed to any stressors or 
treatments, while the positive control was exposed to the pro-inflammatory cytokine cocktail A 
(section 2.3.1). 
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3.1. Cell Viability of Rat Insulinoma Cells 
Rat insulinoma cell viability was assessed by using the MTT and ATP assays, together with 
an AV/PI assay as well as a caspase-3/7 activation assay. 
3.1.1. Inflammation in Rat Insulinoma Cells Exposed to Pro-Inflammatory Cytokines 
In order to induce inflammation in INS1 cells, the cells were exposed to pro-inflammatory 
cytokines for 3, 6, and 24 hours, followed by MTT assays.  The cytokines included different 
concentrations of TNF-α, IFN-γ, and IL-1β.  The INS1 cells were also exposed to two different 
pro-inflammatory cytokine cocktails (A & B), containing the above-mentioned cytokines, but at 
different concentrations.  The negative control, not exposed to cytokines, was set as 100% for 
statistical analysis and graphs. 
Following 3 hours of exposure to the pro-inflammatory cytokines, no effect was observed in 
mitochondrial dehydrogenase activity for TNF-α or IFN-γ.  Exposing the INS1 cells to IL-1β 
induced a slight significant increase in mitochondrial dehydrogenase activity at 0.01 and 1 
ng/ml relative to the negative control (108.90% ± 1.69, p=0.042 and 109.00% ± 1.80, p=0.04 
vs. 100% ± 1.33, respectively).  Albeit not significant, 0.01 and 1 ng/ml of IL-1β showed a trend 
towards increased mitochondrial dehydrogenase activity relative to cytokine cocktail B 
(108.90% ± 1.69, p=0.071 and 109.00% ± 1.80, p=0.069 vs. 100.6% ± 2.62, respectively) 
(Figure 3.2 A). 
After 6 hours of exposing the INS1 cells to TNF-α an increase in mitochondrial dehydrogenase 
activity was seen at 1.1 ng/ml relative to cytokine cocktail B (118.90% ± 4.22, p=0.028 vs. 
97.32% ± 5.92), while relative to the negative control 1.1 ng/ml of TNF-α showed a trend 
towards increased activity (118.90% ± 4.22, p=0.081 vs. 100% ± 5.45), but not significantly.  
Albeit not significant, 25 ng/ml of TNF-α showed a trend towards increased mitochondrial 
dehydrogenase activity relative to cytokine cocktail B (116.50% ± 1.74, p=0.072 vs. 97.32% ± 
5.92).  The cells exposed to IFN-γ had no effect on mitochondrial dehydrogenase activity.  
Cells exposed to IL-1β showed no significant effect on mitochondrial dehydrogenase activity, 
but at 0.1 and 1 ng/ml a trend towards increased activity was observed relative to cytokine 
cocktail B (120.70% ± 5.70, p=0.062 and 119.60% ± 6.50, p=0.089 vs. 97.32% ± 5.92, 
respectively) (Figure 3.2 B).  
Following 24 hours the INS1 cells exposed to cytokine cocktail B showed reduced 
mitochondrial dehydrogenase activity relative to the negative control (80.09 ± 5.89 p=0.031 
vs. 100% ± 4.53) (Figure 3.2 C).   
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The cells exposed to 1.1 ng/ml of TNF-α, albeit not significant, showed a trend towards 
increased mitochondrial dehydrogenase activity after 24 hours when compared to both 
cytokine cocktail A (108.30% ± 5.48, p=0.066 vs. 90.56% ± 3.62) and cytokine cocktail B 
(108.30% ± 5.48, p=0.063 vs. 80.09% ± 5.89).  However, 10 and 25 ng/ml of TNF-α indicated 
a significant increase in mitochondrial dehydrogenase activity relative to both cytokine cocktail 
A (110.30% ± 3.17, p=0.027 and 112.10% ± 4.75, p=0.011 vs. 90.56% ± 3.62) and cytokine 
cocktail B (110.30% ± 3.17, p=0.036 and 112.10% ± 4.75, p=0.021 vs. 80.09% ± 5.89) (Figure 
3.2 C).   
After 24 hours a significant increase in mitochondrial dehydrogenase activity was induced by 
IFN-γ at 1 ng/ml when compared to the negative control (121.10% ± 3.26, p=0.0055 vs. 100% 
± 4.53).  The cells exposed to 1, 10, and 100 ng/ml of IFN-γ showed a significant increase in 
mitochondrial dehydrogenase activity relative to both cytokine cocktail A (121.10% ± 3.26, 
p<0.001; 107.80% ± 3.61, p=0.038; and 107.50% ± 4.06, p=0.044 vs. 90.56% ± 3.62), 
respectively, and to cytokine cocktail B (121.10% ± 3.26, p=0.002; 107.80% ± 3.61, p=0.033; 
and 107.50% ± 4.06, p=0.036 vs. 80.09% ± 5.89) (Figure 3.2 C). 
The cells exposed to 10 ng/ml of IL-1β for 24 hours showed a significant decrease in 
mitochondrial dehydrogenase activity relative to the negative control (77.10% ± 6.81, p=0.032 
vs. 100% ± 4.53).  Albeit not significant, 10 ng/ml of IL-1β showed a trend towards increased 
activity when compared to cytokine cocktail A (110.50% ± 5.55, p=0.083 vs. 90.56% ± 3.62) 
(Figure 3.2 C). 
Thus, after the preliminary screening of the different individual pro-inflammatory cytokines as 
well as both cytokine cocktails it was indicated that cytokine cocktail A was not toxic to INS1 
cells after 24 hours of exposure, while cytokine cocktail B showed a significant reduction in 
mitochondrial dehydrogenase activity.  From these results it was decided to use cytokine 
cocktail A to induce an inflammatory state. 
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Figure 3.1: Effect of pro-inflammatory cytokine cocktails on cell viability.  The effect of 
cytokine cocktail A and cytokine cocktail B on cell viability after 3, 6, and 24 hours of exposure 
under normal cell culture conditions.  Cell viability was quantified by means of a MTT absorbance 
assay (570 nm).         : 3 hours;        : 6 hours;        : 24 hours 
Data presented is the mean (± SEM) of three independent experiments (n=3).  One-way ANOVA (Tukey 
post-hoc test); followed by a Man-Whitney test where appropriate; º=p<0.05 vs. cytokine cocktail A at 3 
hours; ••=p<0.01 vs. cytokine cocktail B at 3 hours. 
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i)                                                               ii)                                                                                   iii) 
Figure 3.2 A: Effect of pro-inflammatory cytokines on INS1 cell viability.  Effect of TNF-α (i), IFN-γ (ii), and IL-1β (iii), as well as two cytokine 
cocktails (A and B), on pancreatic β-cell viability 3 hours after exposure to the cytokines under normal cell culture conditions.  Cell viability was 
quantified by means of a MTT absorbance assay (570 nm).  Negative control: RPMI1640 medium.  
Data presented is the mean (± SEM) of three independent experiments (n=3) relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); followed by a Man-Whitney test where appropriate; #=p<0.05 vs. negative control. 
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Figure 3.2 B: Effect of pro-inflammatory cytokines on INS1 cell viability.  Effect of TNF-α (i), IFN-γ (ii), and IL-1β (iii), as well as two cytokine 
cocktails (A and B), on pancreatic β-cell viability 6 hours after exposure to the cytokines under normal cell culture conditions.  Cell viability was 
quantified by means of a MTT absorbance assay (570 nm).  Negative control: RPMI1640 medium.  
Data presented is the mean (± SEM) of three independent experiments (n=3) relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); followed by a Man-Whitney test where appropriate; $=p<0.05 vs. cytokine cocktail B. 
ii)                                                               ii)                                                                                   iii) 
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Figure 3.2 C: Effect of pro-inflammatory cytokines on INS1 cell viability.  Effect of TNF-α (i), IFN-γ (ii), and IL-1β (iii), as well as two cytokine 
cocktails (A and B), on pancreatic β-cell viability 24 hours after exposure to the cytokines under normal cell culture conditions.  Cell viability was 
quantified by means of a MTT absorbance assay (570 nm).  Negative control: RPMI1640 medium.  
Data presented is the mean (± SEM) of three independent experiments (n=3) relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); followed by a Man-Whitney test where appropriate; #=p<0.05, ##=p<0.01 vs. negative control; †=p<0.05, †††=p<0.001 vs. cytokine cocktail A; $=p<0.05, 
$$$=p<0.001 vs. cytokine cocktail B. 
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iii)                                                               ii)                                                                                   iii) 
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3.1.2. Effect of Asp, PPAG, and GRT on Rat Insulinoma Cell Viability –Toxicity 
The effect of a range of concentrations of Asp, PPAG, and GRT on INS1 cells, in the absence 
of pro-inflammatory cytokines, was assessed by measuring cell viability with MTT assays.  The 
negative control, not exposed to cytokine cocktail A or Asp, PPAG, or GRT, was set as 100% 
for statistical analysis and graphs. 
After 24 hours of exposure of INS1 cells to Asp, no effect on mitochondrial dehydrogenase 
activity was observed when compared to the negative control.  Albeit not significant, the lower 
concentrations of Asp (0.1, 1, 10, and 100 µM) showed a trend towards increased 
mitochondrial dehydrogenase activity relative to the pro-inflammatory cytokine cocktail A 
(108.00% ± 7.38, p=0.059; 106.40% ± 5.93, p=0.0503; 105.50% ± 6.75, p=0.094; and 
101.70% ± 6.19, p=0.094 vs. 89.98% ± 4.08, respectively).  In contrast to the lower 
concentrations, the highest concentration of Asp (1000 µM) showed a significant reduction in 
mitochondrial dehydrogenase activity relative to both the negative control as well as the pro-
inflammatory cytokine cocktail A (46.06% ± 1.18, p<0.001 vs. 100% ± 5.73 and vs. 89.98% ± 
4.08), respectively (Figure 3.3 A). 
Rat insulinoma cells exposed to PPAG for 24 hours showed no measurable effect on 
mitochondrial dehydrogenase activity when compared to the negative control.  However, 10 
and 1000 µM of PPAG indicated a trend towards increased mitochondrial dehydrogenase 
activity relative to the pro-inflammatory cytokine cocktail A (106.00% ± 6.88, p=0.063 and 
102.30% ± 4.77, p=0.094 vs. 89.98% ± 4.08, respectively), but not significantly (Figure 3.3 B). 
Following a similar trend to Asp, INS1 cells exposed to GRT for 24 hours showed no effect on 
mitochondrial dehydrogenase activity, except for 0.1 mg/ml GRT where an increase in 
mitochondrial dehydrogenase activity was seen relative to the pro-inflammatory cytokine 
cocktail A (108.50% ± 5.01, p=0.03 vs. 89.98% ± 4.08); while 1 mg/ml of GRT significantly 
reduced mitochondrial dehydrogenase activity relative to both the negative control (69.83% ± 
4.27, p=0.005 vs. 100% ± 5.73) as well as cytokine cocktail A (69.83% ± 4.27, p=0.008 vs. 
89.98% ± 4.08) (Figure 3.3 C).  
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Figure 3.3: Effect of Asp, PPAG, and GRT on INS1 cell viability.  Effect of Asp (A), PPAG (B), and GRT (C) exposure for 24 hours on pancreatic 
β-cell viability under normal cell culture conditions in the absence of a pro-inflammatory cytokine cocktail.  Cell viability was quantified by means of a 
MTT absorbance assay (570 nm).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3) relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc test); 
followed by a Man-Whitney test where appropriate; ##=p<0.01; ###=p<0.001 vs. negative control; *=p<0.05; **=p<0.01; ***=p<0.001 vs. positive control. 
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3.1.3. Effect of Asp PPAG, and GRT on Rat Insulinoma Cells Exposed to a Pro-
Inflammatory Cytokine Cocktail     
After exposing INS1 cells to cytokine cocktail A, as well as Asp, PPAG, and GRT the effect on 
cell viability was measured by performing MTT assays.  The cells were exposed to the co-
treatment for 24 hours.  The negative control, not exposed to cytokine cocktail A or Asp, PPAG, 
or GRT, was set as 100% for statistical analysis and graphs. 
The cells exposed to the pro-inflammatory cytokine cocktail A, although not statistical 
significant, showed reduced mitochondrial dehydrogenase activity relative to the negative 
control, and may be of biological significance to note (88.70% ± 4.17, p=0.077 vs. 100% ± 
3.59) (Figure 3.4). 
The INS1 cells co-treated with Asp and cytokine cocktail A showed no effect on mitochondrial 
dehydrogenase activity, except at the highest concentration of Asp (1000 μM) where a 
significant reduction was seen relative to both the negative control (19.02% ± 2.98, p<0.001 
vs. 100% ± 3.59) and cytokine cocktail A (19.02% ± 2.98, p<0.001 vs. 88.70% ± 4.17) (Figure 
3.4 A).  The latter correspond with the effect seen when the INS1 cells were exposed to Asp 
in the absence of cytokines, just exacerbated indicative of a synergestic effect (section 3.1.2; 
Figure 3.3 A). 
Cells co-treated with PPAG and the pro-inflammatory cytokine cocktail A showed no effect on 
mitochondrial dehydrogenase activity after 24 hours (Figure 3.4 B). 
As was seen with Asp, cells exposed to cytokine cocktail A and GRT showed a significant 
reduction in mitochondrial dehydrogenase activity only at the highest concentration of 1 mg/ml 
relative to both the negative control (36.88% ± 1.53, p<0.001 vs. 100% ± 3.59) as well as 
cytokine cocktail A (36.88% ± 1.53, p<0.001 vs. 88.70% ± 4.17) (Figure 3.4 C).  The significant 
decrease in mitochondrial dehydrogenase activity corresponds with the toxicity effect seen 
when the INS1 cells were only exposed to the GRT extract, in the absence of induced 
inflammation (section3.1.2; Figure 3.3 C). 
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Figure 3.4: Effect of Asp, PPAG, and GRT on INS1 cells exposed to pro-inflammatory cytokines.  Effect of Asp (A), PPAG (B), and GRT 
(C) on the viability of pancreatic β-cells exposed to pro-inflammatory cytokine cocktail A for 24 hours under normal cell culture conditions.  Cell 
viability quantified by means of a MTT absorbance assay (570 nm).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3) relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); ###=p<0.001 vs. negative control; ***=p<0.001 vs. positive control. 
   A                                                                           B                                                                               C 
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3.1.4. Cellular ATP Content in Rat Insulinoma Cells 
Intracellular ATP content in INS1 cells exposed to pro-inflammatory cytokines was also 
assessed after 24 hours of co-treatment.  Luminescent signals were normalised to the protein 
values obtained by performing the Bradford assay.  The negative control, not exposed to 
cytokine cocktail A or Asp, PPAG, or GRT, was set as 100% for statistical analysis and graphs.  
The INS1 cells co-treated with Asp and cytokine cocktail A showed no effect on cellular ATP 
content, except at the highest concentration of Asp (1000 µM) where a decrease was seen 
relative to the negative control (79.11% ± 2.79, p=0.011 vs. 100% ± 6.62) and to cytokine 
cocktail A (79.11% ± 2.79, p=0.046 vs. 97.64% ± 8.46) (Figure 3.5 A).    
The INS1 cells co-treated with PPAG and cytokine cocktail A showed no marked changes in 
cellular ATP content, except at the highest concentration of PPAG (1000 µM) where an 
increase relative to the negative control (129.70% ± 18.23, p=0.018 vs. 100% ± 6.62) and to 
cytokine cocktail A (129.70% ± 18.23, p=0.049 vs. 97.64% ± 8.46) was seen (Figure 3.5 B).    
The INS1 cells exposed to cytokine cocktail A and GRT showed similar results to the results 
observed for the MTT assay, with decreased cellular ATP content at the highest concentration 
(1 mg/ml) relative to the negative control (46.96% ± 5.27, p=0.0004 vs. 100% ± 6.62) and to 
cytokine cocktail A (46.96% ± 5.27, p=0.0007 vs. 97.64% ± 8.46), respectively (Figure 3.5 C).  
Albeit not significant, 0.01 and 0.1 mg/ml of GRT showed a trend towards reduced ATP 
content when compared to the negative control (80.26% ± 7.93, p=0.094 and 81.59% ± 6.13, 
p=0.059 vs. 100% ± 6.62, respectively) (Figure 3.5 C). 
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Figure 3.5: Effect of Asp, PPAG, and GRT on cellular ATP content in INS1 cells exposed to pro-inflammatory cytokines.  Effect of Asp 
(A), PPAG (B), and GRT (C), on cellular ATP content in INS1 pancreatic β-cells exposed to pro-inflammatory cytokines for 24 hours after co-
treatment under normal cell culture conditions.  Luminescent quantification of cellular ATP content.  Negative control: RPMI1640 medium; Positive 
control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); followed by a Man-Whitney test where appropriate; #=p<0.05, ###=p<0.001 vs. negative control; *=p<0.05, ***=p<0.001 vs. positive control.  
   A                                                                                     B                                                                               C 
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3.1.5. Apoptosis / Necrosis in Rat Insulinoma Cells 
 Annexin-V / Propidium Iodide – Kinetic Assays 
To assess the effect of Asp, PPAG, and GRT on INS1 cells exposed to pro-inflammatory 
cytokine cocktail A, cell survival and death of co-treated cells were assessed by kinetically 
determining early apoptosis as well as necrosis measuring AV/PI fluorescence hourly over a 
period of 24 hours.  The AUC for each treatment was calculated over the 24 hours of co-
treatment and expressed as an overall effect.  The negative control, not exposed to cytokine 
cocktail A or Asp, PPAG, or GRT, was set as 100% for statistical analysis and graphs.     
After 24 hours the cells exposed to pro-inflammatory cytokine cocktail A had no effect of the 
early apoptosis, but, although not significant, a trend towards increased necrosis relative to 
the negative control (143% ± 20.19, p=0.086 vs. 100% ± 12.06) was seen (Figure 3.6). 
The INS1 cells co-treated with Asp only had an effect on the rate of early apoptosis at the 
highest concentration (1000 μM) that showed a significant increase in early apoptosis relative 
to both the negative control (287.10% ± 44.70, p<0.001 vs. 100% ± 12.41) and cytokine 
cocktail A (287.10% ± 44.70, p<0.001 vs. 119.40% ± 15.79), respectively.  Exposure of INS1 
cells to the pro-inflammatory cytokine cocktail A with Asp also showed a significant increase 
in necrosis at the highest concentration (1000 μM)  when compared to both the negative 
control (673.70% ± 135.80, p<0.001 vs. 100% ± 12.06) as well as cytokine cocktail A (673.70% 
± 135.80, p<0.001 vs. 143.00% ± 20.19), respectively (Figure 3.6 A).  These findings verify 
the previous MTT results of cell viability seen (section 3.1.3).  
Cells co-treated with PPAG showed a significant increase in early apoptosis only at the highest 
concentration (1000 μM) relative to the negative control (190.30% ± 22.69, p=0.003 vs. 100% 
± 12.41) and cytokine cocktail A (190.30% ± 22.69, p=0.045 vs. 121.10% ± 15.00).  However, 
PPAG co-treatment had no effect on necrosis in INS1 cells (Figure 3.6 B). 
The INS1 cells co-treated with GRT showed a significant increase in early apoptosis at the 
highest concentration (1 mg/ml) relative to both the negative control (586.50% ± 70.81, 
p<0.001 vs. 100% ± 12.41) and cytokine cocktail A (586.50% ± 70.81, p<0.001 vs. 124.70% 
± 13.97), respectively.  Cells exposed to 0.1 mg/ml of GRT significantly increased necrosis 
relative to the negative control (196.90% ± 18.14, p=0.0002 vs. 100% ± 12.06), the highest 
concentration of GRT also significantly increased necrosis relative to both the negative control 
(1815.00% ± 270.60, p<0.001 vs. 100% ± 12.06) and cytokine cocktail A (1815.00% ± 270.60, 
p<0.001 vs. 143.00% ± 20.19), respectively (Figure 3.6 C).  These effects seen verify the 
results seen in the MTT as well as ATP assays (section 3.1.3 and 3.1.4). 
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Figure 3.6: Early apoptosis and necrosis in INS1 cells exposed to pro-inflammatory cytokines.  
Effect of Asp (A), PPAG (B), and GRT (C) on INS1 pancreatic β-cell death was assessed kinetically over 
24 hours, under normal cell culture conditions.  Fluorescent quantification of early apoptosis and 
necrosis by means of an AV/PI assay using the SpectraMaxi3 (AV: Ex 485 nm/Em 535 nm; PI: Ex 535 
nm/Em 617 nm).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set 
at 100%.  One-way ANOVA (Tukey post-hoc test); followed by a Man-Whitney test where appropriate; ##=p<0.01; 
###=p<0.001 vs. negative control; *=p<0.05, ***=p<0.001 vs. positive control. 
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 Annexin-V / Propidium Iodide - Flow Cytometry 
Survival and death of INS1 cells, 24 hours after exposure to co-treatments, was further 
assessed by measuring early apoptosis, late apoptosis, and necrosis by measuring the 
fluorescence of AV and PI using flow cytometry.  The negative control not exposed to cytokine 
cocktail A or Asp, PPAG, or GRT, was used for statistical analysis and graphs. 
In flow cytometry, the intensity of a distribution can be represented by the position of the 
“centre” of the distribution. The “centre” is usually represented mathematically by the mean, 
median or peak channel number.  However, the data was not normally distributed; therefor 
the mean and median are not equal.  It is necessassary to assess the mean and median of 
the data as change in one or the other may not be the same and may lead to misinterpretation 
of the data.   
Flow cytometry analysis of univariate histograms used to assess the fluorescence intensity, 
as indicated by the treated population’s mean fluorescence intensity, showed a significant 
increase in FL-1 AV intensity in the cells exposed to cytokine cocktail A (15450.00 RFU ± 
1522.00, p<0.001 vs. 7749.00 RFU ± 491.20).  The groups co-treated with Asp, PPAG, GRT, 
and inhibitor A showed a significant decrease in FL-1 intensity in comparison to cytokine 
cocktail A (9892.00 RFU ± 514.90, p<0.001; 7804.00 RFU ± 225.30, p<0.001; 10743.00 RFU 
± 527.60, p=0.0016; and 8484.00 RFU ± 651.80, p<0.001 vs. 15455.00 RFU ± 1522.00) 
(Figure 3.7 and Figure 3.8 A).  Cells co-treated with GRT showed a significant increase in FL-
4 intensity when compared to both the negative control (1424.00 RFU ± 55.22, p<0.001 vs. 
556.00 RFU ± 8.90) and cytokine cocktail A (1424.00 RFU ± 55.22, p<0.001 vs. 617.40 RFU 
± 51.29) (Figure 3.7 and Figure 3.8 A).  However, the fluorescence intensity measured by the 
treated population’s median fluorescence intensity showed no significant change in FL-1 AV 
intensity; while cells co-treated with PPAG showed a significant decrease in FL-4 intensity 
relative to the negative control (373.40 RFU ± 5.64, p=0.0188 vs. 425.70 RFU ± 7.81) and 
cells co-treated with GRT a significant increase when compared to both the negative control 
(695.80 RFU ± 24.78, p<0.001 vs. 425.70 RFU ± 7.81) and to cytokine cocktail A (695.80 RFU 
± 24.78, p<0.001 vs. 401.70 RFU ± 8.36) (Figure 3.7 and Figure 3.8 B).  Results indicated in 
Figure 3.8 can also be seen in the representative images of peak shifts histograms seen in 
Figure 3.7. 
In Figure 3.9 A, a theoretical representation of multivariate dot plot analysis for cell survival 
and death (apoptosis/necrosis) by flow cytometry using AV/PI.  Increasing AV positivity (green 
fluorescence (FL1)) indicates early apoptosis, whilst increasing PI staining (orange/red 
fluorescence (FL-4)) indicates late apoptosis or necrosis.  Representative flow cytometry dot 
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plot images used to quantify population shifts into demarcated quadrants with different 
treatments, indicating live (lower left quadrant), early apoptotic (lower right quadrant), late 
apoptotic (upper right quadrant) and necrotic (upper left quadrant) cells (Figure 3.9 B, C, D, E 
and F).  Cells exposed to cytokine cocktail A showed a significant decrease in the live cell 
population (lower left quadrant) when compared to the negative control (75.85% ± 2.38, 
p<0.001 vs. 88.64% ± 1.71).  A significant decrease in cell viability is also seen in the group 
co-treated with GRT in comparison to the negative control (76.08% ± 0.77, p<0.001 vs. 
88.64% ± 1.71) as graphically illustrated in Figure 3.10.  Cells exposed to Asp, PPAG, or 
inhibitor A showed a significant increase in cell viability when compared to cytokine cocktail A 
(83.55% ± 1.41, p=0.011; 88.70% ± 1.05, p<0.001; and 86.53% ± 1.32, p=0.0002 vs. 75.85% 
± 2.38), respectively as graphically illustrated in Figure 3.10. 
Cells exposed to cytokine cocktail A showed a significant increase in early apoptosis (lower 
right quadrant) in comparison to the negative control (19.15% ± 1.82, p<0.001 vs. 8.63% ± 
1.44).  Groups co-treated with Asp, PPAG, GRT, or inhibitor A showed a significant decrease 
in early apoptosis in comparison to cytokine cocktail A (11.85% ± 0.98, p=0.0011; 8.62% ± 
0.84, p<0.001; 11.34% ± 0.73, p=0.006; and 9.58% ± 0.96, p<0.001 vs. 19.15% ± 1.82, 
respectively) (Figure 3.10). 
After the 24 hours, the cells exposed to cytokine cocktail A and the cells co-treated with GRT 
showed a significant increase in late apoptosis (upper right quadrant) when compared to the 
negative control (3.26% ± 0.89, p=0.02 and 4.79% ± 0.30, p<0.001 vs. 0.98% ± 0.19, 
respectively) (Figure 3.10). 
Interestingly, the cells co-treated with GRT showed a significant increase in necrosis (upper 
right quadrant) when compared to both the negative control and cytokine cocktail A (7.66% ± 
0.32, p<0.001 vs. 1.74% ± 0.23 and 1.75% ± 0.59, respectively); while no effect was seen in 
the other groups (Figure 3.10). 
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Figure 3.7:  FL-4 / FL-1 histograms.  Histograms indicating the shift in fluorescence measured 
by AV/PI, showing the shift in cell viability of INS1 cells assessed 24 hours after exposure to co-
treatment under normal cell culture conditions.  Fluorescent quantification of apoptosis and 
necrosis were assessed using an AV/PI assay by means of flow cytometry. Peak shift in FL-1 (A) 
and FL-4 (B) of the positive control to negative control; peak shift in FL-1 (C) and FL-4 (D) of the 
GRT (0.1 mg/ml) to negative control; peak shift in FL-1 (E) and FL- 4 (F) of the inhibitor A (39 µM) 
to negative control. 
FL-1 FL-4 
B 
D 
F 
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Figure 3.8: Apoptosis and necrosis in INS1 cells – Flow cytometry (AV/PI).  Effect of Asp 
(100 μM), PPAG (100 μM), GRT (0.1 mg/ml), and inhibitor A (39μM) on inflamed pancreatic 
β-cell viability assessed 24 hours after exposure to co-treatment under normal cell culture 
conditions.  Fluorescent quantification of apoptosis and necrosis were assessed using an 
AV/PI assay by means of flow cytometry.  Fluorescent intensity measured by the mean of the 
treated population (A); fluorescent intensity measured by the median of the treated population 
(B).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test); #=p<0.05; ###=p<0.001 vs. negative control; 
**=p<0.01, ***=p<0.001 vs. positive control. 
A 
B 
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Figure 3.9: Effect of Asp, PPAG, and GRT on cell survival and death in INS1 cells exposed to pro-inflammatory cytokines.  Flow cytometry 
analysis of AV/PI stained INS1 cells exposed to pro-inflammatory cytokines and co-treated with Asp, PPAG, or GRT for 24 hours. Diagrammatic 
presentation indicating the shift in cell viability as measured by AV/PI (A).  Population of INS1 cells used for flow cytometry analysis (B).  Negative 
control (C), pro-inflammatory cytokine cocktail A (D), Asp co-treatment (E), PPAG co-treatment (F), GRT co-treatment (G) and treatment with 
inhibitor A (39 µM) (H).   
H
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Figure 3.10: Effect of Asp, PPAG, and GRT on cell survival and death in INS1 cells exposed 
to pro-inflammatory cytokines.  Graphical comparison of flow cytometry analysis of AV/PI 
stained INS1 cells exposed to pro-inflammatory cytokines and co-treated with Asp (100 μM), 
PPAG (100 μM), GRT (0.1 mg/ml), and inhibitor A (39 μM) for 24 hours under normal cell culture 
conditions.  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test); #=p<0.05, ###=p<0.001 vs. negative control; *=p<0.05, 
**=p<0.01, ***=p<0.001 vs. positive control.  
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Table 3.1:  Cell viability as measured by AV/PI by using flow cytometry.  Indication of the 
percentage of cells from the total number of cells (per treatment group) classified according to 
viability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment Viable (%) 
Early Stage 
Apoptosis (%) 
Late Stage 
Apoptosis (%) 
Necrosis (%) Total (%) 
Negative Control 88.64 8.63 0.98 1.76 100 
Positive Control 75.80
a 19.18a 3.20b 1.81 100 
Asp 83.61c 11.80d 2.94 1.65 100 
PPAG 88.64e 8.56e 1.32 1.47 100 
GRT 76.05
a 11.38e 4.82
a 
7.76a, e 100 
Inhibitor A 86.52e 9.54e 1.97 1.97 100 
a: #=p<0.05; b: ###= p<0.001 vs. negative control; c: *= p<0.05, d: **= p<0.01, e: ***= p<0.001 vs. positive control. 
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 Caspase-3/7 Activation in Rat Insulinoma Cells - Kinetic 
Apoptosis of co-treated INS1 cells were assessed by hourly readings of caspase-3/7 activation 
over 24 hours.  The AUC for each treatment was calculated over the 24 hours of co-treatment 
and expressed as an overall effect.  The negative control not exposed to cytokine cocktail A 
or Asp, PPAG, or GRT was set as 100% for statistical analysis and graphs. 
The cells exposed to the pro-inflammatory cytokine cocktail A showed a trend towards 
increased caspase-3/7 activation relative to the negative control (198.60% ± 53.30, p=0.084 
vs. 100% ± 11.54), but not significantly (Figure 3.11).  The fact that this change is not 
significant, while the change in the GRT co-treated group is significant, even if the mean value 
is lower than the cytokine cocktail’s mean compared to the negative control, can be explained 
by the large SEM of the cytokine cocktail group. 
Overall the INS1 co-treated with Asp showed no effect in apoptosis when compared to the 
negative control, except at the highest concentration of Asp (1000 μM) where an increase in 
apoptosis is seen relative to the negative control (303.40% ± 47.47, p=0.0006 vs. 100% ± 
11.54) (Figure 3.11 A).  
Cells co-treated with PPAG and the pro-inflammatory cytokine cocktail A had no effect on 
caspase-3/7 activation (Figure 3.11 B).   
Co-treatment with GRT at the highest concentration (1 mg/ml) showed increased apoptosis 
when compared to the negative control (207% ± 19.26, p=0.005 vs. 100% ± 11.54) (Figure 
3.11 C).  The increase in late apoptosis of INS1 at the highest concentrations of both Asp and 
GRT verify the decrease observed cell viability in other experiments.  
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Figure 3.11: Effect of Asp, PPAG, and GRT on caspase-3/7 activation in INS1 cells exposed to pro-inflammatory cytokines.  Kinetic 
caspase-3/7 activation assay over a 24-hour period presented as the area under the curve of the hourly measurements.  Asp (A), PPAG (B) and 
GRT co-treatment (C).  Caspase-3/7 activation was assessed hourly over 24 hours, under normal cell culture conditions using the SpectraMaxi3 
(Ex 485 nm / Em 535 nm).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); followed by a Man-Whitney test where appropriate; ##=p<0.01, ###=p<0.001 vs. negative control.  
   A                                                                           B                                                                             C 
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 Caspase-3/7 Activation in Rat Insulinoma Cells – Fluorescence Imaging  
Caspase-3/7 activation during the kinetic assay was visualised and quantified by fluorescent 
microscopy; as well as phase microscopy images of to assess cell morphology relating to cell 
viability.  The fluorescent images were taken at the exact same area of the well as the phase 
microscopy images.  Caspase-3/7 positive cells are detected by their intense green 
fluorescent signal (Figure 3.12). 
Under normal culture conditions healthy INS1 cells have a stellate or polyglonal shape and a 
clustering growth orientation, indicating good cell viability as the INS1 cell clusters are closely 
associated and are fixed to cell culture dish and the cytoplasm evenly spread (Figure 3.12 A; 
i) (Asfari et al., 1992; Fu et al., 2009; Hamid et al., 2002; Merglen et al., 2004). 
Compared to the normal control INS1 cells exposed to cytokine cocktail A displayed a more 
multipolar spindle shape with larger open spaces between cells suggesting some retraction of 
cytoplasm volume, a decrease in cell size and loss of adhesion.  The fluorescent images of 
the cells exposed to cytokine cocktail A demonstrate a slight increase in caspase-3/7 positive 
fluorescence cells (Figure 3.12 A; ii).   
The INS1 cells co-treated with Asp (100 µM) and PPAG (100 µM) are morphologically similar 
to the stellate shaped cells and display a similar growth pattern as seen in the normal control 
cells, compared to cell exposed to the pro-inflammatory cytokine cocktail A where fewer 
caspase-3/7 positive cells were present (Figure 3.12 B; iii and iv).   
Rat insulinoma cells co-treated with GRT (0.1 mg/ml) were morphologically similar to stellate 
shaped cells seen in the normal controls, however the cell growth pattern showed less 
clustering with larger spaces, suggesting loss of cells or cell volume compared to the normal 
control.  The increase in caspase-3/7 positive cells compared to the normal control, albeit less 
than the pro-inflammatory control, supports increased apoptosis (Figure 3.12 B; v).  
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Figure 3.12 A: Effect of Asp, PPAG, and GRT on cell morphology and caspase-3/7 
activation in INS1 cells exposed to pro-inflammatory cytokines.  Representative light 
photomicrographs and fluorescent images of caspase-3/7 activation after 24 hours of co-
treatment.  Negative control (i) and cytokine cocktail A (ii).  Images were taken on the Nikon 
inverted microscope at 20x objective; 200x magnification.  Change in cell viability related to 
morphology and number of cells are indicated with black arrows.  Fluorescent signal as result 
of caspase-3/7 activation is indicated with white arrows.  Scale bar: 100 µm. 
 
 
 
 
 
i) 
ii) 
Caspase- 3/7 activation - Fluorescence Phase microscopy images  
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Figure 3.12 B: Effect of Asp, PPAG, and GRT on cell morphology and caspase-3/7 
activation in INS1 cells exposed to pro-inflammatory cytokines.  Representative light 
photomicrographs and fluorescent images of caspase-3/7 activation after 24 hours of co-
treatment.  Aspalathin (iii), PPAG (iv), and GRT (v).  Images were taken on the Nikon inverted 
microscope at 20x objective; 200x magnification.  Change in cell viability related to morphology 
and number of cells are indicated with black arrows.  Fluorescent signal as result of caspase-
3/7 activation is indicated with white arrows.  Scale bar: 100 µm. 
Caspase- 3/7 activation - Fluorescence Phase microscopy images 
v)
 
iii) 
iv) 
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3.2. Rat Insulinoma Cell Function 
Rat insulinoma cell function was assessed by GSIS and intracellular insulin content, followed 
by amylin content and secretion, as well as by measuring the rate of cell proliferation.  
3.2.1. Glucose Stimulated Insulin Secretion in Rat Insulinoma Cells 
Glucose stimulated insulin secretion was determined at basal as well as stimulated levels.  For 
statistical analysis and graphs, the different treatment groups were compared to the amount 
of insulin secreted (ng/ml/mg protein) of the basal and glucose stimulated insulin secretion 
levels of the negative control.   
The negative control showed an increase of 858.96% in insulin secretion after glucose 
stimulation when compared to the basal glucose levels of the negative control (72.19 ng/ml/mg 
± 10.69, p=0.002 vs. 8.40 ng/ml/mg ± 1.66).  Cytokine cocktail A showed an increase of 
1039.19% in insulin secretion after glucose stimulation when compared to the basal levels of 
glucose (71.65 ng/ml/mg ± 6.80, p=0.002 vs. 6.89 ng/ml/mg ± 0.72) (Figure 3.13).  
The INS1 cells exposed to co-treatment with Asp at the highest concentration (1000 μM) 
showed a significant increase in basal insulin secretion relative to negative control (15.93 
ng/ml/mg ± 2.64, p=0.024 vs. 8.40 ng/ml/mg ± 1.66) and to cytokine cocktail A (15.93 ng/ml/mg 
± 2.64, p=0.0038 vs. 6.89 ng/ml/mg ± 0.72) (Figure 3.13 A).  However, after glucose 
stimulation Asp had no effect on insulin secretion. 
The cells co-treated with PPAG had no significant effect on insulin secretion at basal levels or 
after glucose stimulation when compared to the negative control of the basal and stimulated 
levels, respectively (Figure 3.13 B).   
After co-treatment with GRT, at basal levels, insulin secretion increased significantly at all 
concentrations used except the lowest concentration (0.0001 mg/ml) when compared to the 
negative control (27.06 ng/ml/mg ± 3.27, p=0.0011; 27.87 ng/ml/mg ± 3.49, p=0.0006; 28.67 
ng/ml/mg ± 4.10, p=0.0003; and 28.43 ng/ml/mg ± 3.23, p=0.0004 vs. 8.40 ng/ml/mg ± 1.66, 
respectively) as well as cytokine cocktail A (27.06 ng/ml/mg ± 3.27, p=0.0004; 27.87 ng/ml/mg 
± 3.49, p=0.0002; 28.67 ng/ml/mg ± 4.10, p=0.0001; and 28.43 ng/ml/mg ± 3.23, p=0.0001 vs. 
6.89 ng/ml/mg ± 0.719, respectively).  Although the cells maintained their ability to increase 
insulin secretion upon glucose stimulation the insulin secretion levels seemed to reduce in 
comparison to the negative control and cytokine cocktail A after glucose stimulation (Figure 
3.13 C).  
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Figure 3.13: Glucose stimulated insulin secretion in INS1 cells exposed to pro-
inflammatory cytokines.  Effect of Asp (A), PPAG (B), and GRT (C) on basal (2.8 mM 
glucose) and glucose stimulated insulin secretion (16.7 mM glucose) in INS1 β-cells exposed 
to the pro-inflammatory cytokine cocktail A for 24 hours under normal cell culture conditions.  
The absorbence was measured using an ELISA (Ex 450 nm / Em 630 nm).  Negative control: 
RPMI1640 medium; Positive control: Cytokine cocktail A. Basal glucose levels:     ; Glucose 
stimulated levels:      . 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test); followed by a Man-Whitney test where appropriate; 
ΦΦ= p<0.01 stimulated vs. basal glucose levels; #=p<0.05, ##=p<0.01, ###=p<0.001 vs. negative control 
**=p<0.01, ***=p<0.001 vs. positive control. 
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3.2.2. Cellular Insulin Content in Rat Insulinoma Cells 
To assess the residual intracellular insulin content as a measure of insulin synthesis and or 
dysfunction, stored insulin content from ruptured cells was determined by using an ELISA 
assay.  The negative control was used to compare insulin secretion (ng/ml/mg) of the 
treatment groups to for statistical analysis and graphs.   
Overall no significant effect on intracellular insulin content was seen after 24 hours of co-
treatment (Figure 3.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Cellular insulin content in INS1 cells exposed to pro-inflammatory cytokine 
cocktail A.  Effect of Asp and GRT on cellular insulin content in INS1 β-cells, following the 
GSIS assay 24 hours after co-treatment under normal cell culture conditions.  The absorbence 
was measured using an ELISA (Ex 450 nm / Em 630 nm).  Negative control: RPMI1640 
medium; Positive control: Cytokine cocktail A; Asp (µM): 1000; GRT (mg/ml) 1=0.0001; 
2=0.001; 3=0.01; 4=0.1; and 5=1.   
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test). 
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3.2.3. Intracellular Amylin Content in Rat Insulinoma Cells 
Intracellular amylin content in INS1 cells exposed to the pro-inflammatory cytokine cocktail A 
and to either Asp or GRT co-treatment for 24 hours was determined.  The negative control 
was used as reference for statistical analysis and graphs.  In comparison to negative control 
no significant effect of the treatment was observed in intracellular islet amylin content in the 
co-treated groups (Figure 3.15).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Cellular amylin content in INS1 cells exposed to pro-inflammatory 
cytokines.  Effect of Asp and GRT on amylin content in INS1 β-cells, 24 hours after co-
treatment under normal cell culture conditions.  Amylin was quantified spectrophotometrically 
using an ELISA (450 nm).  Negative control: RPMI1640 medium; Positive control: Cytokine 
cocktail A; Asp (µM): 1000; GRT (mg/ml) 1=0.0001; 2=0.001; 3=0.01; 4=0.1; and 5=1.    
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test). 
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3.2.4. Amylin Secretion in Rat Insulinoma Cells 
Amylin secretion of INS1 cells after 24 hours of exposure to pro-inflammatory cytokines and 
to either Asp or GRT co-treatment was determined.  The negative control was used as 
reference or statistical analysis and graphs.  After 24 hours of co-treatment no effect was seen 
in IAPP secretion (Figure 3.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: Amylin secretion in INS1 cells.  Effect of Asp and GRT on amylin secretion in 
INS1 β-cells exposed to pro-inflammatory cytokines, 24 hours after co-treatment under normal 
cell culture conditions.  Amylin was quantified spectrophotometrically using an ELISA (450 
nm).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A; Asp (µM): 
1000; GRT (mg/ml) 1=0.0001; 2=0.001; 3=0.01; 4=0.1; and 5=1.     
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test). 
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3.2.5. Insulin to Amylin Secretion Ratio 
The ratio of insulin to amylin secretion was calculated after 24 hours of co-treatment.  No 
significant changes were seen (Figure 3.17).  
Figure 3.17: Insulin to amylin secretion ratio.  Ratio of insulin to amylin secretion in INS1 
pancreatic β-cells exposed to pro-inflammatory cytokines, 24 hours after co-treatment with 
Asp or GRT under normal cell culture conditions.  Negative control: RPMI1640 medium; 
Positive control: Cytokine cocktail A; Asp (µM): 1000; GRT (mg/ml) 1=0.0001; 2=0.001; 
3=0.01; 4=0.1; and 5=1.     
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control.  One-way ANOVA (Tukey post-hoc test). 
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3.2.6. Proliferation Rate of Rat Insulinoma Cells 
The proliferation rate of INS1 cells exposed to the pro-inflammatory cytokine cocktail A with 
either Asp, PPAG, or GRT was assessed after 24 hours.  The negative control, not exposed 
to cytokine cocktail A or Asp, PPAG, or GRT, was set as 100% for statistical analysis and 
graphs. 
The INS1 cells exposed to the pro-inflammatory cytokine cocktail A showed a significant 
decrease in the rate of proliferation when compared to the negative control (80.21% ± 3.08, 
p=0.021 vs. 100% ± 3.27) (Figure 3.18). 
The cells exposed to the lowest concentration of Asp (0.1 μM) showed a significant increase 
in the rate of cell proliferation relative to cytokine cocktail A (105.90% ± 4.68, p=0.0085 vs. 
80.21% ± 3.08).  In contrast, the highest concentration of Asp (1000 μM) showed a significant 
decrease in the rate of cell proliferation relative to the negative control (71.66% ± 6.92, 
p=0.0025 vs. 100% ± 3.27) (Figure 3.18 A), corresponding with the previous cell viability 
findings.  Albeit not significant, 100 μM of Asp showed a trend towards a decreased rate of 
proliferation relative to the negative control (80.38% ± 3.73, p=0.092 vs. 100% ± 3.27). 
The rate of cell proliferation in the INS1 cells was not affected by PPAG, except at the highest 
concentration (1000 µM) where a significant decrease in the rate of proliferation was seen in 
comparison to the negative control (79.70% ± 4.90, p=0.036 vs. 100% ± 3.27), while 10 μM of 
PPAG, although not significant, showed a trend towards a reduction in the rate of cell 
proliferation relative to the negative control (80.77% ± 3.74, p=0.056 vs. 100% ± 3.27) (Figure 
3.18 B). 
Co-treatment with 0.001, 0.01, and 1 mg/ml of GRT decreased the rate of cell proliferation 
significantly relative to the negative control (76.90% ± 4.58, p=0.0036; 60.39% ± 4.67, 
p<0.001; and 13.18% ± 1.80, p<0.001 vs. 100% ± 3.27); while only 0.01, and 1 mg/ml of GRT 
showed a decrease relative to cytokine cocktail A (60.39% ± 4.67, p=0.02 and 13.18% ± 1.80, 
p<0.001 vs. 80.21 % ± 3.08) (Figure 3.18 C).  The decrease in the rate of cell proliferation, at 
the highest concentration, verifies the effects seen in the other cell viability results, while the 
decrease in the rate of proliferation at 0.1 mg/ml of GRT does not correspond with the cell 
viability results. 
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Figure 3.18: Proliferation rate of INS1 cells exposed to pro-inflammatory cytokines.  Effect of Asp (A), PPAG (B), and GRT (C), on the 
proliferation rate of inflamed INS1 β-cells, 24 hours after co-treatment with Asp, PPAG, and GRT under normal cell culture conditions.  Fluorescent 
quantification of the proliferation rate was assessed by measuring BrdU incorporation into INS1 cells (425 nm).  Negative control: RPMI1640 
medium; Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); #=p<0.05, ##=p<0.01, ###=p<0.001 vs. negative control; *=p<0.05, **=p<0.01, ***=p<0.001 vs. positive control. 
   A                                                                                      B                                                                                C 
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3.3. Oxidative Stress in Rat Insulinoma Cells 
Oxidative stress in INS1 cells was assessed, first, by the DCF assay measuring ROS, and 
thereafter by the Griess assay measuring nitrites formed from NO.  The negative control, not 
exposed to cytokine cocktail A or Asp, PPAG, or GRT, was set as 100% for statistical analysis 
and graphs.  
3.3.1. Reactive Oxygen Species Production in Rat Insulinoma Cells - End-point 
Assay  
Oxidative stress in INS1 cells exposed to pro-inflammatory cytokines, was assessed by 
measuring ROS production using an end-point DCF assay 24 hours after co-treatment.  After 
24 hours, the pro-inflammatory cytokine cocktail A significantly increased ROS production 
(133.10% ± 5.09, p=0.0014 vs. 100% ± 3.72) (Figure 3.19). 
More specifically, 100 and 1000 μM of Asp showed a significant increase in ROS production 
in comparison to the negative control (139.10% ± 7.99, p=0.0013 and 153.90% ± 14.04, 
p<0.001 vs. 100% ± 3.72, respectively), while 0.1 and 10 μM of Asp showed a significant 
reduction in ROS production in comparison to cytokine cocktail A (97.66% ± 3.75, p=0.0098 
and 96.67% ± 2.24, p=0.0072 vs. 133.10% ± 5.09, respectively) (Figure 3.19 A).  
Cells co-treated with PPAG showed a significant decrease in ROS production at all 
concentrations in comparison to cytokine cocktail A (101.80% ± 3.77, p=0.0030; 103.20% ± 
4.70, p=0.0053; 95.54% ± 5.61, p=0.0002; 107.30% ± 8.04, p=0.024; and 90.53% ± 3.93, 
p<0.001 vs. 133.10% ± 5.09, respectively) (Figure 3.19 B).   
Co-treatment of INS1 cells with GRT indicated a significant decrease in ROS at all 
concentrations when compared to cytokine cocktail A (103.30% ± 6.15, p=0.008; 96.80% ± 
3.67, p=0.0006; 102.30% ± 4.60, p=0.0053; and 86.05% ± 7.02, p<0.001 vs. 133.10% ± 5.09, 
respectively).  However, the highest concentration of GRT (1 mg/ml) significantly increased 
ROS production in comparison to the negative control (130.80% ± 7.18, p=0.006 vs. 100% ± 
3.72) (Figure 3.19 C).  
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Figure 3.19: Oxidative stress; reactive oxygen species in INS1 cells – End-point.  Effect of Asp (A), PPAG (B), and GRT (C), on ROS 
generation in inflamed pancreatic β-cells, assessed 24 hours after co-treatment under normal cell conditions.  Fluorescent quantification of ROS 
was measured by using the DCF (Ex 485 nm / Ex 535 nm).  Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); #=p<0.05, ##=p<0.01, ###=p<0.001 vs. negative control; *=p<0.05, **=p<0.01, ***=p<0.001 vs. positive control. 
   A                                                                                  B                                                                                  C 
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3.3.2. Reactive Oxygen Species Production in Rat Insulinoma Cells - Kinetic 
Oxidative stress in INS1 cells was also kinetically assessed by measuring ROS production at 
1-hour intervals over 24 hours.  The AUC for each treatment was calculated over the 24 hours 
of co-treatment and expressed as an overall effect.  The negative control, not exposed to 
cytokine cocktail A or Asp, PPAG, or GRT, was set as 100% for statistical analysis and graphs. 
The INS1 cells co-treated with Asp at 1, 100, and 1000 μM significantly reduced ROS 
production over 24 hours compared to the negative control (22.06% ± 3.04, p=0.0065; 21.67% 
± 5.21, p=0.0061; and 22.21% ± 4.05, p=0.007 vs. 100% ± 17.23, respectively) as well as 
cytokine cocktail A (22.06% ± 3.04, p=0.047; 21.67% ± 5.21, p=0.044; and 22.21% ± 4.05, 
p=0.047 vs. 85.53% ± 16.60, respectively) (Figure 3.20 A). 
Co-treatment with PPAG showed a significant decrease in ROS production at 0.1, 10, and 
1000 μM in comparison to the negative control (19.03% ± 2.64, p=0.0039; 19.94% ± 3.23, 
p=0.0044; and 14.25% ± 0.91, p=0.0018 vs. 100% ± 17.23, respectively) and to cytokine 
cocktail A (19.03% ± 2.64, p=0.03; 19.94% ± 3.23, p=0.034; and 14.25% ± 0.91, p=0.016 vs. 
85.53% ± 16.60, respectively) (Figure 3.20 B). 
In a similar trend to Asp, co-treatment with GRT showed a significant decrease in ROS 
production over 24 hours at 0.001, 0.1, and 1 mg/ml in comparison to the negative control 
(16.83% ± 2.21, p=0.0007; 13.94% ± 3.42, p=0.0004; and 20.83% ± 4.43, p=0.0014 vs. 100% 
± 17.23, respectively) as well as cytokine cocktail A (16.83% ± 2.21, p=0.0083; 13.94% ± 3.42, 
p=0.0052; and 20.83% ± 4.43, p=0.016 vs. 85.53% ± 16.60, respectively) (Figure 3.20 C). 
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Figure 3.20: Oxidative stress; reactive oxygen species in INS1 cells exposed to pro-inflammatory cytokines.  Effect of Asp (A), PPAG 
(B), and GRT (C), on ROS generation INS1 pancreatic β-cells, exposed to pro-inflammatory cytokines was assessed kinetically for 24 hours 
under normal cell culture conditions.  Fluorescent quantification of ROS was measured by using the DCF (Ex 485 nm / Ex 535 nm).  Negative 
control: RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); ##=p<0.01, ###=p<0.001 vs. negative control; *=p<0.05, **=p<0.01 vs. positive control. 
   A                                                                                 B                                                                                   C 
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3.3.3. Nitric Oxide Production in Rat Insulinoma Cells 
Oxidative stress was further assessed by the amount of nitrates as an indirect measure of NO 
production in INS1 cells exposed to the pro-inflammatory cytokine cocktail A with either Asp, 
PPAG, or GRT for 24 hours.  The negative control, not exposed to cytokine cocktail A or Asp, 
PPAG, or GRT, was used as reference for statistical analysis and graphs. 
Overall there was no significant effect seen between the treated groups and the negative 
control or pro-inflammatory cytokine cocktail A after 24 hours of exposure (Figure 3.21).  
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iii) 
Figure 3.21: Oxidative stress; nitrate generation in INS1 cells.  Effect of Asp (i), PPAG (ii), and GRT (iii), 
on NO in INS1 pancreatic β-cells in without cytokine cocktail A (A) and with cytokine cocktail A (B) for 24 
hours.  Fluorescent quantification of nitrites was measured by using the Griess assay (540 nm).  Negative 
control: RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control.  One-way 
ANOVA (Tukey post-hoc test). 
B With Cytokine Cocktail A A Without Cytokine Cocktail A 
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3.4. Beta Secretase Inhibition in Rat Insulinoma Cells 
Beta secretase inhibition activity of Asp, PPAG, and GRT in INS1 cells was assessed by a 
purified BACE enzyme assay, followed by a BACE assay in vitro. 
3.4.1. Beta Secretase Inhibition - Purified-enzyme Assay 
Beta secretase inhibition activity of Asp, PPAG, and GRT was compared to that specific 
treatment’s lowest concentration used.  The BACE inhibition assay indicates a concentration 
dependent response after 2 hours of incubation with the known BACE inhibitor, as an 
enhancement in fluorescence is seen, indicating that the substrate is cleaved by BACE.  After 
2 hours, the two highest concentrations of the known inhibitor (LY2886721); 3.9 and 39 μM, 
reduced BACE activity significantly when compared to the lowest concentration used (0.0039 
μM), (71.89% ± 6.44, p=0.0010; 23.44% ± 5.88, p<0.001, vs. 103.50% ± 0.73, respectively).  
Aspalathin and PPAG showed no significant effect after the 2 hours of incubation, while GRT, 
more specifically the highest concentration (1 mg/ml), showed a significant effect on BACE 
activity as a decrease in BACE activity was observed (83.37% ± 3.40, p<0.001 vs. 102% ± 
1.75) (Figure 3.22).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22: Beta secretase inhibition by Asp, PPAG, and GRT.  Beta secretase inhibition activity 
of Asp, PPAG, and GRT was compared to a known inhibitor (LY2886721) using a purified BACE 
enzyme assay.  Beta secretase activity assessed 2 hours after incubation at room temperature (Ex 
320 nm / Ex 405 nm).  *Concentrations: LY2886721 (mM): 1=0.0039, 2=0.039, 3=0.39, 4=3.9, 5=39; 
Asp and PPAG (μM): 1=0.1, 2=1, 3=10, 4=100, 5=1000; GRT (mg/ml): 1=0.0001, 2=0.001, 3=0.01, 
4=0.1, 5=1.   
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to that specific treatment’s 
lowest concentration used; ##=p<0.05, ###=p<0.001 vs. control of LY2886721; ***=p<0.001 vs. control of GRT.  
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3.4.2. Beta Secretase Inhibition by Asp, PPAG, and GRT - Cell Based Assay 
Beta secretase inhibition by Asp, PPAG, and GRT was assessed kinetically over 24 hours 
measuring the fluorescence, which is enhanced when BACE cleaves the substrate.  A known 
BACE inhibitor was used as second control at two different concentrations; A: 39 μM, and B: 
3.9 μM.  The negative control, not exposed to cytokine cocktail A or Asp, PPAG, or GRT, was 
set as 100% for statistical analysis and graphs. 
Inhibitor A (39 μM) showed a significant decrease in BACE activity when compared to the 
negative control (61.56% ± 10.55, p<0.001 vs. 100% ± 2.84) as well as cytokine cocktail A 
(61.56% ± 10.55, p<0.001 vs. 96.23% ± 2.51) (Figure 3.23). 
The INS1 cells co-treated with Asp showed a significant decrease in BACE activity at 100 and 
1000 μM in comparison to the negative control (77.42% ± 1.73, p=0.0073 and 56.20% ± 2.05, 
p<0.001 vs. 100% ± 2.84, respectively) and to cytokine cocktail A (77.42% ± 1.73, p=0.048 
and 56.20% ± 2.05, p<0.001 vs. 96.23% ± 2.51, respectively) (Figure 3.23 A). 
In contrast to Asp, cells co-treated with PPAG showed no effect on BACE activity except at 
the highest concentration (1000 μM) where a significant increase in BACE activity was 
observed over 24 hours in comparison to the negative control (235.80% ± 15.78, p<0.001 vs. 
100% ± 2.84) and cytokine cocktail A (235.80% ± 15.78, p<0.001 vs. 96.23% ± 2.51) (Figure 
3.23 B). 
Following a similar trend to Asp, cells co-treated with GRT showed a significant decrease in 
BACE activity at 0.1 and 1 mg/ml when compared to the negative control (67.47% ± 1.20, 
p<0.001 and 39.80% ± 0.55, p<0.001 vs. 100% ± 2.84, respectively) as well as cytokine 
cocktail A (67.47% ± 1.20, p=0.0002 and 39.80% ± 0.55, p<0.001 vs. 96.23% ± 2.51), (Figure 
3.23 C). 
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Figure 3.23: Beta secretase inhibition by Asp, PPAG, and GRT.  Effect of Asp (A), PPAG (B), and GRT (C), on BACE activity in INS1 
pancreatic β-cells exposed to the pro-inflammatory cytokines, was assessed kinetically for 24 hours, under normal cell culture conditions.  
Fluorescent quantification of BACE activity was assessed using the BACE assay (Ex 320 nm / Ex 405 nm).  Negative control: RPMI1640 medium; 
Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative control set at 100%.  One-way ANOVA (Tukey post-hoc 
test); ##=p<0.01, ###=p<0.001 vs. negative control; *=p<0.05, ***=p<0.001 vs. positive control. 
   A                                                                                     B                                                                                C 
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3.4.3. Protein Expression in Rat Insulinoma Cells Exposed to Pro-Inflammatory 
Cytokines 
The effect of Asp, PPAG, and GRT on protein expression was assessed in INS1 cells exposed 
to the pro-inflammatory cytokine cocktail A by Western blots. 
 Western blots 
Western blot analysis, also known as the protein immunoblot, was used to assess molecular 
markers of interest and the potential signalling pathways that are altered in INS1 cells by pro-
inflammatory cytokines.  Proteins of interest include amylin, TMEM27, BACE2, NF-κB, and 
COX2, relating to cell viability, cell function, oxidative stress, and autophagy.  
Chemiluminescent images of PVDF membranes were taken (Figure 3.24) where after the 
images were quantified as the intensity of protein expressed.  Values obtained were 
normalised to β-tubulin which served as the house keeping protein.  The negative control was 
used as reference for statistical analysis and graphs.   
3.4.3.1.1. Amylin Expression 
Although not significant, the cells co-treated with GRT (0.1 mg/ml) for 24 hours had the largest 
fold decrease (0.5 X fold change) in amylin expression in comparison to the negative control 
(0.51 ± 0.04 vs. 1.0 ± 0.25 ) (Figure 3.25). 
3.4.3.1.2. TMEM27 Expression 
Although no significant changes were seen in TMEM27 expression after 24 hours of co-
treatment, cytokine cocktail A had the most extensive fold decrease (0.5 X fold change) in 
TMEM27 expression (0.59 ± 0.13 vs. 1.0 ± 0.21) , followed by PPAG (100 µM) and GRT (0.1 
mg/ml) (Figure 3.26). 
3.4.3.1.3. BACE2 Expression 
Rat Insulinoma cells showed no significant change in BACE2 expression.  The cells co-treated 
with Asp (100 µM) showed the largest fold increase in BACE2 expression compare to the 
negative control (1.30 ± 0.36 vs. 1.0 ± 0.40), however it is not significant (Figure 3.27). 
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3.4.3.1.4. COX2 Expression 
Rat Insulinoma cells showed no significant change in COX2 expression after 24 hours of co-
treatment.  However, cytokine cocktail A showed the largest fold increase in COX2 expression 
(1.5 X fold change) when compared to the negative control (1.61 ± 0.53 vs. 1.0 ± 0.34), 
however it is not significant (Figure 3.28). 
3.4.3.1.5. Phosphorylated NF- κB to Total NF- κB Expression 
The ratio of pNF-κB to NF-κB was determined to assess phosphorylation of NF- κB.  After 24 
hours of co-treatment no significant change was observed.  However, the cells exposed to 
cytokine cocktail A and the group co-treated with GRT (0.1 mg/ml) showed a fold increase 
(1.5 X fold change, respectively) in the ratio of pNF-κB to NF-κB in comparison to the negative 
control (1.39 ± 0.57 vs. 1.0 ± 0.36 and 1.33 ± 0.58 vs. 1.0 ± 0.36, respectively) (Figure 3.29). 
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Figure 3.24: Western blot images of protein expression in INS1 cells exposed to 
inflammatory cytokines.  Representative images of PVDF membranes after incubation with 
the primary antibodies overnight, followed with their specific secondary antibodies for 1.5 
hours.  After incubation, the membranes were exposed to ECL for 5 minutes where after the 
ChemiDoc was used to take chemiluminescent images.  (-): without cytokine cocktail A and 
treatment; (+): with cytokine cocktail A and Asp, PPAG, or GRT. 
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Figure 3.25: Amylin expression in INS1 cells exposed to pro-inflammatory cytokines.  
Amylin expression in INS1 cells 24 hours after co-treatment with cytokine cocktail A and 100 
µM of Asp, 100 µM of PPAG, 0.1 mg/ml of GRT, and 39 µM of Inhibitor A.  Chemiluminescent 
images were obtained on the ChemiDoc to quantify protein expression.  Negative control: 
RPMI1640 medium; Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control; One-way ANOVA (Tukey post-hoc test). 
Figure 3.26: TMEM27 expression in INS1 cells exposed to pro-inflammatory cytokines.  
TMEM27 expression in INS1 cells 24 hours after co-treatment with cytokine cocktail A and 
100 µM of Asp, 100 µM of PPAG, 0.1 mg/ml of GRT, and 39 µM of Inhibitor A.   
Chemiluminescent images were obtained on the ChemiDoc to quantify protein expression.  
Negative control: RPMI1640 medium; Positive control: Cytokine cocktail A. 
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control; One-way ANOVA (Tukey post-hoc test). 
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Figure 3.27: BACE2 expression in INS1 cells exposed to pro-inflammatory cytokines.  
BACE2 expression in INS1 cells 24 hours after co-treatment with cytokine cocktail A and 100 
µM of Asp, 100 µM of PPAG, 0.1 mg/ml of GRT, and 39 µM of Inhibitor A.  Chemiluminescent 
images were obtained on the ChemiDoc to quantify protein expression.  Negative control: 
RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control; One-way ANOVA (Tukey post-hoc test). 
Figure 3.28: COX2 expression in INS1 cells exposed to pro-inflammatory cytokines.  
COX2 expression in INS1 cells 24 hours after co-treatment with cytokine cocktail A and 100 
µM of Asp, 100 µM of PPAG, 0.1 mg/ml of GRT, and 39 µM of Inhibitor A.  Chemiluminescent 
images were obtained on the ChemiDoc to quantify protein expression.  Negative control: 
RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control; One-way ANOVA (Tukey post-hoc test). 
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Figure 3.29: NF-κB expression in INS1 cells exposed to pro-inflammatory cytokines.  
NF-κB expression in INS1 cells 24 hours after co-treatment with cytokine cocktail A and 100 
µM of Asp, 100 µM of PPAG, 0.1 mg/ml of GRT, and 39 µM of Inhibitor A.  Chemiluminescent 
images were obtained on the ChemiDoc to quantify protein expression.  Negative control: 
RPMI1640 medium; Positive control: Cytokine cocktail A.  
Data presented is the mean (± SEM) of three independent experiments (n=3), relative to the negative 
control; One-way ANOVA (Tukey post-hoc test). 
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3.5. Summary of Results  
 
Table 3.2: Summary of Results. Summary of the effect of Asp, PPAG, and GRT on cell 
viability, cell function, oxidative stress, and BACE activity in inflamed INS1 cells.  
 
 Asp PPAG GRT 
Cell Viability *Arrows indicate a decrease in cell viability not a decrease in the measurement. 
-MTT at high [ ] No effect at high [ ] 
-Cellular ATP Content at high [ ] at high [ ] at high [ ] 
-Early Apoptosis/Necrosis at high [ ] 
at high [ ], but no 
effect on necrosis 
at high [ ] 
-Late Apoptosis at high [ ] No effect at high [ ] 
Cell Function 
-Insulin Secretion 
Increased at basal 
glucose levels at 
only the highest [ ] 
No effect 
Only increased at 
basal glucose levels 
at higher [ ] 
-Insulin Content No effect  No effect 
-Amylin Content No effect  No effect 
-Amylin Secretion No effect  No effect 
-Proliferation Rate at high [ ] at high [ ] at high [ ] 
Oxidative Stress 
-ROS (End-point) at lower [ ] Overall at lower [ ] 
-ROS (Kinetic) at low and high [ ]  at low and high [ ]  at low and high [ ] 
-NO (End-point) No significant effect No significant effect No significant effect 
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 Asp PPAG GRT 
BACE Inhibition 
-Purified Enzyme Assay No effect No effect 
BACE Inhibition at 
high [ ] 
-Cell Based (Kinetic) 
BACE Inhibition at 
high [ ] 
Increase BACE 
activity at highest [ ] 
BACE Inhibition at 
high [ ] 
Western Blots 
-Amylin No effect No effect No effect 
-TMEM27 No effect No effect No effect 
-BACE2 No effect No effect No effect 
-COX2 No effect No effect No effect 
-pNf-κB / Nf-κB  No effect No effect No effect 
*  : Increase;    : Decrease; ---- : Was not tested in that particular experimental technique. 
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CHAPTER 4 
Discussion 
Exposure of pancreatic β-cells to perpetual damage linked to chronic low-grade inflammation 
and stressors such as gluco- and lipotoxicity lead to the progression of T2D.  These stressors 
negatively influence pancreatic β-cell function via several mechanistic and signalling pathways 
involved in inflammation, as well as oxidative stress culminating in IR (Abedini and Schmidt, 
2013; Harding and Ron, 2002; Hull et al., 2004; Prentki and Nolan, 2006; Robertson et al., 
2004; Weir and Bonner-Weir, 2004).  At first, pancreatic β-cells maintain homeostasis by 
activating anti-inflammatory pathways and increasing insulin secretion to compensate for IR.  
The chronic exposure of pancreatic β-cells to excessive glucose levels leads to β-cell 
dysfunction and hyperglycemia.  Insulin resistance and hyperglycemia in turn exacerbate the 
inflammatory pathway and ultimately results in the loss of pancreatic β-cell functional mass 
due to an imbalance between cell death and proliferation of β-cells (Kahn, 1998; Larsson and 
Ahrén, 1996; Maedler et al., 2002; Perley and Kipnis, 1967; Polonsky et al., 1988). 
Pancreatic β-cell inflammation also results from elevated levels of toxic IAPP due to misfolding 
and aggregation of toxic amyloid fibril depositions.  Amylin is co-secreted with insulin after 
glucose stimulation.  Increased levels of amylin are observed in T2D individuals and positively 
correlate with BACE2 levels (Figure 4.1) (Alcarraz-Vizán et al., 2017, 2015, Clark et al., 1996a, 
1996b; Gasa et al., 2001; Hou et al., 1999; Kahn et al., 1999).  High levels of BACE2 are 
expressed in pancreatic β-cells, however, there are speculations regarding the role of BACE2 
in the pancreas and its role in the progression of T2D.  Beta secretase 2 is seen to both benefit 
and damage pancreatic β-cells by regulating insulin secretion through the cleavage of 
TMEM27, and by increasing IAAP deposition, respectively (Figure 4.1) (Abedini and Schmidt, 
2013; Alcarraz-Vizán et al., 2017, 2015; Esterházy et al., 2011; Southan and Hancock, 2013; 
Stützer et al., 2013; Vassar, 2014).  Therefore, investigating the interaction between 
inflammation, BACE activity and amyloid deposition may provide insights into the role(s) 
thereof in pancreatic β-cell impairment and may reveal an opportunity for the development of 
novel therapeutic targets to protect and preserve pancreatic β-cells, such as specifically 
targeting the activities of BACE2.   
Aspalathin and PPAG, both polyphenolic components of Rooibos, have strong antioxidant 
properties, the ability to increase glucose uptake in muscle cells and increase insulin secretion 
from β-cells (Beltrán-Debón et al., 2011; Bramati et al., 2002; Joubert et al., 2008; Joubert and 
de Beer, 2011; Kawano et al., 2009; Ku et al., 2015; McKay and Blumberg, 2007).  In addition 
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to antioxidant properties, several studies have indicated that polyphenols exert a protective 
effect against Aβ formation and aggregation by acting as BACE1 inhibitors (Shimmyo et al., 
2008).  Elevated BACE1 expression is seen to increase Aβ levels via NF-κB, indicating that 
BACE1 interplays with inflammatory pathways (Figure 4.1) (Buggia-Prevot et al., 2008; Fu et 
al., 2014).  In the pancreatic islets BACE2 is highly expressed and its inhibition has been 
associated with increased β-cell mass and improved hyperglycemia as a result of increased 
insulin secretion and glucose uptake.  In this study, the GRT Rooibos extract, rich in Asp and 
PPAG, was assessed as a potential novel therapeutic agent that directly targets BACE2 
activity and consequently protects β-cell mass, decreases β-cell inflammation and the 
progression of T2D.  Furthermore, the Rooibos extract may remediate inflammation-induced 
cellular damages, thereby indirectly reducing the deleterious effects of BACE.  Thus far, 
neither the BACE inhibitory effect, nor the anti-inflammatory effect of Rooibos in pancreatic β-
cells has been reported on. 
In this study, pro-inflammatory cytokines were used to mimic a state of moderate inflammation, 
associated with IAPP and T2D, in vitro using INS1 cells.  An Aspalathin-rich Rooibos extract, 
and two of its major bioactive phenolic compounds, Asp and PPAG, were assessed for their 
protective effect(s) on INS1 cells exposed to a pro-inflammatory cytokine cocktail over 24 
hours.  Furthermore, their ability to inhibit BACE activity and thereby reduce the risk for 
developing T2D, was assessed by studying cell function and viability, as well as its effect on 
oxidative stress via several mechanistic and signalling pathways.  
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Figure 4.1:  Proposed mechanisms involved in beta secretase 2 inhibition in pancreatic beta-cells.  Type 2 diabetes is associated with a 
loss of pancreatic β-cell functional mass.  In T2D subject, amylin levels are elevated and are associated with increased BACE2 expression.  Beta 
secretase 2 modulates amylin expression.  Amylin-induced inflammation in conjunction with other stressors such as glucotoxicity, lipotoxicity, and 
oxidative stress leads to β-cell dysfunction by decreasing ATP production as well as cell death.  The latter can be compensated for by increasing 
the rate of proliferation.  However, the increased levels of BACE2, seen in T2D, decreases the rate of proliferation and negatively influences 
insulin signalling, exacerbating β-cell dysfunction and the progression of T2D.  Plant polyphenols may inhibit BACE activity as well as directly 
target inflammatory responses. 
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4.1. Establishing a Non-Lethal Pro-Inflammatory State in Rat Insulinoma Cells 
The first part of the aim of the study was to determine whether GRT, Asp, and PPAG can 
reduce a state of moderate inflammation in INS1 cells.  Therefore, the first objective of the aim 
was to establish a pro-inflammatory model using the INS1 cells and a non-lethal combination 
of pro-inflammatory cytokines.   In a disease state, elevated levels of glucose would be present 
and will further induce inflammation.  However, for the purpose of this study co-exposure with 
high glucose levels, apart from the cytokine cocktail, was excluded as the cytokine cocktail 
directly stimulates inflammation.  A cytokine cocktail of three different pro-inflammatory 
cytokines were used to establish the inflammatory condition in rat insulinoma INS1 cells, 
representative of the T2D disease state.  A range of literature-based concentrations of TNF-
α, IL-1β, and IFN-γ acting as inducers of moderate inflammation were assessed in INS1 cells 
(Chellan, 2014; Dai et al., 2013; Kacheva et al., 2011; Yang et al., 2015; Yang and Johnson, 
2013).   In addition to assessing the effect of the individual cytokines at different 
concentrations, two previously published pro-inflammatory cytokine cocktails, A and B, were 
used to assess the combined effects of the cytokines, characteristic of T2D pathophysiology.  
The two pro-inflammatory cytokine cocktails provide more insights into the effect(s) these 
cytokines might exert; such as a synergistic or antagonistic effect on each other.  Cell viability 
of INS1 cells was assessed after 3, 6, and 24 hours of exposure to these cytokines.  After 3 
and 6 hours, no measurable effect was seen in the cells exposed to TNF-α or IFN-γ (Figure 
3.2 A and B).  However, the cells exposed to IL-1β showed a significant increase in 
mitochondrial dehydrogenase activity at two concentrations (0.01 and 1 ng/ml) after 3 hours 
(Figure 3.2 A).  The increased mitochondrial activity could reflect a pro-inflammatory mediated 
superoxide flash response whereby increased ROS functions to scavenge NO and thereby 
attenuate the cytokine-induced NO response (Broniowska et al., 2015).  It has been proposed 
that IL-1β and IL-6 simulate the production and secretion of each other (Cahill and Rogers, 
2008) and IL-6 has previously been shown to exert both pro- and anti-inflammatory effects 
(Kamimura et al., 2003; Starkie et al., 2003; Steensberg et al., 2003; Z. Xing et al., 1998).  A 
study by Choi et al. (2004), showed that IL-6 protects pancreatic β-cells from pro-inflammatory 
cytokine-induced cell death and functional impairment in vitro and in vivo.  After 24 hours of 
exposure, TNF-α had no measurable effect on mitochondrial dehydrogenase activity, while 
IFN-γ exposure induced a significant increase at 1 ng/ml relative to the negative control (Figure 
3.2 C).  Although TNF-α is one of the most important death effector molecules, most cells are 
not susceptible to apoptosis by TNF-α alone due to the concomitant activation of the anti-
apoptotic process by TNF-α (Beg and Baltimore, 1996; Van Antwerp et al., 1996).  Nuclear 
factor-kappa B has been implicated as an important molecule in the protection of cells against 
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TNF-α induced apoptosis (Chu et al., 1997), while other studies reported increased cell death 
in pancreatic islet cells through NF-κB activation (Han et al., 2001; Heimberg et al., 2001), 
indicating a complex interplay between cytokines and TFs, which may be different according 
the modes of cell death.  Chang et al. (2003), found evidence supporting the role of NF-κB in 
the protection of pancreatic β-cells against TNF-α induced apoptosis, which may explain why 
our study indicated that TNF-α had no effect on mitochondrial dehydrogenase activity (cell 
death).  After 24 hours of exposure, IL-1β was the only cytokine to significantly reduced 
mitochondrial dehydrogenase activity, but only at the highest concentration used (10 ng/ml) 
(Figure 3.2 C).  Interleukin 1-beta has previously been proposed to be the master switch of 
inflammation.  In comparison to 3 and 6 hours of exposure, 24 hours of exposure to cytokine 
cocktail A and B induced the largest reduction in mitochondrial activity (Figure 3.1).  Previously 
it has been reported that TNF-α, IL-1β, and IFN-γ exert  a synergistic effect on the production 
of IL-12 in β-cells (Taylor-Fishwick et al., 2013), which may explain our findings showing that 
the cytokines in the cocktails exert a synergistic effect, resulting in decreased cell viability in 
comparison to the cytokines individually.  Another study by Rabinovitch et al. (1990) showed 
that IL-1β and TNF-α, as individual stressors, are cytotoxic to islet cells and that this 
cytotoxicity may be amplified by combining IL-1β and TNF-α and/or adding IFN-γ.  
Furthermore, a study by Chang et al. (2003) used an IFN-γ/TNF-α in a synergistic model to 
study the role of NF-κB activation in pancreatic cell death, linking the effects of the cytokine 
cocktails to the induction of a pro-inflammatory state.  It is important to reﬂect on the complexity 
of the pathogenesis of different disease states and the various roles of each cytokine during 
the different stages of disease progression.  Although only cytokine cocktail B induced a 
significant decrease in mitochondrial dehydrogenase activity after 24 hours (Figure 3.2 C), 
cytokine cocktail A was selected to induce inflammation in our study, as a state of moderate 
inflammation was needed to represent the T2D disease state, without inducing premature and 
large scale INS1 cell death.  Furthermore, Chellan (2014) used a similar cytokine cocktail  as 
cytokine cocktail A, in cells derived from mice,  where cell viability was significantly reduced 
after 24 hours of exposure.  In contrast to our results, the same combination of cytokines at 
similar concentrations to cytokine cocktail B did not induce cell death after 24 hours.  However, 
this contradiction may possibly be explained by the fact that our cells are derived from rats 
while Yang and Johnson (2003) used cells derived from mice.  It should be considered that 
the initial point of the pro-inflammatory state might have been missed and might have started 
before 24 hours as the previous time point was at 6 hours.  It was also decided to use 24 hours 
as the standard period for exposure since we sought to induce a chronic state of inflammation 
and this was the longest feasible period within which to maintain this immortalised cell 
population.  
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Although cytokine cocktail A showed no significant change in the MTT results, it did show 
some apoptosis inducing effects, as measured by means of flow cytometry using the AV/PI 
assay.  Beta-cell apoptosis in T2D has been reported in only a few studies (Butler et al., 2003; 
Kaneto et al., 1999), presumably owing to low probability of detecting ongoing β-cell apoptosis 
in given pancreatic sections of slowly progressive T2D.  Therefore, by assessing cell death 
kinetically, as in this study, the probability of missing the point of cell death is reduced.  The 
kinetic assays of cell death, although not statistically significant, showed a trend towards 
increased necrosis in the cells exposed to cytokine cocktail A, which may be of biological 
significance.  In addition to elevated insulin levels, recent studies have described elevated 
circulating levels of IL-1β, TNF-α, and/or AGEs (Donath and Shoelson, 2011), which could 
potentially induce β-cell dysfunction or apoptosis in the long term.  However, in this study no 
measurable effect was seen when comparing the insulin secretion of the negative control to 
cytokine cocktail A (Figure 3.13).  The 1.5X fold change seen in protein expression of COX2 
(Figure 3.28) and NF-κB (Figure 3.29), verified  the inflammatory state induced by the 
cytokines, as both these proteins are involved in related inflammatory pathways.  However, a 
study by Poligone and Baldwin (2001) demonstrated that COX2 expression may inhibit nuclear 
translocation of NF-κB and that the cyclopentenone prostaglandins inhibit NF-κB.  They also 
indicated that prostaglandin E2 strongly synergizes with the inflammatory cytokine TNF-α to 
promote NF-κB-dependent transcription and gene expression.  Furthermore, cytokine cocktail 
A, although not significantly, negatively influenced insulin signalling through TMEM27 
cleavage as a 0.5X fold change in TMEM27 (Figure 3.26) as well as amylin (Figure 3.25) 
expression was observed; both of these proteins are associated with insulin signalling.  The 
latter verifies the findings of previous studies that have shown that BACE2 cleaves TMEM27 
and can negatively influence insulin production (Alcarraz-Vizán et al., 2015; Esterházy et al., 
2011; Stützer et al., 2013).  A study by Zhang and Kim, 1995 showed that TNF-α inhibits GSIS 
in INS1 cells.  Furthermore, Kiely et al., 2007 showed that the addition of IL-1β, TNF-α, and 
IFN-γ (at concentrations that did not induce apoptosis) inhibited chronic and acute stimulated 
levels of insulin secretion while increasing cellular glucose uptake.  However, more time points 
need to be assessed to determine the effect of these stressors in a more chronic state of 
moderate inflammation, and levels of IL-6 will need to be assessed to determine if INS1 cells 
first initiate an anti-inflammatory state before exerting a pro-inflammatory state.  It is also 
important to consider that this study only assessed the treatment effects of Asp, PPAG, or 
GRT by performing co-treatments, while in a physiological state representative of T2D an 
inflammation state will already be present and glucose levels would be elevated.  Therefore, 
it will be vital to assess the treatment effect of Asp, PPAG, or GRT by doing pre-treatment with 
these cytokines to induce a chronic low-grade inflammatory state prior to treatment.  
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Furthermore, it should also be considered to pre-treat the INS1 cells with Asp, PPAG, and 
GRT to determine if these extracts will prevent damage induced by inflammation in INS1 cells. 
4.2. Effect of Asp, PPAG, and GRT on Rat Insulinoma Cells in a Pro-Inflammatory State 
4.2.1. Rat Insulinoma Cell Viability 
The first objective to the first aim was also to determine the potential protective effect of Asp, 
PPAG, and GRT on inflamed INS1 cells.  This was done by assessing the effect of Asp, PPAG, 
and GRT on INS1 cells with experimentally induced moderate inflammation after 24 hours of 
co-treatment with cytokine cocktail A.  After 24 hours, no change was observed in 
mitochondrial dehydrogenase activity, except at the highest concentrations of Asp (1000 μM) 
and GRT (1 mg/ml) used, both inducing a significant reduction in mitochondrial 
dehydrogenase activity (Figure 3.4 A and C).  A study done by Bae et al., 2015 showed that 
pre-treatment with either kazinol C or isokazinol D abolished cytokine-induced toxicity in both 
RINm5F cells and pancreatic islets by inhibiting NF-κB signalling, however, our results showed 
no change in NF-κB expression after co-treatment (Figure 3.29).  To determine if the toxic 
effects seen at these concentrations of Asp and GRT were the result of the induced 
inflammation state in conjunction with Asp and GRT or if it is just a result of its toxicity, INS1 
cells were exposed for 24 hours in the absence of the cytokine cocktail A with the same range 
of concentrations of Asp, PPAG, and GRT used in the inflamed cells.  This showed that Asp 
and GRT seem to exhibit a positive effect on INS1 cells, although not statistically significant, 
by showing a trend towards increased mitochondrial dehydrogenase activity at lower 
concentrations (Figure 3.3 A and C) and may be biological significant.  However, it is important 
to note that the highest concentrations of Asp and GRT reduced the mitochondrial 
dehydrogenase activity of the cells, while PPAG had no measurable effect (Figure 3.3 B).  This 
may be due to the higher content of Asp than PPAG in the GRT extract.  Therefore, it can be 
proposed that the highest concentrations of Asp and GRT exerted prooxidative effects 
(Joubert et al., 2005), and that an induced inflammation state in INS1 cells exacerbates the 
toxic effect.  However, it has previously been stated that plant polyphenols could negatively 
influence MTT results as these plant polyphenols interact with the MTT (Bruggisser et al., 
2002; Piwen Wang et al., 2010), therefore an ATP assay was done to verify MTT cell viability 
results.  Overall no measurable effect was seen on cellular ATP production except at the 
highest concentration of Asp and GRT, which indicated a significant reduction in cellular ATP 
production (Figure 3.5 A and C) and can be associated with the decreased mitochondrial 
dehydrogenase activity seen.  In contrast to our findings, Li et al., 2006 reported that green 
tea polyphenols increase insulin secretion and ATP production.  Interestingly, PPAG at the 
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highest concentration assessed in this study showed an increase in cellular ATP production, 
indicative of increased mitochondrial activity (Figure 3.5 B).  A similar effect of PPAG, at the 
highest concentration, was seen when assessing oxidative stress, where a significant 
reduction in ROS production was seen both after 24 hours (Figure 3.19 B), relative to cytokine 
cocktail A, and kinetically over 24 hours (Figure 3.20 B), relative to both the negative control 
and cytokine cocktail A.  The GRT extract showed a significant increase in insulin secretion at 
basal levels, while only the highest concentration of Asp showed an increase (Figure 3.13 A 
and C).  It has previously been proposed that ATP production correlates positively with insulin 
secretion where increased mitochondrial ATP production, in response to hyperglycemia, 
closes the ATP sensitive K+ channels, leading to membrane depolarization, opening of 
voltage‐sensitive Ca2+ channels, Ca2+ ion influx and insulin granule exocytosis (Chatterjee et 
al., 2012). 
All the aforementioned assays only assessed cell viability after 24 hours of co-treatment which 
is only indicative of the viability of the cells at that specific moment, giving a snapshot of what 
is happening in the INS1 cells.  Therefore, cell viability was further assessed, by measuring 
early and late apoptosis and necrosis kinetically.  As previously mentioned, Bae et al., 2015 
showed that pre-treatment with either kazinol C or isokazinol D abolished cytokine-induced 
toxicity in both RINm5F cells and islets by inhibiting NF-κB signalling pathways, thus inhibiting 
apoptotic cell death and defects in insulin secretion.  This effect is verified in our study as the 
lower concentrations of Asp, PPAG, and GRT decreased cell death measured by AV/PI 
(Figure 3.6 A,B, and C) and caspase-3/7 (Figure 3.11 A, B, and C) kinetically, as well as 
increased basal insulin secretion in INS1 cells were observed after GRT exposure (Figure 
3.13 C).  The higher concentrations of Asp, and, in particular, GRT, did not have this protective 
effect on the INS1 cells.  This was observed as a reduction in mitochondrial dehydrogenase 
activity (Figure 3.4 A and C), decreased ATP production (Figure 3.5 A and C), and increased 
early apoptosis and necrosis were seen after 24 hours of co-treatment with Asp and GRT at 
its highest concentrations (Figure 3.6 A and C), as well as increased caspase-3/7 activation 
(Figure 3.11 A and C) with Asp exposure, as seen in the kinetic assay.  These results were 
verified by means of flow cytometry as this affords assessment of each cell individually and a 
clear distinction can be made between early and late apoptosis, as well as necrosis.  The flow 
cytometry results showed that the higher concentrations of Asp and GRT reduce cell viability 
as increased fluorescence of AV and PI were measured, with GRT showing a significant 
increase especially in necrosis and Asp in early apoptosis (Figure 3.10).  
Fluorescent and phase microscopy images were taken after 24 hours of co-treatment.  The 
phase microscopy images indicate a change in cell morphology in the GRT-exposed cells as 
more areas void of cells were seen.  In addition, there was a change in the morphology and 
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size of the cells, from stellate to a smaller and more circular shape, with the cytoplasm 
unevenly spread.  These cells were also less adhesive and had poor cluster orientation.  
Furthermore, the GRT-exposed cells had increased fluorescence, indicative of cell death 
(Figure 3.12 B; x).   
It is important to note that the highest concentrations of Asp and GRT that showed decreased 
cell viability.  Interestingly, as was confirmed by Joubert et al., (2005), Rooibos and Asp have 
been shown to exhibit both antioxidant and prooxidant effects depending on the dose used.  It 
is also important to realise that cell culture does not account for bioavailability of the extracts 
the and compounds, and therefore the concentrations used are more representative of the 
plasma concentrations.  The concentrations of GRT, Asp, and PPAG where toxic effects were 
observed were extremely high and thus not physiologically relevant if it were to be extrapolated 
to any form of sentient model, particularly in light of most polyphenolic compounds, including 
Asp, having low bioavailability (Bowles et al., 2017; Breiter et al., 2011; Stalmach et al., 2009).   
4.2.2. Rat Insulinoma Cell Function 
The main function of pancreatic β-cells is to secrete insulin in response to plasma glucose 
concentrations, therefore a GSIS assay was done to measure insulin secretion.  At basal 
glucose levels, only the highest concentrations of Asp induced a significant increase in insulin 
secretion, while PPAG had no measurable effect.  In the presence of cytokine cocktail A, the 
INS1 cells exposed to GRT significantly increased insulin secretion overall (Figure 3.13 C), 
correlating with the suggested trend towards increased cell activity at the lower concentrations 
of GRT.  Glucose stimulated insulin secretion indicated an overall increase in insulin secretion 
after glucose stimulation in the cells treated with Asp, PPAG, and GRT (Figure 3.13 A, B, and 
C).  Interestingly, the stimulatory effect of GRT seen at basal levels seems to be lost after 
glucose stimulation (Figure 3.13 C).  This may be explained by the possibility that the insulin 
stores are depleted at basal levels and thus there was insufficient stored insulin to adequately 
respond to glucose stimulation.  However, cellular insulin content of the INS1 cells was also 
determined, but no measurable changes were seen (Figure 3.14).  In contrast to our findings, 
it has previously been shown that Asp and PPAG increase insulin secretion from several β-
cell lines which were not exposed to stressors (Bramati et al., 2002; Kawano et al., 2009; Ku 
et al., 2015; McKay and Blumberg, 2007).  
Insulin and amylin are co-secreted from β-cells; thus, amylin is also indicative of cell function.  
No measurable effect was seen in both glucose stimulated amylin secretion and cellular 
content (Figure 3.15 and Figure 3.16).  It is important to note that amylin content was 
measured from the same samples used to measure GSIS.  It is possible that amylin levels 
Stellenbosch University  https://scholar.sun.ac.za
116 | P a g e  
 
may already be depleted at basal levels as seen in the insulin secretion results.  In addition, 
the insulin:amylin secretion ratio in INS1 cells is yet to be published.  For further studies, 
amylin secretion at basal levels needs to be measured.  Cell function was also assessed by 
measuring the proliferation rate of INS1 cells.  After 24 of co-treatment with the highest 
concentration of Asp and the two highest concentrations of GRT a significant decrease in the 
rate of INS1 cell proliferation was seen (Figure 3.18 A and C), verifying the reduction in cell 
viability in previous experiments.  These results show that the second highest concentration 
of GRT, as previously mentioned, might decrease both cell viability and function by increasing 
cell death and reducing cell proliferation.   
In contrast to our findings, genistein, an isoflavone first isolated from Genista tinctoria, is seen 
to increase insulin secretion and cell proliferation rate in β-cells (Fu et al., 2010).  Amylin was 
expressed at approximately 65 kDa in our Western blot analysis.  In contrast to our finding, 
most studies showed amylin expression at 4-6 kDa (Cai et al., 2011).  Trikha and Jeremic, 
2013, showed amylin expression in RIN-m5F cells, with induced human amylin, at 6 kDa.  A 
study done by Despa et al., 2012, showed that amylin trimers in diabetic heart tissue vary from 
10 to 50 kDa depending on the type of trimer.  However, it has been seen in studies that have 
probed for the amyloid precursor protein that the expression was between 95 – 130 kDa (Kulas 
et al., 2017), indicative of a bigger molecule.  This finding suggests that amylin polymerization, 
an indication of a toxic environment, has not occurred.  Furthermore, the INS1 cells used in 
this study were derived from rats, which are reported to not have the capacity to polymerize 
amylin to form amyloid fibrils (Betsholtz et al., 1989).  This further supports the notion that 
amylin polymerization did not occur and corresponds with our previous findings (Gilead and 
Gazit, 2008). 
4.2.3. Oxidative Stress in Rat Insulinoma Cells 
Cell viability and function are closely related to oxidative stress.  The interplay between 
oxidative stress and inflammatory states directly affects cell function and viability; with an 
escalation in either state exacerbating the other.  Therefore, the reduction in cell viability seen 
at the highest concentration of Asp may be explained by the significant increase in ROS 
production after 24 hours of treatment.  The lower concentrations of Asp as well PPAG and 
GRT show an overall decrease in ROS production.  Polyphenols, including Asp exhibit both 
antioxidant, and at high concentrations pro-oxidant activities that deplete the intrinsic 
antioxidant systems resulting in increased ROS (Joubert et al., 2005) as was observed in this 
study. However, when ROS were monitored kinetically Asp, PPAG, and GRT reduced ROS 
production, but not in a dose dependent manner.  This contradiction can be explained by the 
fact that the end-point DCF assay readings were only taken at one specific moment and that 
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by making use of the DCF assay kinetically, an overall observation can be measured.  The 
kinetic data was collected hourly for the 24 hours, whereafter the AUC was calculated which 
was an indication of what the overall effect was during the 24 hours and not what happened 
at each time point.  For future analysis it may help to assess the effects at each time point to 
look at kinetic patterns which will also indicate when in the 24-hour period effects was induced.  
In pancreatic β-cells two types of cellular responses can be distinguished depending on the 
level of NO production. Stressors, such as inflammation, lipotoxicity or hyperglycaemia lead 
to elevated levels of NO, and are due to the activation of iNOS, which promotes cell death 
(Lee et al., 2010; Meidute Abaraviciene et al., 2008). However, during homeostasis, low levels 
of NO is produced by endothelial NO synthase (eNOS) and promotes cell survival (Bachar et 
al., 2010; Cahuana et al., 2008). NO mediates cellular responses induced by cytokines. 
Several cytokines, including mixed cocktail of cytokines, IL-1β, IFN-γ, TNF-α, IL-177 and IL-
6,8 increase NO production by inducing iNOS expression through activation of NF-κB (Darville 
and Eizirik, 1998; Ortis et al., 2008).  Cytokine cocktail A contained similar cytokines and 
therefore NO production was assessed.  Nitric oxide is unstable and is converted to nitrates, 
which were measured by means of a Griess assay.  Aspalathin, PPAG, and GRT had no 
measurable effect on nitrate production (Figure 3.21 A, B, and C).  A study by Chang et al., 
2003 indicated that NO does not play a signiﬁcant role in β-cell death in the presence of TNF-
α, and in fact, at physiological levels, plays a vital role in normal cellular signalling (Chan et 
al., 2011).  Quercetin, a flavonol derived from Quercus, and naringenin, a flavanone found in 
citrus fruits, are seen to induce pAkt activation and participate in β-cell protection from 
cytokine-induced apoptosis, possibly by a NO-independent mechanism and are proposed to 
be potent agents to benefit β-cell mass preservation (Lin et al., 2012).  It is important to 
consider that the type of oxidative stress influences the antioxidant properties of polyphenols, 
as seen in RINm5F cells.  The latter showed that ROS levels generated via different oxidative 
stresses were variable and that drug screening (or, in this case, Asp, PPAG, and GRT) using 
a single type of stress can create bias when assessing antioxidant properties of a compound.  
Therefore, a combination of several stresses with several cellular and molecular approaches 
would provide a more accurate experimental outcome in determining the efficacy of the 
antioxidant (Auberval et al., 2015). 
4.3. Inhibition of Beta Secretase Activity with Asp, PPAG, and GRT in Rat Insulinoma 
Cells 
The second part of the aim was to determine if Asp, PPAG, and GRT can inhibit the activity of 
BACE.  Beta secretase is involved in both insulin signalling through TMEM27 cleavage and 
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amyloid deposition.  In the purified BACE enzyme assay, the highest concentration of GRT 
seems to have BACE inhibition activity, while PPAG and Asp had no measurable effect (Figure 
3.22).  However, the effect seen in the purified assay is not indicative of what happens in vitro.  
Therefore, an in vitro BACE inhibition assay was optimised, as this assay has not been 
previously described, using INS1 cells.  Two concentrations (a high and a low concentration) 
of a known BACE inhibitor were used as positive controls.  As all the other experiments were 
done either after 24 hours or over a 24-hour period, this in vitro assay was also performed 
after 24 hours of co-treatment.  As seen in the purified assay, the highest concentration of the 
known inhibitor significantly reduced BACE activity, while the lower concentration of the 
inhibitor had no measurable effect on BACE activity (Figure 3.23).  Similar to the purified 
assay, GRT seems to reduce BACE activity in a dose-dependent manner with the two highest 
concentrations significantly reducing BACE activity in INS1 cells (Figure 3.22 C).  In contrast 
to the purified assay, Asp also seems to reduce BACE activity in a dose-dependent manner 
as the two highest concentrations used reduced BACE activity significantly (Figure 3.23 A).   
A study done by Jeon et al (2003) showed that the methanolic extract of commercial green 
tea has the ability to inhibit BACE1.  Catechin, a phenol derived from Senegalia catechu, has 
also been seen to inhibit BACE1 in a dose dependent and non-competitive manner.  A study 
done by Shimmyo et al. 2008 showed that four flavonols, quercetin, kaempherol, myricetin, 
and morin, and one flavone, apigenin, directly inhibited BACE1 activity in both a cell-free 
system and neuronal cells (Shimmyo et al., 2008).  However, therapeutic BACE1 inhibition to 
block Aβ production and associated toxicity needs to be balanced as negative effects might 
arise from diminishing other physiological functions of BACE1, such as processing of 
substrates involved in neuronal function of the brain and periphery (Koelsch, 2017).  The latter 
also needs to be considered as the inhibition of BACE2 might have negative effects on other 
systems.  
It is proposed that the BACE1 promoter contains NF-κB binding elements (Bourne et al., 2007) 
and therefore elevated BACE1 expression may elevate Aβ levels in a NF-κB-dependent 
manner (Buggia-Prevot et al., 2008).  Chronic treatment with luteolin, a flavone derived from 
Lamiaceae, and also present in Rooibos, was shown to inhibit BACE1 activity and reduce Aβ 
levels in the brain (Zheng et al., 2015), therefore more research is needed on chronic exposure 
of Asp, PPAG, and GRT on β-cells as this study only assessed BACE inhibition over 24 hours.  
The different effects seen in the two assays may be explained by the fact that by using the 
purified BACE assay, no other cellular processes were considered.  Further, the molecule 
size, its half-life, and the time of inhibition may play a role.  Although a decrease in BACE 
activity is seen in the in vitro assay, protein expression in the Western blot assay did not show 
a decrease in the expression of BACE2 (Figure 3.27).  This can be said to be an advantage 
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as BACE2 also plays a role in other physiological processes, making it crucial that there is 
reduction in BACE enzyme activity without diminishing its expression.  
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CHAPTER 5 
Conclusion 
By investigating the correlation between inflammation and BACE modulation in pancreatic β- 
cells, our INS1 cytokine-induced inflammatory cell model revealed two divergent effects of 
GRT and Asp.  At high concentrations GRT and Asp increased ROS, activated caspase-3/7, 
and decreased cell viability, suggesting that at high concentrations GRT and Asp could induce 
pro-oxidative effects, a well described phenomenon in polyphenols purported to have strong 
antioxidant effects.  However, at lower concentrations GRT, Asp, and PPAG ameliorate 
oxidative stress.  This is a key finding since a strong correlation between inflammation and 
oxidative stress exists in many chronic diseases of lifestyle including T2D.  Thus, ameliorating 
oxidative stress may have profound effects on vulnerable pancreatic β-cells, which are well 
described as having reduced antioxidative capacity.  Since BACE regulation indirectly affects 
islet inflammation, the BACE inhibitory capacity of GRT and Asp is also an important finding 
of this study and the link between this inhibition and the regulation of oxidative stress warrants 
further investigation.  In addition to improving cell viability at lower concentrations, Asp and 
GRT also modulated cell function by increasing basal insulin secretion; the potential benefit of 
this effect still needs to be explored. 
Taken together, the lower concentrations of Asp and GRT tested in this study show promise 
in the amelioration of inflammation-induced oxidative stress and pancreatic β-cell damage. 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
121 | P a g e  
 
CHAPTER 6 
Study Limitations and Future Work 
This study presents with some limitations, however, with more time and resources it is possible 
to overcome many of these obstacles.  As seen in many studies, factors such as the treatment 
period, acute or chronic, the mode of treatment and treatment dosages, as well as the model 
influence the outcome.   
This study only assessed the effect of Asp, PPAG, and GRT for a period of 24 hours.  More 
investigation is needed to assess the effect of these compounds over a longer period as T2D 
is a chronic disease state.  Furthermore, INS1 cells were co-treated to assess the effect of 
Asp, PPAG, and GRT on cell viability and function in the setting of inflammation.  Thus, it is 
necessary to assess the effect(s) of these compounds when the cells are pre-treated with the 
cytokine cocktail to first induce the inflammatory state and then with the compounds to serve 
as treatment.  This will be more representative of a chronic, progressive disease state.  
Moreover, the effect(s) of the compounds should also be tested by pre-treating INS1 cells with 
these compounds followed by the induction of an inflammatory state.  The latter may provide 
insights into the preventative/prophylactic effect(s) of these compounds on inflammation in 
pancreatic β-cells.  Further investigation into the effect(s) of cytokine cocktail B on cell viability 
(i.e. mitochondrial dehydrogenase activity and ATP production) and function (i.e. proliferation) 
could have been done before excluding it from these experiments.  The latter will unsure that 
the most appropriate cytokine cocktail is used to induce a state of moderate inflammation.   
Postive controls for the probes (i.e. DCF) were not included in our experiments. Including 
positive controls in future studies will ensure that the measuremnts are indeed indicative of 
what should be measured and not due other factors.  It will also be important to include the 
BACE inhibitor in all the cell viability and function assays to help elucidate its effect. 
The INS1 cell line was chosen for this study, as these cells possesses key physiological 
properties of human pancreatic β-cells; such as physiological responses to glucose as well as 
presenting with a moderate amount of insulin and amylin content.  However, INS1 cells are 
derived from rat insulinomas.  Rodents, and in this case rats, are shown to be unable to form 
amyloid fibrils from the secreted amylin.  This limits this study to fully elucidate the role of the 
compounds on amyloid-induced inflammation, and moreso directly on toxic amyloid formation 
and/or breakdown.  Transfections with hIAPP may be useful to overcome this obstacle.  
Moreover, non-cell based amyloid fibril formation inhibition assays may help to elucidate the 
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mechanistic and signalling pathways involved in amyloid formation and associated 
inflammation that are altered/regulated by novel therapeutic targets.  The purity of the INS1 
cells were not assessed.  For future studies it will be nessesasry to assess the purity of the 
cells by measuring the response of the INS1 cells to glucose and compare the response to 
other pancreatic β-cell lines. 
Importantly, the development and progression of T2D is a result of multiple stressors including; 
glucotoxicity, lipotoxicity, oxidative stress, and inflammation.  It is necessary to induce the 
disease state with these stressors respectively, as well as in combination, as this study only 
assessed cytokine-induced inflammation.  More insights into the interplay between the 
mechanistic and signalling pathways altered by these different stressors may reveal novel 
therapeutic targets to protect and preserve vulnerable β-cells.   
This study showed limited changes in protein expression in the proteins tested for.  It is 
necessary to assess the effect of Asp, PPAG, and GRT on proteins further downstream in the 
signalling pathways to see the effect of these compounds.  Gene expression assays can help 
to further assess the effect of Asp, PPAG, and GRT on gene regulation of the genes of interest.  
This will also provide more insights into the mechanisms involved by indicating if any change 
in gene expression corresponds with protein expression; revealing if these compounds just 
effect protein expression or if they change the genes itself. 
Due to limited time and resources, a small sample size was assessed (n=3).  The latter may 
have had a negative effect on the statistical power of the results, as poor signicance was 
observed in most of the experiments.  A larger sample size will help to unsure that the effect(s) 
observed are not / are significant and not just coincidence.   The kinetic data was analysed 
using a One-way ANOVA and are therefore not a complete indication of results as time and 
treatments are involved.  To fully interrogate our kinetic assay data a statistician will be 
consulted, and a Two-way ANOVA will be performed. 
Importantly, the results in this study are only representative of a specific cell line, thus one 
minor part of an organ, and moreso, biological system.  It is vital to assess the effect(s) of 
these compounds in more physiological accurate models such as co-culturing with different 
cell lines (e.g. 3D cultures or transwell co-cultures) and/or animal models.  Nevertheless, the 
results from this study provide an excellent starting point as it helps to complete the picture of 
interactions between an organisms’ cellular components and environment, which ultimately 
determines its functionality. 
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CHAPTER 8 
Addendum A: Aseptic Tecniques 
Effective and efficient cell culture procedures depend on keeping the cells free from micro-
organisms such as bacteria, fungi, and viruses which lead to contamination.  Aseptic 
techniques are designed to serve as a barrier between the micro-organisms in the 
environment and sterile cell culture, reducing the risk of contamination.  The essentials of 
working aseptically are a sterile work area, sterile reagents, and sterile handling.  Sterile work 
areas include the use of a cell culture hood, running at all times.  For the purposes of this 
study a biosafety level 2 cell culture hood was used.  The work area should be organized with 
only the items necessary for the specific procedure and should be cleaned with 70% ethanol 
(EtOH) before and after use.  Everything that enters the hood, such as flasks, reagents, and 
pipettes, should be sprayed down with 70% EtOH.  A Bunsen burner was used to sterilize 
glass pipettes.  Protective wear, such as shoe covers, gloves, lab coats, and face masks were 
worn at all times, to reduce the risk of contamination as well as protect the user from chemicals 
that might spill.  Spillage should be reported and cleaned according to the specific standard 
operating procedure (SOP: TC B1-V03).   
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Addendum B: Assay Protocols 
Table 8.1: Purified BACE enzyme assay.  Protocol steps as provided with assay kit. 
 
 
Reaction Number 1 2 3 4 5 6 7 8 
Assay Description 
Negative Control: No 
enzyme (µl) 
Positive Control: Enzyme 
(µl) 
Inhibition 
(µl) 
Test 
Samples 
(µl) 
Standard Curve (µl) 
Fluorescent Assay Buffer 80 78 78-X 80-Y 79 78 77 75 
BACE1 Substrate Solution (50 µM) 20 20 20 20 20 20 20 20 
BACE1 Enzyme Solution (0.3 units / µl)  2 2      
Inhibitor Solution   X      
Sample Enzyme    Y     
Assay Standard Solution (100 µM)     1 2 3 5 
Total 100 100 100 100 100 100 100 100 
*X: Amount (μl) of inhibitor added; Y: Amount (μl) of test samples added 
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Figure 8.1: Diagrammatic presentation of ATP assay steps.  Add CellTiter-Glo® buffer to 
CellTiter-Glo® substrate to get the CellTiter-Glo® reagent.  Add 75 µl of CellTiter-Glo® 
reagent to each well after treatment incubation.  Incubate for 30 minutes, under normal cell 
culture conditions.  Record luminescence. 
ATP Assay 
1. Prepare 96 multi-well plates with INS1 cells in complete growth medium, 75 µl per well 
for 96-well plates. 
2. Prepare control wells containing medium without cells to obtain a value for background  
3. luminescence.  
4. Add extracts compound to experimental wells and incubate according to culture 
protocol (24 hours of incubation).  
5. Add 75 µl of CellTiter-Glo® Reagent to each well after the 24 hours of treatment 
incubation.  
6. Incubate for 30 minutes under normal cell culture conditions (Mix contents every 10 
minutes to induce cell lysis) 
7. Record luminescence.  
 
 
 
 
 
 
 
 
 
 
 
 
Griess Assay 
1. Mix equal volumes of 1× Griess Reagent and sample.  
2. Incubate for 15 minutes in the dark. 
3. Read the absorbance at 540 nm. 
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Cell Proliferation Rate 
A: Reagent Preparation 
1. Prepare 1X wash buffer by diluting 20X wash buffer (included in each BrdU ELISA kit) 
in purified water.  
2. Prepare 1X detection antibody solution by diluting BrdU detection antibody 1:100 with 
detection antibody diluent (green). 
3. Prepare 1X HRP-conjugated secondary antibody solution by diluting antimouse IgG, 
HRP-linked antibody 1:100 with HRP-linked antibody diluent (red).  
4. Prepare 10X BrdU solution by diluting BrdU 1:100 with cell culture medium.  
 
B: BrdU Incorporation 
1. Plate cells in 96-well plate and incubate with extracts substance.   
2. Add prepared 10X BrdU solution to plate wells, for a final 1X concentration. (Example: 
for 100 µl medium in the plate, add 10 µl of 10X BrdU solution per well). 
3. Place cells in incubator for 24 hours.  
4. Remove medium.  
 
C: BrdU Assay 
1. Add 100 µl / well of the fixing / denaturing solution, keep the plate at room temperature 
for 30 min. Remove solution.  
2. Add 100 µl / well prepared 1X detection antibody solution, keep plate at room 
temperature for 1 hour. Remove solution and wash plate 3 times with 1X wash buffer.   
3. Add 100 µl / well prepared 1X HRP-conjugated secondary antibody solution, keep 
plate at room temperature for 30 min. Remove the solution and wash plate 3 times with 
1X wash buffer.  
4. Prepare working solution by mixing equal parts luminol / enhancer solution and stable 
peroxide buffer.  
5. Add 100 µl of the working solution to each well. Use a plate-based luminometer to 
measure relative light units (RLU) at 425 nm within 1-10 min following addition of the 
substrate. Optimal signal intensity is achieved when read within 10 min.   
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ELISA – Insulin Secretion / Content 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.2: Steps of insulin ELISA kit.    
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ELISA – IAPP Secretion / Content 
 
1. Add 50 μL of standard or sample to each well. 
 
2. Immediately add 50 μL of biotinylated detection 
antibody to each well. 
 
3. Incubate for 45 min at 37℃.  Aspirate and wash 3 
times. 
 
4. Add 100 μl of HRP conjugate to each well.  Incubate 
for 30 min at 37℃. Aspirate and wash 5 times. 
 
5. Add 90 μL of substrate reagent.  Incubate for 15 min 
at 37°C. 
 
6. Add 50 μL of stop solution. 
 
7. Read the OD at 450 nm immediately. Calculation of 
the results. 
Figure 8.2: Diagrammatic presentation of IAPP ELISA steps.  Add samples to each well, 
followed by the addition of the biotinylated detection antibody.  After 45 minutes of incubation 
at 37°C, add HRP conjugate and incubate for 30 minutes.  Wash 5 times then add the 
substrate reagent and incubate for 15 minutes.  After incubation add stop solution and read 
the OD at 450nm. 
Stellenbosch University  https://scholar.sun.ac.za
  174 | P a g e  
 
Addendum C: Solutions 
Krebs’s-Ringer Bicarbonate HEPES Buffer  
Table 8.3: Krebs’s-Ringer Bicarbonate HEPES Buffer components. 
 Component mM MW In 125 ml 
NaCl 119 58.44 0.87 g 
NaCHO3 25 84.01 0.26 g 
KCl 4.74 74.01 0.045 g 
MgCl2 1.19 95.21 0.014 g 
CaCl2 2.54 110.98 0.035 g 
2% BSA 2% 100 2.5 g 
10 nM Hepes10 mM 10 nM 238.3 1.25 ml 
                                                            + Sterile water to 125 ml 
 
Glucose 
• Stock: 500 mM (180.16 MW) into 10 ml of KRHB  
• Basal: 2.8 mM: 252 µl into 45 ml of KRHB 
• Stimulated: 16.7 mM: 1.503 ml into 45 ml of KRHB 
 
Ethanol-acid Solution 
• 37.5 ml of EtOH (molecular graded) + 644 μl of conc HCl + 11.85 ml cell culture tested 
H2O.  
 
Sorensen’s Glycine Buffer  
• 0.751 g glycine (0.1M) + 0.584 g NaCl (0.1 M) in 100 ml cell culture tested H2O. 
 
MTT 
• 90 mg (2 mg/ml) + 45 ml DPBS   
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BSA Assay 
• Dye: methanol and phosphoric acid 
• Standards (BSA): 2, 1.5, 1, 0.75, 0.5, 0.25, 0.125 mg/ml 
 
BCA Assay 
• Reagent S: surfactant solution 
• Reagent A: sodium carbonate, sodium bicarbonate, bicinchoninic acid and sodium 
tartrate in 0.1 M sodium hydroxide 
• Reagent B: 4% cupric sulphate 
• Standards (BSA): 2, 1.5, 1, 0.75, 0.5, 0.25, 0.125 mg/ml 
 
Sample Buffer 4X (SB) 
• 100 μl (β- Mercaptoethanol) + 900 μl (Laemli sample buffer) 
 
10X TBS (pH = 7.6):  
Table 8.4:  Components of 10X TBS. 
Reagent 1 l 2 l 
200 mM Tris 24.22 g 48.44 g 
1.37 M NaCl [MW=58.44] 80.06 g 160.12 g 
                                                                                                 +  Make up to 1 l with ddH2O 
 
1X TBST 
• Dilute 100 ml of 10X TBS to 900 ml dH2O and add 1 ml Tween-20  
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Lysis Buffer 
Table 8.5: Components of lysis buffer used to lyse cells for protein determination. 
 Stock Final Conc. 50 ml 
Tris 1 M 50 mM 2.5 g 
DTT - 1 mM 0.008 g 
NaF - 50 mM 0.104 g 
Na3VO4 10 mM 100 μM 500 μl 
NP40 - 1% 500 μl 
Triton X 114 - 1% 500 μl 
RNase 10 mg/ml 25 μg/ml 125 μl 
Protease inhibitor tablets   2 Tablets 
Phospho inhibiting tablets   5 Tablets 
                                                                                                       + Sterile water to 50 ml 
*Add PMSF before using (10 µl/300 µl of lysis buffer) 
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Addendum D: Extract Treatments 
Treatment with extract in the absence of the cytokine cocktail. 
*All stocks dissolved in RPMI 1640 cell culture medium. 
Asp 
• Stock concentrations: 1000 μM 
• 452.41 mM = 0.45 mg/ml 
PPAG 
• Stock concentration: 1000 μM 
• 320.25 mM = 0.32 mg/ml 
GRT 
• Stock concentration: 1000 μg/ml  
• 1 mg/ml 
 
Table 8.6: Concentrations used for extract treatment in the absence of the cytokine 
cocktail. 
Asp (μM) PPAG (μM) GRT (mg/ml) 
1000 1000 1 
100 100 0.1 
10 10 0.01 
1 1 0.001 
0.1 0.1 0.0001 
 
Co-treatment of extracts with cytokine cocktails. 
*All stocks dissolved in RPMI 1640. 
Asp 
• Stock concentrations: 2000 μM 
• 452.41 mM = 0.90 mg/ml 
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PPAG 
• Stock concentration: 2000 μM 
• 320.25 mM = 0.64 mg/ml 
GRT 
• Stock concentration: 2000 μg/ml 
• 2 mg/ml 
 
Table 8.7: Concentrations used for co-treatment.  *Concentrations of stocks are doubled 
since co-treatment was done in a 1:1 ratio. 
Asp (μM) PPAG (μM) GRT (mg/ml) 
2000 2000 2 
200 200 0.2 
20 20 0.02 
2 2 0.002 
0.2 0.2 0.0002 
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Addendum E: Cytokines and Cytokine Cocktails 
Individual cytokine treatments 
• TNF-α: Stock: 10 000 ng/ml 
• IFN-γ: Stock: 100 000 ng/ml 
• IL-1β: Stock: 10 000 ng/ml 
 
Table 8.8: Concentrations used for treatment. 
TNF-α (ng/ml) IFN-γ (ng/ml) IL-1β (ng/ml) 
100 100 10 
25 50 1 
10 10 0.1 
1.1 1 0.01 
 
Cytokine cocktails 
Cocktail A 
• 1.1 ng/ml (TNF-α) 
• 1 ng/ml (IFN-γ) 
• 0.1 ng/ml (IL-1β) 
Cocktail B 
• 25 ng/ml (TNF-α) 
• 10 ng/ml (IFN-γ) 
• 10 ng/ml (IL-1β) 
 
Co-treatment of extracts with cytokine cocktails. 
Cytokine cocktail A  
*Concentrations of stocks are doubled since co-treatment was done in a 1:1 ratio 
• 2.2 ng/ml (TNF-α) 
• 2 ng/ml (IFN-γ) 
• 0.2 ng/ml (IL-1β) 
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Addendum F: Catalogue Numbers 
 
Equipment 
 
Description Manufacturer  
Absorbance microplate reader (ELX800) Bio-Tek Instruments; Friedrichshall, Germany 
Benchtop centrifuge (SL 16R)  Thermo Fisher Scientific 
Benchtop microfuge (5415 R) Eppendorf; Hamburg, Germany 
Benchtop microfuge (5810 R) Eppendorf 
Biohazard safety cabinet, class II Airvolution; Johannesburg, South Africa 
Bunsen burner INTEGRA Biosciences AG; Landquart, Switzerland 
ChemiDoc Bio-Rad 
Cylinders (50, 100, 500, 1000, 2000 ml) Lasec; Cape Town, South Africa  
Fine Balance scale United Scientific  
Flow Cytometer BD Accuri ™ C6 BioSciences, Johannesburg, South Africa 
Haemocytometer Bright-Line™ Hausser Scientific Company; Horsham, PA, USA 
Heating block Labnet International Inc.; NJ, US  
Homogenising Beads Qiagen; Hilden, Germany  
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Description Manufacturer  
Incubator (Galaxy R) RS Biotech; West Lothian, United Kingdom  
Inverted microscope (CKX 41) Olympus; NY, USA  
Magnetic Stirrer Lasec  
Mini Protean Tetra Cell Bio-Rad  
Multichannel Pipette Eppendorf  
Nikon Inverted fluorescence microscope  Nikon; NY, USA  
Orbital shaker Stoval life Science  
pH meter Lasec  
Pipette boy Labnet International; Edison, NJ, USA  
Pipettes (10 ,20, 100, 200, 300, 1000 µl) Eppendorf  
PowerPac HC Bio-Rad  
Scale United Scientific  
Glass bottles (100, 200, 1000 2000, 5000 ml) Lasec; Cape Town, South Africa  
SpectraMax i3 Molecular Devices, California, United States  
Tissue Lyser Qiagen   
Trans-Blot® TurboTM Bio-Rad  
Waterbath Memmert; Heilbronn, German  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
  182 | P a g e  
 
Reagents 
 
Description Manufacturer Catalogue Number 
10X Tris / Glycine / SDS Buffer (Running Buffer) Bio-Rad 161-0772 
4X Laemmli sample buffer Bio-Rad 161-0747 
Annexin- V Sigma-Aldrich A9210 
Anti-Amylin Abcam 115766 
Anti-BACE2 Abcam Ab5670 
Anti-Mouse IgG Santa Cruz Biotechnology sc-2318 
Anti-Rabbit IgG Santa Cruz Biotechnology sc-2357 
Anti-TMEM27 Abcam 200664 
Asp High Force Research Ltd; Durham, England batch: SZ1-356-54 
BACE Inhibition Assay Sigma-Aldrich CS0010 
BACE Inhibitor  BioVision 2299-5, 25 
Bovine serum albumin (BSA) Roche A4919 03117332001 
BrdU proliferation assay kit Cell Signalling 5492 
CaCl2 Sigma-Aldrich C5670 
Carbon dioxide (Co2) Air Products; Centurion, Cape Town, SA N/A 
Caspase – 3 / 7 Invitrogen™, ThermoFisher C10732 
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Description Manufacturer Catalogue Number 
CellTiter-Glo® Luminescent Cell Viability Assay Promegra G7571 
ClarityTM Western ECL Substrate Bio-Rad 170-5061 
COX2 Abcam Ab52237 
DCF Sigma-Aldrich 35848 
DCTM Protein Assay Reagent A Bio-Rad 500-0113 
DCTM Protein Assay Reagent B Bio-Rad 500-0114 
DCTM Protein Assay Reagent S Bio-Rad 500-0115 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich D4540 
DTT Sigma-Aldrich 43815 
Dulbecco's phosphate buffered saline (DPBS) Lonza BE17-513F 
Ethanol Sigma-Aldrich 32221 
Fetal bovine serum (FBS) - Gibco Thermo Fisher Scientific SH3007903HI 
Glucose Sigma-Aldrich G7021 
Glycine Sigma-Aldrich G7126 
Griess reagent Sigma-Aldrich G4410 
GRT Afriplex (Pty) Ltd., Paarl, South Africa N/A 
HCl Sigma-Aldrich H1758 
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Description Manufacturer Catalogue Number 
Hepes Lonza BE17-737E 
INS1 rat insulinoma cells Gift from Vrije Universiteit, Brussels, Belgium  
Instant Skimmed Powder Milk  SPAR - 
Interferon gamma (IFN-γ) Sigma-Aldrich I3275 
Interleukin-1 beta (IL-1β) Sigma-Aldrich I2393 
KCl Sigma-Aldrich P5405 
Liquid Nitrogen Air Products; Centurion, Cape Town, SA N/A 
Methanol Sigma-Aldrich 67-56-1 
MgCl2 Sigma-Aldrich M4880 
Mini-Protean® TGX Stain-FreeTM Gels  Bio-Rad 456-8044 
Molecular graded EtOH Sigma-Aldrich 34870 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoluim) Sigma-Aldrich M5655 
Na3VO4 Sigma-Aldrich S6508 
NaCHO3 Sigma-Aldrich S3817 
NaCl Sigma-Aldrich S5886 
NaF Sigma-Aldrich S7920  
NF-κB Phospho Cell Signalling 3033 
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Description Manufacturer Catalogue Number 
NF-κB Total Cell Signalling 8242 
Nitrate  Sigma-Aldrich 74246 
NP40 Sigma-Aldrich CA-630 (1-3021) 
PageRuler™ Prestained Protein Ladder Thermo Fisher Scientific 26619 
Phosphor inhibiting tablet  Roche 4906837001  
PMSF Sigma-Aldrich 78830 
Ponceau S Stain Sigma-Aldrich P23295 
PPAG High Force Research Ltd; Durham, England N/A 
Precision plus protein™, WesternC™ Bio-Rad 1610399 
Precision Protein™ StrepTactin-HRP Conjugate Bio-Rad 161-0381 
Propidium iodide Sigma-Aldrich P4170 
Protease inhibiting cocktail Roche 5892953001  
Quick Start™ Bradford Protein Assay Kit Bio-Rad  500-0203 
Rat IAPP ELISA Kit Elabscience E-EL-R2448 
Rat/Mouse Insulin ELISA Kit Merck  EZRMI-13K 
RestoreTM PLUS Western Blot Stripping Buffer Thermo Fisher Scientific 46430 
RNase  Sigma-Aldrich R6513 
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Description Manufacturer Catalogue Number 
Rosswell Park Memorial Institute 1640 (RPMI 1640) Lonza BE12-115F 
Sterile water Sigma-Aldrich W3500 
Transblot® TurboTM RTA Transfer Kit, LF PVDF Bio-Rad 170-4274 
Tris Sigma-Aldrich 93352 
Triton X114 Sigma-Aldrich 93422  
Tryphan Blue Invitrogen™, ThermoFisher T10282 
Tumor necrosis factor alpha (TNF-α) Sigma-Aldrich PMC3014 
Tween-20 Sigma-Aldrich 58980C 
β- Mercaptoethanol Sigma-Aldrich 60-24-2 
β-Tubulin Cell Signalling 2146 
 
Software 
Description Manufacturer 
ChemiDoc™ Touch Imaging System BioRad; California, USA 
Gen5 software (version 1.05) Bio-Tek Instruments 
GraphPad Prism 7 Graphpad Software; CA, USA 
ImageLab BioRad; California, USA 
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Description Manufacturer 
Leica Qwin Software Leica Microsystems; Nussloch, German 
Microsoft: Excel / Word / PowerPoint Microsoft Corporation; WA, USA 
NIS-Elements - Microscope Imaging Software Nikon; NY, USA 
SoftMax® Pro Molecular Devices; CA, USA 
Software, Accuri c6 BioSciences, Johannesburg, South Africa 
 
Consumables 
  
Description Manufacturer Catalogue Number 
Cell culture flask 25 cm2 Whitehead, Nest 707003 
Cell culture flask 75 cm2 Whitehead, Nest 708003 
Cell culture plate (black, 96 well) Lasec P1PLA045K-000096ST 
Cell culture plate (clear, 6 well) Lasec P1PLA044C-000006 
Cell culture plate (clear, 96 well) Whitehead, Nest 701001 
Cell culture plate (white, 96 well) Lasec P1pLA045W-000096ST 
Cell scrapers Whitehead, Nest 710001 
Cryogenic vial (2 ml) Greiner PGRE122279 
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Description Manufacturer Catalogue Number 
Eppendorf tube (2 ml) Eppendorf, Hamburg, Germany 22363344 
Filters (500 ml) Corning CR/430769 
Filters (syringes) Merck SLGP033RS 
Gel loading tips Whitehead 010-1-200µl 
Glass Pasteur pipet tips (aspirate) Lasec GLASP20M150 
Glass Tips (10, 25, 50 ml) (Pippeteboy) Lasec PLAS1PI033 
Pipette tips (10 ,20, 100, 200, 300, 1000 µl) Scientific group  AX/TF-300-L-R-S/S  
Reservoirs  Scientific group CR/4870 
Sterile falcon tube 15 ml Whitehead, Nest 601001 
Sterile falcon tube 50 ml Whitehead, Nest 602072 
Syringe-driven filters Merck Millipore SLGP033RS 
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Addendum F: Outputs from Study 
Conferences / symposiums 
Poster Presentations 
• Stellenbosch University, Faculty of Medicine and Health Sciences Annual Academic 
Day (30 August 2017): 
J. Burger, C.J.F. Muller, N. Chellan, J. Lopes; Beta secretase regulation and 
inflammation in pancreatic beta cells: the potential role of Rooibos. 
• Stellenbosch University, Faculty of Medicine and Health Sciences Annual Academic 
Day (29 August 2018): 
J. Burger, C.J.F. Muller, N. Chellan, J. Lopes; Beta secretase regulation and 
inflammation in pancreatic beta cells: the potential role of Rooibos. 
 
Oral Presentations 
• BRIP Research Symposium (16 October 2017): 
J. Burger, C.J.F. Muller, N. Chellan, J. Lopes; Beta secretase regulation and 
inflammation in pancreatic beta cells: the potential role of Rooibos. 
• European Association for the Study of Diabetes Scientist Training Course, Barcelona, 
Spain November 2017. 
N. Chellan, J. Burger, J-L Jansen van Vuuren, C. Muller, A novel assessment of the 
role of beta secretase in pancreatic beta  
• CoBNeST (PSSA) Conference (7- 10 October 2018): 
J. Burger, C.J.F. Muller, N. Chellan, J. Lopes; The effect of Rooibos phenolic 
compounds on inflammation in pancreatic β-cells. 
• BRIP Research Symposium (16 October 2018): 
J. Burger, C.J.F. Muller, N. Chellan, J. Lopes; Beta secretase regulation and 
inflammation in pancreatic β-cells: the potential role of Rooibos. 
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Addendum G: Electronic Copy 
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